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Summary 
Miniaturized liquid chromatography (LC) is ideally suited to reduce the resource consumption 
without compromising data quality in the analytical laboratory. However, the applicability and 
handling of miniaturized LC in routine analysis is often being questioned. In addition, only little 
information on the theoretical performance limits of this separation technique is available. 
Therefore, the aim of this study was the characterization of micro-liquid chromatography 
(micro-LC) from the theoretical and practical point of view. For the evaluation the development 
of a fast method for the analysis of antineoplastic drugs from wipe samples using micro-LC-
MS/MS was applied. The investigated analytes comprise polar as well as non-polar compounds. 
In addition, three critical peak pairs were included that either cannot be differentiated by mass 
spectrometry or are affected by ion suppression at co-elution. Therefore, a chromatographic 
separation was mandatory. Micro-LC was used as separation dimension using a column with 
an inner diameter of 300 µm due to the advantages of reduced resource consumption and high 
linear velocity leading to increased sample throughput. To achieve a chromatographic 
separation, a suitable chromatographic phase system was identified by principal component 
analysis (PCA). Afterwards, the column efficiency was investigated using van Deemter and 
kinetic plot analysis for isocratic and gradient elution. The results indicate a higher packing 
quality of the sub-2 µm fully porous particle packed column compared to larger particle 
diameters of various morphology. In addition, similar values for the reduced plate height were 
found in micro-LC compared to conventional column inner diameters (≥ 2.1 mm). The 
investigation of peak capacity also demonstrates the benefit of sub-2 µm fully porous particles 
for gradient times between 5 s and 5 min. Further optimization of the extraction efficiency, ion 
source parameters and system design was done to establish the method on basis of micro-LC-
MS/MS. This hyphenation technique enables to separate the target analytes within 2.5 min at a 
flow rate of only 25 µL min-1. Thereby the sample throughput can be increased by a factor of 2 
reducing the resource consumption by 98% compared to the previously used conventional LC-
MS/MS method. Method validation was accomplished to demonstrate that sensitivity and 
robustness of the developed method is given in a routine environment. Furthermore, it was 
shown that the method can be used to analyze real samples from hospital pharmacies in order 
to verify the reference value of 0.1 ng cm-2 for workplace contamination of antineoplastic drugs. 
In summary, it was exemplarily demonstrated that micro-LC can successfully replace 
conventional LC-MS in targeted ultrasensitive MS analysis. 
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Zusammenfassung 
Verfahren wie die miniaturisierte Hochleistungsflüssigkeitschromatographie (LC) sind ideal 
geeignet, um den Verbrauch an Ressourcen zu verringern ohne dabei die Datenqualität im 
analytischen Labor negativ zu beeinflussen. Nichtsdestotrotz wird die Anwendbarkeit dieser 
Technik in der Routineanalytik aufgrund der Handhabbarkeit oftmals kritisch hinterfragt. Des 
Weiteren sind nur wenige Informationen bezüglich der theoretischen Leistungsfähigkeit dieser 
Trenndimension verfügbar. Aus diesem Grund ist das Ziel dieser Arbeit die Charakterisierung 
der Mikro-Flüssigkeitschromatographie (Mikro-LC) aus Sicht der Theorie und Praxis. Zur 
Bewertung wurde die Entwicklung einer schnellen Analysenmethode ausgewählter Zytostatika 
von Wischproben mittels Mikro-LC-MS/MS verwendet. Die untersuchten Analyten umfassen 
dabei sowohl polare als auch unpolare Substanzen. Weiterhin sind drei kritische Peakpaare 
enthalten, bei denen entweder eine Ionensuppression bei Koelution beobachtet wird oder eine 
Unterscheidung mittels Massenspektrometrie nicht möglich ist. Aus den genannten Gründen ist 
eine chromatographische Trennung notwendig. Um dies zu erreichen, wurden Mikro-LC-
Säulen mit einem Innendurchmesser von 300 µm eingesetzt. Dies bietet neben dem reduzierten 
Verbrauch von Ressourcen den Vorteil, dass durch hohe lineare Fließgeschwindigkeiten ein 
erhöhter Probendurchsatz generiert werden kann. Um eine chromatographische Trennung zu 
erreichen, wurde ein geeignetes Phasensystem durch den Einsatz der 
Hauptkomponentenanalyse (PCA) identifiziert. Anschließend wurde die Effizienz 
miniaturisierter Trennsäulen mittels van Deemter und Kinetic Plot Analyse sowohl für die 
isokratische Arbeitsweise als auch für die Gradientenelution untersucht. Dabei stellte sich 
heraus, dass vollporöse Partikel mit einem Partikeldurchmesser von kleiner 2 µm (sub-2 µm) 
eine verbesserte Packungsqualität gegenüber größeren Partikeln unterschiedlicher Morphologie 
aufweisen. Weiterhin konnte festgestellt werden, dass im Vergleich zu konventionellen 
Innendurchmessern vergleichbare Packungsqualitäten erreicht werden können. Die 
Untersuchung der Peakkapazität für Gradientenlaufzeiten zwischen 5 s und 5 min ergab, dass 
mit vollporösen sub-2 µm Partikeln eine höhere Peakkapazität pro Zeiteinheit generiert werden 
konnte. Des Weiteren wurden neben dem Systemaufbau, die Extraktionseffizienz sowie die 
Ionenquellenparameter optimiert, um die Methode auf Basis der Mikro-LC-MS/MS zu 
etablieren. Durch diese Kopplung konnten die Komponenten innerhalb von 2.5 min bei einer 
Flussrate von lediglich 25 µL min-1 getrennt werden. Dadurch konnte der Probendurchsatz um 
den Faktor 2 bei gleichzeitiger Reduzierung der Ressourcen um 98% im Vergleich zur zuvor 
etablierten konventionellen LC-MS/MS gesteigert werden. Anschließend wurden 
Validierungsdaten erhoben, um die Sensitivität und Robustheit der entwickelten Methode im 
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Routineumfeld zu demonstrieren. Anhand von Realproben aus Krankenhausapotheken wurde 
gezeigt, dass der Referenzwert für die Arbeitsplatzkontamination von Zytostatika von 
0,1 ng cm-2 mittels der Methode überprüft werden kann. Damit konnte exemplarisch gezeigt 
werden, dass die Mikro-LC qualifiziert ist, die konventionelle LC-MS im Bereich der ultra-
sensitiven Targetanalytik zu ersetzen. 
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Chapter 1 Introduction and theoretical background 
1.1 Introduction 
Every year, the Global Footprint Network calculates the so-called Earth Overshoot Day on the 
basis of the world biocapacity and ecological footprint [1]. This day specifies the date on which 
the naturally resources of one year are exhausted. Whereas the Earth Overshoot Day was on the 
19th of December in 1987, the date continuously moves forward to the 8th of August in 2016 
demonstrating that the exploitation of natural resources has increased drastically. Therefore, 
sustainable processes are needed to ensure the ecological health of the earth in the future. Of 
course this development also comprises the analytical laboratory. Beside the reduction of 
energy consumption, the more efficient use of resources is one of the main objectives. 
Liquid chromatography (LC) is nowadays one of the most important separation technique. Its 
fundamentals were first discovered by Michail Semjonowitsch Tswett in 1903 [2-4]. Almost 
50 years later, Martin and Synge were awarded the Nobel Prize for their work on partition 
chromatography [5, 6]. The first commercially available liquid chromatography system was 
developed by Jim Waters in 1964 [7]. Until today, the system design has been further developed 
and improved several times. Today, LC systems are capable of 1,500 bar system pressure using 
reduced column inner diameters (i.d., 0.075 - 2.1 mm) packed with small particles (dp, 
1.3 – 3.0 µm) of various morphology [8-11]. Today it is also known as ultra-high performance 
liquid chromatography (UHPLC) [12-14]. The design of a liquid chromatography system is 
schematically depicted in Figure 1.1. 
 
Figure 1.1: Illustration of the general system design of a liquid chromatography system. 
One fundamental desire in liquid chromatography is to achieve more efficient separations in 
faster analysis time [15-17]. To that end, the development of miniaturized column inner 
diameters was identified as the most promising approach. It was early recognized that small i.d. 
columns have several advantages like reduced solvent consumption as well as improved 
compatibility to mass spectrometry [18]. Further advantages are discussed in more detail in the 
following. Depending on the column i.d., liquid chromatography can be divided into different 
categories as illustrated in Table 1.1. 
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Table 1.1: Classification of liquid chromatography depending on the column inner diameter and 
resulting flow rate range. It must be noted, that the specified flow rate ranges are only a rough 
classification. 
Analytical LC 
Category Column i.d. / mm Flow rate range / µL min-1 
(U)HPLC 
4.6 1000 - 2000 
3.0 500 - 1000 
UHPLC 
2.1 300 - 500 
1.0 100 - 300 
Miniaturized LC 
Category Column i.d. / mm Flow rate range / µL min-1 
Micro-LC 
0.5 20 - 100  
0.3 5 - 50 
Nano-LC 
0.1 0.5 - 2 
0.075 0.1 - 0.5 
 
Whereas at the beginning of HPLC, column i.d.s of 4.6 mm were used, there has been a 
subsequent reduction of the inner diameter up to today. Nevertheless, this dimension is still 
standard in many laboratories. However, with introduction of UHPLC and mass spectrometry, 
the column inner diameter decreases to 1.0 - 2.1 mm due to the improved flow rate 
compatibility with common ion sources. This trend continues to even smaller column i.d.s 
depending on the field of application. Nowadays, miniaturized LC systems that can be used 
with column inner diameters between 0.075 - 0.5 mm are available. In addition, the 
miniaturization is accompanied with a consequent reduction of the flow rate in the 
nL min-1 - µL min-1 range. The usage of miniaturized LC was early discussed in the literature 
[19-21]. Tsuda and Novotny were among the first pioneers using microbore liquid 
chromatography columns with an i.d. of 50 µm to 200 µm [22]. Scott and Kucera demonstrated 
the potential of miniaturized separation techniques in a series of impressive contributions [23-
27]. For example, the authors investigated the performance of 1 m long columns of various i.d. 
between 1 mm and 500 µm packed with particle diameters between 5 µm – 35 µm using a 
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specially designed UV detection with a cell volume of only 1-3 µL. Impressively, they reported 
reduced plate heights of almost 2 for 20 µm particles at a retention factor of 1.8 which represents 
a good column packing quality as will be discussed below. In addition, they mentioned the 
advantage of increased heat dissipation of miniaturized columns, which is nowadays known as 
frictional heating [26]. However, the corresponding chromatograms were either characterized 
by long analysis times or decreased resolution when applying shorter columns. In general, the 
system designs of former times were not suitable to successfully apply small i.d. columns for 
several reasons. 
At the beginning of using miniaturized column i.d. conventional HPLC systems were applied 
using flow splitters to reduce the flow rate [22]. This approach has several disadvantages 
because flow splitting can affect system robustness since the resulting flow rate can be 
influenced by temperature changes as well as clogging. Therefore, specially designed 
miniaturized LC systems were developed. Renewed interest in the field of miniaturized 
separation technique was given by the inspiring work of Joergensen et al. in 1999 [28-30]. The 
group developed a miniaturized LC system on the basis of syringe pumps capable of 9,000 bar 
maximum pressure using a column i.d. of only 33 µm packed with 1.0 µm non-porous particles 
demonstrating the potential of miniaturized LC with improved equipment [29]. 
Nowadays, most of the commercially available miniaturized liquid chromatography systems 
are based on flow meters using pneumatic syringe pumps controlled by the so-called 
microfluidic flow control (MFC) or automatic flow control (AFC) depending on the 
manufacturer instead of conventional piston pumps to ensure flow rate accuracy and to 
minimize the influence of pulsation which is of utmost importance when utilizing small flow 
rates. When using pneumatic syringe pumps, a flow calibration of the flow meters depending 
on the mobile phase viscosity and temperature needs to be done. During operation, the flow 
meter monitors the pressure drop of the individual solvent channel and sends a signal to the 
controller that is connected to the pressure source. The main task of the controller is the 
adjustment of the pressure source to regulate the flow rate. By changing the pressure, the flow 
rate is automatically adjusted according to the flow calibration. The pressure is established by 
a connected gas stream like nitrogen. Dedicated miniaturized systems are characterized by low 
gradient delay volumes (Vdwell). The gradient delay volume includes the volume from the point 
of mixing of the mobile phases to the head of the column. This volume is responsible for the 
involuntary isocratic step at the beginning of every solvent gradient and leads to a temporal 
offset of the separation. Moreover, analytes eluting within this time-frame cannot be affected 
by the gradient. Figure 1.2 shows a schematic representation of the gradient delay volume. 
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Figure 1.2: Illustration of the gradient delay volume for binary mixing LC systems. 
Figure 1.3 demonstrates the influence of the gradient delay volume for different Vdwell at a flow 
rate of 40 µL min-1 which is a standard flow rate for 0.3 mm - 0.5 mm i.d. columns. A delay 
volume of 500 µL represents a typical value for a conventional HPLC system, whereas using a 
fully optimized UHPLC system, a gradient delay volume of 50 µL can be achieved. In contrast, 
specially designed miniaturized LC systems are characterized by a Vdelay in the range of only 
1 µL. 
 
Figure 1.3: Illustration of the influence of the applied flow rate and gradient delay volume on the 
gradient delay time. 
As can be identified from the double logarithmic plot, it takes 12.5 min until the gradient 
reaches the column at a flow rate of 40 µL min-1 using a HPLC system having a delay volume 
of 500 µL. Reducing Vdwell to 50 µL leads to a gradient delay time (tdwell) of 1.25 min for an 
optimized UHPLC system. These values clearly demonstrate the necessity of decreasing the 
gradient delay volume when using low flow rates and miniaturized column i.d to achieve fast 
separations. For a gradient delay volume of 1 µL in a dedicated miniaturized LC system tdwell is 
only 0.025 min and thereby an immediate effectiveness of the gradient can be ensured. Another 
0.1 1 10 100 1000
0.001
0.01
0.1
1
10
100
1000
10000
t
dwell
: 12.5 min
t
dwell
: 1.25 min
t
dwell
: 0.025 min
ti
m
e
 /
 m
in
F / µL min
 V
dwell
: 1 µL
 V
dwell
: 50 µL
 V
dwell
: 500 µL
flow rate: 40 µL min
-1
Chapter 1: Introduction and theoretical background  16 
 
important characteristic of miniaturized LC system is the reduced extra-column volume which 
is a decisive parameter when using small i.d. columns to utilize the separation performance of 
the column. The influence of the extra-column volume on column performance was already 
discussed in the 1970’s by Kirkland [26, 31] and is still one of the most important parameters 
when designing new LC instrumentation [32]. In general, this volume is responsible for extra-
column band broadening and all components of a LC system are contributors. In general, a 
measure for band broadening in the chromatographic system is the peak variance (σ2) of a 
Gaussian elution profile [29, 33, 34]. According to the Equation 1.1, the number of theoretical 
plates can be calculated by the square of the ratio of the retention time (tR) and the standard 
deviation (σ) of the Gaussian peak. 
𝑁 = (
𝑡𝑅
𝜎
)
2
 Equation 1.1 
The total system variance (σ²v,total) is defined as the sum of the variances of the different LC 
system components as shown in Equation 1.2. 
𝜎𝑣,𝑡𝑜𝑡𝑎𝑙
2 = 𝜎𝑣,𝑖𝑛𝑗
2 + 𝜎𝑣,𝑐𝑎𝑝
2 + 𝜎𝑣,𝑐𝑜𝑙
2 + 𝜎𝑣,𝑑𝑒𝑡
2  Equation 1.2 
where σ²v,inj is the variance caused by the injector, σ²v,cap the variance of the connection 
capillaries, σ²v,col the column variance and σ²v,det the contribution of the detector. In general, the 
extra-column variance (σ²ec) including σ²v,inj, σ²v,cap and σ²v,det should be at least a factor of 4-10 
smaller than the column variance to avoid excessive loss of separation performance [35]. It is 
therefore an important aim to minimize the contribution of extra-column system components to 
achieve a more favourable ratio between the column and extra-column variance in order to 
utilize the full performance of miniaturized columns. When an LC system with unfavourable 
extra-column variance is used for small i.d. columns, the extra column band broadening 
significantly affects the separation performance because the small peak volumes achieved on 
the chromatographic column gets broadened leading to decreased separation power. The 
variance caused by the connection capillaries typically contributes strongly to the overall extra-
column variance. It can be reduced by decreasing the inner diameter of the connection 
capillaries. For analytical LC columns, the inner diameter of the capillaries is typically in the 
range of 100 µm - 250 µm. In contrast, for miniaturized LC columns a further reduction of the 
capillary i.d. to 25 µm - 75 µm is mandatory to avoid a pronounced loss of separation 
efficiency. To identify the appropriate capillary inner diameter for miniaturized LC, Figure 1.4 
demonstrates the influence of the capillary i.d. on the resulting separation using a common LC 
performance mix on a 50 x 0.3 mm micro-LC column as defined in Table 1.1. 
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Figure 1.4: Resulting chromatograms for the separation of a common performance mix on a 
50 x 0.3 mm column using different outlet capillary inner diameters. a) 25 µm, b) 50 µm, c) 75 µm 
and d) 100 µm. 
It can be seen from Figure 1.4 a) and b) that the inner diameter of the connection capillary 
should be between 25 µm - 50 µm because no significant performance differences between the 
obtained chromatograms can be identified. A further increase of the i.d. to 75 µm or 100 µm 
leads to a decrease in sensitivity as well as to a loss of separation efficiency as can be seen for 
the resolution between the compounds 4 and 5 in Figure 1.4 c) and d) which continuously 
decreases from 2.02 for the 25 µm i.d. capillary to 1.47 for the 100 µm connection tubing. Since 
no significant differences between Figure 1.4 a) and b) are observed, an inner diameter of 50 µm 
should be used for a 0.3 mm i.d. column due to the reduced back pressure. 
To further emphasize the importance of the extra-column variance, the variance of a 
chromatographic peak obtained on the column can be calculated for the example of a 
50 x 0.3 mm micro-LC column, a porosity (ε) of 0.7, a number of theoretical plates (N) of 
10,000 and a retention factor (k) of 2 using Equation 1.3. 
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𝜎𝑣,𝑐𝑜𝑙𝑢𝑚𝑛
2 =
𝜀2 ∙ 𝜋2 ∙ 𝑟𝑐
4 ∙ 𝐿2
𝑁
(1 + 𝑘)2 Equation 1.3 
According to Equation 1.3, the column variance is only 5.5 x 10-3 µL2. Based on the 
requirement of at least a factor 4 smaller extra-column variance compared to the column 
variance, σ²ec has to be in the order of 1.4 x 10-3 µL2. Whereas fully optimized conventional LC 
systems have a σ²ec of 2.4 µL² [32], miniaturized LC systems are characterized by an extra-
column variance in the order of 10-2 µL2 demonstrating the need of further minimization [35]. 
This could be one reason why earlier the applicability of small i.d. columns was not successful 
although the theoretical background and advantages of micro-LC were already well known [19-
21].  
As indicated in Equation 1.2, the variances and therefore the i.d. of the connection tubings need 
to be considered for reduced inner diameter columns. In general, when a liquid flows through 
a capillary a laminar flow profile forms, which is illustrated in Figure 1.5. 
 
Figure 1.5: Illustration of the formed laminar flow profile and resulting velocity flow paths in a 
capillary. 
Because of the resulting flow profile there are regions with different flow velocities as indicated 
by the arrows. The flow velocity continuously decreases from the center to the capillary wall 
and is zero at the wall due to friction [36]. As a consequence, the migration for each analyte 
molecule is different depending on the current position in the tubing and resulting velocity. 
Therefore, it is important that the molecules are able to cross the different velocity regions by 
diffusion to experience different flow velocities in order to obtain a sharp analyte band. Figure 
1.6 shows a computational fluid dynamic (CFD) simulation of the resulting peak profiles in a 
capillary assuming enabled and disabled analyte diffusion [37]. 
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Figure 1.6: Illustration of the resulting peak profile simulated for enabled and disabled analyte 
diffusion in an unfilled capillary [37]. Parameter: capillary length: 30 cm, inner diameter: 50 µm, 
flow rate: 1 µL min-1, mobile phase: methanol, analyte: toluene. The diffusion coefficient was 
calculated according to the Wilke-Chang equation (see Chapter 5.3.1). 
As can be seen it is of utmost importance that the analytes diffuse into different regions where 
the flow velocities are different. Otherwise, a pronounced peak tailing can be observed. 
However, these diffusion processes are time-dependent and therefore controlled by the analyte 
diffusion coefficient. The smaller the analyte the higher the diffusion coefficient which leads to 
faster migration between the flow paths. In addition to the capillary inner diameter, the column 
cross section is also an important parameter that affects the time an analyte molecule needs to 
diffuse from the column wall to the center of the column and therefore from a region with low 
flow velocity to the faster velocity section to obtain a small peak width on the chromatographic 
column. The time the analyte needs to diffuse from the column wall to the center of the column 
is also known as critical diffusion time (tD) which is shown in Equation 1.4 [30]. 
𝑡𝐷 =
𝑟2
2 ∙ 𝛾 ∙ 𝐷𝑚
 Equation 1.4 
where r is the column radius, γ the tortuosity factor and Dm the molecular diffusion coefficient. 
Decreasing the column i.d. consequently leads to a reduction of tD and a faster radial diffusion 
of the analyte is possible. Thereby, the analyte band is compressed and sharper peak profiles 
are obtained. Figure 1.7 illustrates the resulting tD for different column i.d. and molecular 
diffusion coefficients. 
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Figure 1.7: Illustration of the resulting critical diffusion time (tD) depending on the column inner 
diameter and analyte diffusion coefficient for the lower molecular weight compound naphthalene 
and higher mass substance etoposide. The diffusion coefficients were calculated according to the 
Wilke-Chang equation (see Chapter 5.3.1). 
As becomes clear, decreasing the column i.d. from e.g. 4.6 mm to 0.3 mm reduces tD from 
2260 s to 9.6 s for the lower molecular weight compound naphthalene, whereas for the lower 
diffusion coefficient analyte etoposide tD decreases from 4740 s to 20 s demonstrating the 
benefit of miniaturized column i.d. By decreasing the column i.d., tD is reduced by the factor of 
236 independently of the molecular diffusion coefficient. Reducing the tubing and column i.d. 
has another important advantage regarding the linear velocity (u0). According to the continuity 
equation shown in Equation 1.5, the linear velocity increases for incompressible fluids when 
the radius is decreased [38]. 
𝑄 = 𝐴1 ∙ 𝑣1 = 𝐴2 ∙ 𝑣2 Equation 1.5 
where A1 and A2 are the cross-sectional areas of a column or tubing, v1 and v2 are the flow 
velocities and Q the volume based velocity. For a given Q obtained for a defined cross-sectional 
area A1 and a velocity v1, the velocity v2 increases when the cross-sectional area A2 decreases 
to obtain a constant volume based velocity. As a consequence, the separation speed in liquid 
chromatography increases with decreasing inner diameter when a constant flow rate is used. 
This property is demonstrated in Figure 1.8 where the u0 is plotted versus the column i.d. 
assuming a flow rate of 40 µL min-1, a column length (L) of 50 mm and a porosity of 0.7. 
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Figure 1.8: Illustration of the resulting linear velocity depending on the column inner diameter 
for a flow rate of 40 µL min-1. 
As becomes clear, at a constant flow rate of e.g. 40 µL min-1 a significant increase of the linear 
velocity can be observed when the column i.d. is reduced below 1.0 mm. An even more 
pronounced shift of u0 can be observed when changing the column i.d. from 0.5 mm to 0.3 mm 
demonstrating the benefit of 0.3 mm i.d. columns and smaller. This property directly leads to 
increased separation speed. For example, u0 is 0.28 mm s
-1 for a 2.1 mm i.d. column which is 
the standard dimension for LC-MS whereas a linear velocity of 13.6 mm s-1 can be achieved at 
the same flow rate and column length using a column inner diameter of 0.3 mm. On the other 
hand, to achieve similar separation speed the flow rate needs to be increased for an enlarged 
inner diameter. This dependency is illustrated in Figure 1.9 under consideration of a u0 of 
13.6 mm s-1. 
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Figure 1.9: Illustration of the resulting flow rate depending on the column inner diameter to 
achieve a linear velocity of 13.6 mm s-1. 
It can be identified that e.g. a flow rate of approximately 4 mL min-1 is necessary to obtain a 
similar separation speed for a 3.0 mm i.d. column compared to only 40 µL min-1 using a column 
inner diameter of 0.3 mm. This is an undisputed benefit of miniaturized separation techniques 
because a lower flow rate leads to faster separations with decreased solvent consumption 
reducing the cost for purchase and disposal of organic solvents at the same time in terms of 
green analytical chemistry [18, 39-41]. However, the influence on column performance at 
increased linear velocities must be considered as shown below. The flow rate reduction is 
consequently advantageous when certain detection techniques are coupled to liquid 
chromatography. Especially aerosol based detectors benefit from low flow rates due to the 
smaller volume of organic solvent that needs to be evaporated and removed [18]. In particular 
the hyphenation to mass spectrometry (MS) is favoured by decreased flow rates due to the 
increased ionization efficiency as was demonstrated by Shen et al [42]. However, the common 
ion sources are developed to handle high flow rates up to several millilitres per minute. 
The miniaturization of liquid chromatography has not only advantages. Considering the loading 
capacity of small i.d. columns, the injection volume needs to be decreased to avoid both mass 
and volume column overloading. Mass overloading occurs due to the high amount of analytes 
injected onto the column. The number of analyte molecules is too high compared to the capacity 
of the stationary phase resulting in triangular peak shapes. In contrast, volume column 
overloading is caused by unusual high injection volumes which leads to broad but symmetrical 
peak shapes sometimes associated with a formation of a plateau. For an ideal chromatography, 
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the injection volume should be chosen to be around less than 10% of the column void volume 
(Vcol,eff) [43]. The column void volume can be calculated according to Equation 1.6. 
𝑉𝑐𝑜𝑙,𝑒𝑓𝑓 = (
𝑑𝑐
2
)
2
∙ 𝜋 ∙ 𝐿 ∙ 𝜖 Equation 1.6 
As can be seen, the effective column volume depends on the column inner diameter, column 
length and porosity. Therefore, a drastic reduction of the injection volume is necessary to ensure 
optimum chromatographic conditions when small i.d. columns are used. The relation between 
the column i.d. and optimum injection volume is depicted in Figure 1.10. 
 
Figure 1.10: Illustration of the optimum injection volume depending on the column inner 
diameter. 
The optimum injection volume decreases from 58 µL for a standard 4.6 mm column to 12 µL 
for the preferred conventional LC-MS 2.1 mm i.d. column whereas for miniaturized column 
inner diameters such as 0.3 mm a decreased injection of only 0.25 µL should be used. As a 
consequence, the injected mass is dramatically decreased for small i.d. columns. This seems 
disadvantageously for mass-dependent detection techniques like mass spectrometry and it is 
often being stated that miniaturized column i.d. is only advantageously when the sample volume 
is limited [18]. However, the reduced injected mass has two further advantages. First, the 
chromatographic band gets less diluted by the column volume. Therefore, small i.d. columns 
will always lead to higher sensitivity at constant injection volumes no matter if concentration- 
or mass-dependent detectors are used as shown in Figure 1.11 [39, 44]. 
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Figure 1.11: Illustration of the resulting sensitivity at a constant injection volume of 7 µL for a 
column i.d. and flow rate of a) 4.6 mm at 1.4 mL min-1, b) 3.9 mm at 1.0 mL min-1, c) 3.0 mm at 
0.6 mL min-1 and d) 2.1 mm at 0.29 mL min-1 [44]. 
Secondly, due to the reduction of injected mass, the amount of matrix ingredients is reduced 
leading to smaller amount of dirt that is introduced into highly sensitive detectors and 
consequently to extended cleaning intervals. That is an important characteristic because the 
absolute sensitivity or analyte response is not the decisive parameter. The parameter of interest 
for routine application is the signal-to-noise (S/N) ratio, which decreases with more 
contaminated equipment. To summarize, both the advantages as well as disadvantages 
regarding miniaturized column i.d. are illustrated in Figure 1.12. 
 
Figure 1.12: Illustration of both advantages and disadvantages of miniaturized LC. 
The chromatographic column is the heart of every separation. It is often being questioned 
whether small i.d. columns can provide the same separation efficiency like their conventional 
counterparts [18, 35, 45]. In the past, the packing quality of miniaturized columns seems to 
have been an issue why this separation dimension was not successfully applied. In addition, the 
commercial availability was limited. However, over the last years a development of stationary 
Chapter 1: Introduction and theoretical background  25 
 
phases with inner diameters below 1 mm has occurred and new generations of small i.d. 
columns became commercially available from several manufacturers like YMC or Waters [46, 
47]. Different chromatographic supports such as fully porous and core-shell particles with 
varying particle diameter were also introduced for miniaturized LC. In addition, monolithic 
columns synthesized in fused silica capillaries were developed [48].  
To evaluate the separation efficiency of chromatographic columns, different approaches were 
developed over the last 50 years. The most familiar one is the van Deemter analysis describing 
the column performance depending on the linear velocity and peak broadening effects [49, 50]. 
The van Deemter equation is shown in Equation 1.7 whereas the van Deemter plot is illustrated 
in Figure 1.13. 
𝐻(𝑢0) = 𝐴 ∙ 𝑑𝑝 +
𝐵 ∙ 𝐷𝑚
𝑢0
+ 𝐶 ∙
𝑑𝑝
2
𝐷𝑚
 Equation 1.7 
where H is the plate height, A the Eddy diffusion, dp the particle diameter, B the longitudinal 
diffusion and C the mass transfer.  
 
Figure 1.13: Illustration of the van Deemter plot including the Eddy diffusion (A), longitudinal 
diffusion (B) and the mass transfer (C). 
Considering the van Deemter equation, the plate height depends on the packing quality (A-
term), diffusion in longitudinal direction (B-term) and the mass transfer (C-term) of the analyte 
between the stationary phase and mobile phase. All parameters depend on the linear velocity. 
At the optimum linear velocity (uopt), the plate height is minimal (Hmin) as indicated by the 
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dashed circle. However, the efficiency depends on the particle diameter and molecular diffusion 
coefficient as shown in Equation 1.7 [51, 52]. Therefore, Giddings proposed the use of reduced 
parameters to achieve a fair comparison between various stationary phases of different particle 
diameter or morphology to evaluate the columns in terms of the packing quality using the 
reduced plate height (h) and reduced velocity (v) as shown in Equation 1.8 and Equation 1.9. 
[53, 54]. 
ℎ =
𝐻
𝑑𝑝
 Equation 1.8 
𝑣 =
𝑢0 ∙ 𝑑𝑝
𝐷𝑚
 Equation 1.9 
where h is the reduced plate height and v the reduced linear velocity. For well packed columns 
the minimum reduced plate height (hmin) should be 2-2.5 [8]. This equation directly enables to 
compare different stationary phases with varying particle diameter. In addition, differences in 
analyte diffusion coefficients are considered. Subsequently, Knox developed the Knox equation 
on the basis of reduced parameters to take these dependencies into consideration as illustrated 
in Equation 1.10 [54, 55]. 
ℎ(𝑣) = 𝑎 ∙ 𝑣
1
3⁄ +
𝑏
𝑣
+ 𝑐 ∙ 𝑣 Equation 1.10 
where a, b and c are dimensionless coefficients. To emphasize the difference of the van Deemter 
and the Knox equation, Figure 1.14 shows the obtained plots for two different columns packed 
with 1.9 µm fully porous particles and 2.7 core-shell particles. 
 
Figure 1.14: Comparison of a) the van Deemter and b) the Knox plot for 1.9 µm fully porous and 
2.7 µm core-shell particle packed columns. 
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According to Equation 1.7, pronounced differences of the minimum plate height (Hmin) between 
the two different columns can be observed as expected for the van Deemter plot in Figure 1.14 
a) due to the varying particle diameter. Considering the Knox plot in Figure 1.14 b), it can be 
demonstrated that the columns show a similar reduced plate height and therefore a comparable 
packing quality. This conclusion cannot be drawn from the van Deemter analysis. However, 
both equations include no information about the back pressure characteristic of a column which 
depends on mobile phase viscosity (η) and permeability (Kv0) [56, 57]. These parameters are 
especially important when trying to accelerate the separation. In addition, column efficiency 
can easily be improved by using a lower mobile phase viscosity or longer columns. To address 
this issue, Bristow and Knox introduced the theory of column separation impedance (E0) as 
illustrated in Equation 1.11 [55]. 
𝐸0 =
𝑡0
𝑁2
∙
∆𝑃
𝜂
=
𝐻2
𝐾𝑣0
= ℎ2 ∙ Ф Equation 1.11 
𝐾𝑣0 =
𝑢0 ∙ 𝜂 ∙ 𝐿
(∆𝑃𝑡𝑜𝑡𝑎𝑙 − ∆𝑃𝑠𝑦𝑠𝑡𝑒𝑚)
 Equation 1.12 
𝜙 =
𝑑𝑝
2
𝐾𝑣0
 Equation 1.13 
where ϕ is the flow resistance, ΔPtotal the total backpressure and ΔPsystem the pressure drop only 
caused by the LC system. The column permeability can be calculated according to Equation 
1.12 whereas the flow resistance is shown in Equation 1.13. 
The separation impedance is ideally suited to compare the performance of columns packed with 
different particles sizes and morphology [58]. However, as a dimensionless parameter, no direct 
information in terms of practical purposes can be obtained. Therefore, Giddings was the first 
who pointed out that the more straightforward way to compare different columns for practical 
applications is the time dependent ability to create separation performance [59]. Hans Poppe 
introduced plots of the so-called plate time as the ratio of the column void time (t0) and plate 
number (N) versus N (the so-called Poppe plots) as shown in Figure 1.15 [60]. 
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Figure 1.15: Illustration of a Poppe plot for 1.9 µm and 3.0 µm fully porous particles. 
Thereby, it can be directly identified how long it takes to create a theoretical plate depending 
on the applied particle diameter [60]. In 2005, Desmet and co-workers established 
transformation equations to obtain several versions of the so-called kinetic plot limits [56, 61]. 
These types of plots directly enable to compare columns at maximum pressure and therefore at 
maximum efficiency and to visualize which length it takes to create a certain efficiency. The 
comparison at maximum pressure is useful due to the proportionality of efficiency, column 
length and back pressure as illustrated in Equation 1.14 and Equation 1.15. Higher pressure 
capabilities enable to use longer columns to achieve higher efficiency. Therefore, it is 
straightforward to compare different columns at maximum pressure. 
Until today, the kinetic plot theory has been expanded to gradient elution and is the ideal tool 
to design a chromatographic system on the basis of the underlying requirements [61-63]. In the 
following, the theoretical derivation of the kinetic plot theory is shown for an isocratic 
transformation. Equation 1.14 illustrates the calculation of the back pressure (ΔP) depending 
on the mobile phase viscosity (η), column length (L), linear velocity (u0) and column 
permeability (Kv0). 
∆𝑃 =
𝜂 ∙ 𝑢0 ∙ 𝐿
𝐾𝑣𝑜
 Equation 1.14 
The column length can be replaced by Equation 1.15. 
𝐿 = 𝑁 ∙ 𝐻 Equation 1.15 
The obtained equation can be transformed leading to Equation 1.16. 
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𝑁 = (
∆𝑃
𝜂
) ∙ [
𝐾𝑣0
𝐻 ∙ 𝑢0
]
𝑒𝑥𝑝
 Equation 1.16 
This equation can be transformed to calculate the column void time (t0) by introducing Equation 
1.17. 
𝑡0 =
𝐿
𝑢0
=
𝑁 ∙ 𝐻
𝑢0
 Equation 1.17 
Inserting Equation 1.16 into Equation 1.17 leads to Equation 1.18. 
𝑡0 = (
∆𝑃
𝜂
) ∙ [
𝐾𝑣0
𝑢0
2 ]
𝑒𝑥𝑝
 Equation 1.18 
Since all parameter are linked to the van Deemter analysis, all experimentally obtained van 
Deemter data can be transferred into a couple of N and t0 data to illustrate the time needed to 
achieve a certain number of theoretical plates. The transformation is shown in Figure 1.16. 
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Figure 1.16: Transformation of experimentally obtained H(u0) data to the more practical relevant 
plot of t0 versus N. 
This type of plot can be used to identify a column void time which depends on the applied flow 
rate to obtain a certain number of theoretical plates. As mentioned above, the kinetic plot theory 
directly enables to compare columns at maximum pressure (ΔPmax) by replacing the 
experimental ΔP with ΔPmax of the column or applied LC system leading to Equation 1.19 and 
Equation 1.20. 
𝑁 = (
∆𝑃𝑚𝑎𝑥
𝜂
) ∙ [
𝐾𝑣0
𝐻 ∙ 𝑢0
]
𝑒𝑥𝑝
 Equation 1.19 
𝑡0 = (
∆𝑃𝑚𝑎𝑥
𝜂
) ∙ [
𝐾𝑣0
𝑢0
2 ]
𝑒𝑥𝑝
 Equation 1.20 
The resulting transformation is depicted in Figure 1.17. 
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Figure 1.17: Illustration of the transformation of experimentally obtained N and t0 data to the 
kinetic plot limit at maximum pressure. 
Now the experimentally obtained N and t0 data are transformed to the maximum pressure as 
indicated by the full line arrows, illustrating the maximum performance that can be achieved 
using this chromatographic support. This type of plot allows for the fairest comparison between 
different stationary phases since the performance is compared at maximum efficiency. 
Despite all described advantages, the acceptance of miniaturized separation techniques is still 
limited preventing the extension of this technique. The usage is often restricted to certain fields 
of applications as e.g. bioanalysis, where the sample volume is limited [18]. Small i.d. columns 
are favourable due to the decreased dilution by the column and commonly nano-LC with an i.d. 
of 0.1 mm and less are used [39]. However, the question arises how the applicability of 
miniaturized LC systems can be extended to different fields of application where the sample 
volume is not a limiting factor. Especially the robustness and handling is often being questioned 
[64] when small i.d. columns are applied compared to conventional inner diameters (≥ 2.1 mm). 
Due to the small resulting column volumes, decreased column i.d. are more vulnerable to extra-
column band broadening as discussed above. This becomes even more pronounced for nano-
LC or chip-LC compared to micro-LC due to the further reduction of the column i.d. from 
300 µm for micro-LC to 100 µm and less for nano-LC or chip-LC. In addition, when using 
nano-LC or chip-LC often dedicated detection capabilities are necessary leading to additional 
cost for the purchase of specialized equipment. For example, dedicated nano-LC ion sources 
are needed for the hyphenation to mass spectrometry which are often characterized by 
complicated handling. In general, mass spectrometry is nowadays the detection of choice due 
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to the possibility of separating compounds by their mass-to-charge (m/z) ratio. Several 
manufacturers responded to this issue by introducing specialized systems to simplify the usage. 
One example is the so-called IonKey introduced by Waters in 2014 [65]. However, it would be 
much more straightforward to use already existing equipment without the need of additional 
high investments and to increase sample throughput at the same time. In addition, the 
advantages of high linear velocity at low flow rates and decreased critical diffusion times should 
be maintained. Especially, the high linear velocity is of interest to achieve fast separations and 
decreased analysis cycle times. Thereby, the sample throughput can be significantly increased 
leading to a high return of invest for routine laboratories applying LC-MS. This can be achieved 
by using column inner diameters of 0.3 µm as shown in Figure 1.6 - Figure 1.9 using dedicated 
micro-LC systems. These systems can be used with column i.d. between 0.1-1.0 mm and are 
cheaper to purchase than an additional mass spectrometer to handle a higher number of samples. 
Moreover, the increase of column i.d. to 0.3 mm compared to 0.1 mm leads to increased loading 
capacity by a factor of approximately 10. In addition, already established mass spectrometers 
can be used without the need of dedicated ion sources. The only necessary modification is the 
change of the inner diameter of the emitter tip to reduce extra-column band broadening. 
Therefore, micro-LC used with a column i.d. of 0.3 mm is ideally suited and represents the most 
promising approach to combine the properties of high linear velocities, decreased analysis cycle 
times and sufficient loading capacity at reduced flow rates with conventional detection 
techniques. In addition, the influence of the extra-column volume is less pronounced for 0.3 mm 
i.d. columns compared to even smaller inner diameters. However, only a few reports about the 
performance of micro-LC columns as well as the applicability in high throughput analysis in 
routine environments are available.  
When developing an LC method, there is one equation that illustrates the influence parameter 
of resolution (R) in liquid chromatography. This equation is also known as Purnell equation 
[66, 67] and is shown in Equation 1.21 and Equation 1.22 both for isocratic and gradient elution. 
𝑅 =
1
4
∙ √𝑁 ∙ (𝛼 − 1) ∙
𝑘
𝑘 + 1
 Equation 1.21 
𝑅 =
1
4
∙ √𝑁∗ ∙ (𝛼∗ − 1) ∙
𝑘∗
𝑘∗ + 1
 Equation 1.22 
where N is the number of theoretical plates, α the selectivity and k the retention factor, N*, α*, 
k* are the corresponding values in gradient elution. As can be seen, there are three parameters 
affecting the chromatographic resolution with different impact as shown in Figure 1.18. 
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Figure 1.18: Illustration of the resulting chromatographic resolution depending on column 
efficiency (N), analyte retention (k) and selectivity (α). For the calculation an α of 1.03, a k of 3 and 
an N of 5,000 was used. 
The lowest impact on resolution can be achieved by increased retention. However, retention is 
necessary otherwise no resolution is obtained. Although the efficiency of the chromatography 
shows a medium influence on resolution, chromatographic separations are often achieved by 
increased efficiency when using for example longer columns or smaller particle diameter as 
shown in Chapter 7. However, large changes in efficiency have only a limited influence on 
resolution, whereas the selectivity (α) is of utmost importance to be able to resolve compounds 
during chromatography. Small changes of α lead to a significant increase in resolution which is 
especially important when isobaric compounds are included that need to be resolved by 
chromatography. 
1.2 Scope of the thesis 
The aim of this work was the characterization of micro-LC systems from theoretical and 
practical points of view. Moreover, method development and implementation of a robust and 
reliable method for the analysis of antineoplastic drugs from wipe samples is performed to 
replace conventional LC-MS and to demonstrate the potential of this separation dimension. 
Antineoplastic drugs are applied during cancer therapy and are differentiated by their 
mechanism of action [68]. In general, this class of compounds is of high interest due to the 
possibility of occupational exposure for healthcare workers [69]. The selected range of analytes 
comprises the most frequently used pharmaceuticals and include polar as well as non-polar 
compounds. In addition, isobaric compounds are included that cannot be differentiated by MS. 
Therefore, a chromatographic separation is mandatory and challenging. Figure 1.19 illustrates 
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the different parts of the investigation to characterize the micro-LC dimension to establish a 
method on the basis of micro-LC-MS/MS. 
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Figure 1.19: Graphical overview of the thesis scope. 
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During this work the influence of selectivity is characterized by a column screening and 
subsequent data analysis by principal component analysis (PCA, see Chapter 2) whereas the 
efficiency is evaluated by van Deemter and kinetic plot theory (see Chapter 3 - Chapter 5) to 
demonstrate the benefit of such theoretical approaches for the real analytical world. All aspects 
and conclusions of these theoretical investigations are being used for the development of the 
final method (see Chapter 6) before analytical performance parameters are determined to 
evaluate the robustness of micro-LC-MS/MS for routine application. 
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Abstract 
Optimization of the chromatographic selectivity is the most important parameter if a separation 
is needed for the hyphenation of liquid chromatography with mass spectrometry. In mass 
spectrometry this is necessary if the investigated analytes have identical mass transitions, like 
isomers or epimers. For the separation of the twelve most important antineoplastic drugs, a 
selectivity screening was performed using 20 columns, two organic modifiers and temperatures 
to find a suitable phase system in order to separate critical peak pairs. Therefore, an evaluation 
strategy was applied in form of a principal component analysis (PCA), selectivity factor and 
overall selectivity comparison to find a suitable phase system. Some boundary conditions were 
defined to consider the specific requirements of tandem mass spectrometry. The results clearly 
indicated that the selectivity factor of the critical peak pairs is increased using methanol at 
higher temperature. 
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2.1 Introduction 
With the introduction of powerful mass spectrometers (MS), multi-component analysis comes 
into focus to save time and resources by including many target analytes into one method. For 
target analysis, triple quadrupole mass spectrometers are used for quantification using the 
multiple reaction monitoring (MRM) mode. Usually, two mass transitions are selected to 
identify and quantify the target compounds. The fast cycle times enable recording a high 
number of mass transitions in a short time. Therefore, a chromatographic separation of all 
analytes is often not deemed necessary if the analytes can be distinguished by their specific 
mass transitions. However, sometimes even the mass spectrometer reaches a limit. This 
especially occurs if the target components have identical mass transitions like isomers or 
epimers. At this point, the optimization of the chromatographic phase system, which is defined 
in this manuscript as combination of stationary phase, mobile phase and temperature, is 
mandatory to achieve a separation for an unequivocal identification and quantification. Besides 
that, the quality of mass spectrometric detection will increase when target compounds are well 
separated.  
However, the systematic evaluation of a suitable phase system can be time consuming and 
complex, if the procedure is governed by trial and error. In the pharmaceutical industry, method 
development is a crucial step. Once a method has been validated, a change in the separation 
conditions that leads to a revalidation is associated with high costs. Although there exist many 
approaches based on systematic method development, the explanation why a specific phase 
system has been chosen is usually not based on a statistical data evaluation. 
In the literature, many column tests are described to characterize the different retention 
mechanisms of the stationary phase to represent selectivity differences [1-5]. Usually, model 
components are used to determine specific parameters like hydrophobicity or silanol activity. 
Unfortunately, such tests only reveal which column chemistries provide the highest selectivity 
differences on the basis of the selected model compounds. For a specific separation problem, 
these tests can only hint at a possibly suitable column. Many different impact factors for 
selectivity changes are described. It is known that the type of the organic co-solvent as well as 
the column surface modification have a significant influence on separation selectivity [6-9]. 
Most studies revealed that methanol has a positive effect on separation selectivity due to its 
protic nature and lower elution strength [10]. Other influence factors are the column 
temperature [9, 11, 12] and mobile phase pH [7, 8]. 
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Several automated method scouting systems are available which offer the possibility to 
optimize the chromatographic resolution but not the selectivity of the phase system. Therefore, 
this study is focused on the question whether statistical methods like e. g. principal component 
analysis (PCA) can be used to unambiguously identify the best phase system which corresponds 
to the highest selectivity for a specific separation problem. This is demonstrated for a separation 
of the twelve most important cytotoxic drugs as part of a study of the European Society of 
Oncology Pharmacy (ESOP) [13]. These substances are applied during cancer therapy and are 
divided into several groups depending on their mode of action. The analyte spectrum includes 
polar and non-polar substances as well as acidic and basic compounds. Furthermore, three 
critical peak pairs can be identified that have to be resolved chromatographically. Additionally, 
for the polar compounds a retention factor higher than two is desirable to reduce ion suppression 
and matrix effects [14-16]. The selectivity screening was performed using 20 columns, two 
organic modifiers and two temperatures. 
2.2 Material and methods 
All measurements were performed on an Agilent 1200 system (Agilent Technologies, 
Waldbronn, Germany). In front of the pump a vacuum degasser is used. The binary pump offers 
the possibility to select four different mobile phases up to 600 bar with a gradient delay volume 
of 400 µL. The sample injection is done by a flow through autosampler with a loop volume of 
100 µL. Furthermore, a column oven with an integrated switching valve is used for temperature 
control of the stationary phase to ensure reproducible chromatographic conditions. For data 
acquisition, a diode array detector (DAD) is employed with a cell volume of 1.7 µL. The tubing 
in front of the column is made of stainless steel (SS) with an inner diameter (ID) of 125 µm. In 
the low pressure range, polyetheretherketone (PEEK) capillaries are used with the same inner 
diameter for the connection of the column to the DAD. For data acquisition and analysis the 
Chemstation for LC 3D Systems (Rev. B. 04.02 (96)) was used. Further data processing was 
done using Origin Lab v. 9.1 and Microsoft Excel 2010. 
Table 2.1 presents an overview of the investigated columns. Because of varying column 
dimensions, the flow rate as well as the injection volume had to be adapted [17]. In this way 
the results are directly comparable. The flow rate was adjusted to 350 µL min-1 and the injection 
volume was set to 2 µL for 2.1 mm ID columns. Due to the generic approach, a linear gradient 
was used with a gradient slope of 9.8% B min-1. Further adjustments of the gradient slope were 
not necessary because all investigated columns have identical column length. The column oven 
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temperature is varied between 30 and 50 °C. A lower temperature limit of 30 °C was chosen in 
order to avoid high back pressure for mobile phases containing methanol. An upper temperature 
limit of 50 °C was defined because of limited temperature stability of some of the selected 
columns. For data acquisition the UV-spectra between 190 - 800 nm are recorded. 
Table 2.1: List of the investigated columns. 
description surface modification particle end capping particle size / µm pore diameter / Å 
Agilent Zorbax SB C18 fully porous sterically protected 1.8 80 
ChromaNik Sunshell RP-Aqua C28 core-shell multistage 2.6 160 
Macherey Nagel Nucleoshell RP 
18plus 
C18 core-shell multistage 2.7 90 
Merck Chromolith FastGradient RP 
18e 
C18 monolithic fully endcapped macro pores 1.5 meso pores 130 
Phenomenex Kinetex C18 core-shell trimethyl silane 2.6 100 
Phenomenex Synergi RP polar ether-linked phenyl phase fully porous polar endcapped 2.5 100 
Restek Raptor ARC 18 C18 
core-shell 
sterically protected 
2.7 90 
Restek Raptor Biphenyl fully endcapped 
Supelco Ascentis Express 
C18 
core-shell trimethyl silane 2.7 90 
C8 
CN 
ES C18 
EPG a) Amide 
Phenyl-Hexyl 
TCI Kaseisorb LC ODS-SAX Super C18 + Anion-Exchange fully porous fully endcapped 3 120 
Thermo HypersilGold PFP fully porous fully endcapped 1.9 175 
Waters Acquity BEH C18 
fully porous fully endcapped 
1.7 130 
Waters HSS T3 C18 1.8 100 
Waters XBridge C18 2.5 130 
YMC Triart C18 fully porous multistage 1.9 120 
a) EPG = embedded polar group 
 
Water, acetonitrile and methanol were used as mobile phase constituents. All solvents were 
purchased from Th. Geyer-Chemsolute (Renningen, Germany) with purity for LC-MS. Formic 
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acid (FA), purchased from Sigma-Aldrich (Seelze, Germany) was used as solvent additive to 
adjust the pH of the mobile phase. A content of 0.1% FA was added to the mobile phases and 
analyte mixture, because it is more favorable for MS analysis of the selected antineoplastic 
drugs [18-21]. 
Table-S 2.1 shows a list of the selected substances including the provider of the drugs as well 
as important physico-chemical properties, while the structural formulas are compiled in Figure 
2.1. Stock solutions were prepared using dimethyl sulfoxide (DMSO) from Sigma Aldrich. This 
solvent was used to ensure high solubility of all substances in a sufficient concentration. For 
HPLC analysis the multicomponent standard was diluted with acidified water (0.1% FA) in the 
ratio of 1 to 10. The final concentration of all analytes was 0.1 mg mL-1 with a composition of 
90/10 (v/v) H2O/DMSO + 0.1% FA. 
 
Figure 2.1: Structures of the investigated compounds: (1) 5-fluorouracil, (2) gemcitabine, (3) 
methotrexate, (4) topotecan, (5) irinotecan, (6) ifosfamide, (7) cyclophosphamide, (8) doxorubicin, 
(9) epirubicin, (10) etoposide, (11) paclitaxel, (12) docetaxel [22]. Note: Only the neutral species 
are shown which are not necessarily present at the applied pH. 
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2.3 Results and discussion 
In order to compare different phase systems, Neue et al. choose a very illustrative way to 
express column differences [7, 23]. They plotted the retention factors of each investigated 
substance on two columns under certain analysis conditions against each other to compare the 
selectivity of different stationary phases. Afterwards, the correlation and the resulting variance 
were taken to quantify differences in selectivity. This kind of representation was also applied 
in this study to express the overall selectivity differences for the whole range of analytes 
depending on the applied separation conditions. To evaluate the selectivity change of the 
different columns in terms of the three critical pairs (ifosfamide/cyclophosphamide, 
doxorubicin/epirubicin, docetaxel/paclitaxel) the selectivity factor (α) can be calculated to 
express selectivity differences independent of the particle diameter of the stationary phase. 
The above-mentioned kind of representation was done for every column-, organic modifier- 
and temperature-combination for all investigated substances. For calculation of the retention 
factor (k, Equation-S 2.1) the injection signal, which is represented by the first distortion of the 
UV baseline, was used as column void time. Figure 2.2 shows an exemplary plot of the retention 
factors obtained on the Restek Raptor ARC-18 and YMC Triart C18 column. Because of the 
same surface modification a similar overall selectivity can be expected. 
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Figure 2.2: Overall selectivity comparison of the columns Restek Raptor ARC-18 and YMC Triart 
C18 under the following conditions. a) Mobile phase: H2O - ACN, column temperature: 30 °C; b) 
mobile phase: H2O - ACN, column temperature: 50 °C; c) mobile phase: H2O - MeOH, column 
temperature: 30 °C; mobile phase: H2O - MeOH, column temperature: 50 °C. Target compounds: 
() 5-fluorouracil, () gemcitabine, () methotrexat, () topotecan, () irinotecan, () 
ifosfamide, () cyclophosphamide, () doxorubicin, () epirubicin, () etoposide, () paclitaxel, 
() docetaxel. The dashed line represents the bisecting line. 
As can be seen, the retention is always higher for the Restek Raptor ARC-18 than for the YMC 
Triart C18 except for the polar compounds 5-fluorouracil and gemcitabine (Figure 2.2 a-d). In 
addition, methanol provides higher retention than acetonitrile due to its lower elution strength. 
Moreover, a better band spacing of all target compounds is obtained for methanol instead of 
acetonitrile. To prove this assumption, the separation of the coeluting compounds 
(irinotecan(), ifosfamide(), cyclophosphamide(), doxorubicin(), epirubicin(), 
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etoposide()) for every phase system can be compared. To that end, the ratio of the difference 
of the retention factor between the first and last eluting compound of this cluster Δ(klast-kfirst) to 
the actually available chromatographic space Δktotal was calculated as shown in Table 2.2. 
Table 2.2: Comparison of the utilization of the chromatographic space using acetonitrile and 
methanol at 30 °C and 50 °C. 
column Restek Raptor ARC-18 YMC Triart C18 Restek Raptor Biphenyl 
separation condition 
ACN MeOH ACN MeOH ACN MeOH 
30 °C 50 °C 30 °C 50 °C 30 °C 50 °C 30 °C 50 °C 30 °C 50 °C 30 °C 50 °C 
Δ(klast-kfirst) 1.40 1.61 3.03 2.87 0.98 1.03 2.30 2.09 1.67 1.91 2.86 3.04 
Δktotal 14.94 15.21 18.30 19.06 9.74 9.72 10.92 11.33 13.00 13.54 17.93 18.38 
Δ(klast-kfirst)/Δktotal / % 9.34 10.59 16.56 15.06 10.09 10.60 21.03 18.44 12.82 14.14 15.93 16.56 
 
The results clearly show that the use of methanol leads to a higher utilization of the available 
chromatographic space. For the YMC Triart C18, the distribution of the selected compounds is 
better when methanol is used compared to acetonitrile because 21% instead of 10% of the 
available retention space is covered at 30 °C. In general, the requirement for k ≈ 2 for polar 
compounds can be obtained for gemcitabine using methanol at 30 °C. At this point it should be 
stressed that the higher retention of the polar compounds can be explained by the lower elution 
strength of a mobile phase containing methanol instead of acetonitrile. In contrast, the higher 
coverage of the retention space when using methanol is based on the specific interactions. This 
leads to a more even distribution of all analytes across the gradient window which is not 
correlated with the lower elution strength of methanol when compared to acetonitrile. 
As depicted in Figure 2.2 d), increasing the temperature from 30 °C to 50 °C reduces the 
retention factor of the first eluting compounds due to the increasing elution strength of the 
mobile phase. This also applies to acetonitrile as co-solvent (Figure 2.2 b). For all other target 
compounds besides the polar analytes, the retention factors obtained on the Restek Raptor ARC-
18 column show always higher values. One possible explanation for this phenomenon could be 
the surface coverage of the particles which is different for both stationary phases. High surface 
coverage could lead to a hindrance for bulky target compounds to migrate between the chains 
of the stationary phase and therefore to lower retention, which is known as shape selectivity 
[3]. Wise et. al. found that shape selectivity is influenced by the chain length, organic solvent, 
ligand density and temperature. In addition the separation of structurally similar compounds is 
favored by lower temperature and increased shape recognition [24-26]. This could explain why 
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the small polar analytes are retarded well on the YMC Triart C18 whereas bulky molecules 
show lower retention factors despite the high carbon load (20%) of the YMC Triart C18 phase. 
At a first glance, this result is unexpected and seems to contradict the findings by Haun et al. 
[27]. The authors of that study obtained very high retention factors for acenaphthene. However, 
the planar structure of this molecule favors a migration into the alkyl chains and therefore a 
high interaction with the stationary phase, whereas the compounds used in this study are 
sterically hindered to migrate deep into the C18 moieties. 
Unfortunately, the high carbon content of 20% for the YMC Triart C18 column neither provides 
information about the exact amount of carbon which actually offers the possibility for 
interactions nor about the hydrophobicity of the stationary phase. It might be possible that a 
high content of the carbon is part of the particle backbone and therefore not accessible to the 
analytes. Because of the use of multiple endcapping procedures in the preparation of the YMC 
Triart phase, a large part of the carbon content could result from the endcapping reagents. As a 
consequence, the hydrophobicity of the stationary phase is not as high as suspected. This could 
also explain why the non-polar compounds are less retarded on the YMC Triart C18 phase. 
Nevertheless, both columns show almost the same overall selectivity behavior confirmed by R2 
close to one (R2 = 0.987-0.993, s² = 0.007-0.013). However, the resulting α-values for the three 
critical pairs are different as shown in Table 2.3. Comparing the three different columns, using 
acetonitrile as organic co-solvent, the resulting α-values for ifosfamide/cyclophosphamide and 
paclitaxel/docetaxel are higher independent of the column temperature for the YMC Triart C18 
phase. In contrast, the use of methanol as organic modifier results in a higher selectivity for 
doxorubicin/epirubicin as well as for paclitaxel/docetaxel for the Restek Raptor ARC-18 phase. 
Table 2.3: Resulting selectivity factor for the three critical peak pairs using acetonitrile and 
methanol at 30 °C and 50 °C. Critical peak pairs (1: ifosfamide/cyclophosphamide; 2: 
doxorubicin/epirubicin; 3: docetaxel/paclitaxel). 
Column 
selectivity factor α 
Acetonitrile Methanol 
30 °C 50 °C 30 °C 50 °C 
critical pair critical pair critical pair critical pair 
1 2 3 1 2 3 1 2 3 1 2 3 
Restek Raptor ARC-18 1.016 1.036 1.028 1.030 1.035 1.019 1.048 1.033 1.013 1.055 1.036 1.014 
Restek Raptor Biphenyl 1.011 1.028 1.054 1.014 1.025 1.049 1.010 1.025 1.030 1.014 1.019 1.031 
YMC Triart C18 1.030 1.032 1.034 1.034 1.035 1.025 1.056 1.028 1.005 1.062 1.032 1.009 
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Figure 2.3 shows a plot of the retention factors obtained on the Restek Raptor Biphenyl and 
YMC Triart C18 column. Because of the different bonding, different retention and selectivity 
could be expected. 
 
Figure 2.3: Overall selectivity comparison of the column Restek Raptor Biphenyl and YMC Triart 
C18 under the following conditions. a) Mobile phase: H2O - ACN, column temperature: 30 °C; b) 
mobile phase: H2O - ACN, column temperature: 50 °C; c) mobile phase: H2O - MeOH, column 
temperature: 30 °C; mobile phase: H2O - MeOH, column temperature: 50 °C. Target compounds: 
() 5-fluorouracil, () gemcitabine, () methotrexat, () topotecan, () irinotecan, () 
ifosfamide, () cyclophosphamide, () doxorubicin, () epirubicin, () etoposide, () paclitaxel, 
() docetaxel. The dashed line represents the bisecting line. 
In principle, all previous statements regarding the retention characteristic are also valid for this 
example. As depicted in Figure 2.3 a) and b), the retention factors for the compounds 
methotrexate () and topotecan () show a co-elution on the Restek Raptor Biphenyl whereas 
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the YMC Triart C18 column is able to separate these substances at least at 50 °C. In Figure 2.3 
c), the Biphenyl column shows a change in the retention order for these substances. Increasing 
the temperature leads to a co-elution for the Restek Raptor Biphenyl as shown in Figure 2.3 d). 
This co-elution presents no problem because these substances can be separated by mass 
spectrometry due to their specific mass transitions, but it clearly shows the influence of the 
organic modifier and temperature on the chromatographic selectivity. In general, considering 
the correlation values and resulting variances (R2 = 0.957-0.986; s² = 0.014-0.043), a large 
difference between the two stationary phases can be observed. As for the example depicted in 
Figure 2.2, the distribution of the target compounds across the chromatogram is higher using 
methanol (Table 2.2). In addition, the Restek Raptor Biphenyl column provides a good 
separation for the critical pair paclitaxel and docetaxel. This can be shown by α listed in Table 
2.3. In general, the α-values for the Restek Raptor Biphenyl indicate higher selectivity using 
acetonitrile instead of methanol for the three critical peak pairs in this case. Figure 2.2 and 
Figure 2.3 reveal that different selectivity does not automatically provide a better 
chromatographic separation. In addition, the same surface modification does not lead to the 
same selectivity as can be seen in Table 2.3 for the different C18 columns. More detailed 
background of the calculations as well as all other resulting variance values of the investigated 
columns can be found in the supplementary material (Chapter 2.7.1.1 - 2.7.1.2, Table-S 
2.2 - Table-S 2.5). The drawback of this approach is that a graphical comparison can only be 
made of two columns. If a high number of columns have to be compared, an alternative strategy 
on the basis of multivariate data analysis should be attempted. 
The calculated α enables to classify similarities and differences in selectivity performing a 
principal component analysis (PCA) over all α-values of the critical peak pairs including all 
separation conditions [10, 28-31]. The used data for the PCA as well as some background 
information on PCA can be found in supplementary material (Table-S 2.6, Chapter 2.7.1.3). 
Figure 2.4 shows the result of the PCA for the principal component 1 (PC1) and 2 (PC2). 
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Figure 2.4: Principal component analysis over all estimated selectivity factors for all columns and 
operation conditions showing principal component 1 (PC1: 50.3%) and principal component 2 
(PC2: 20.3%). a) loading plot; b) score plot; IF/CP: ifosfamide/cyclophosphamide, Doxo/Epi: 
doxorubicin/epirubicin, Pac/Doc: paclitaxel/docetaxel. Note: All investigated Supelco columns 
belong to the Ascentis Express series. 
The presented loadings in Figure 2.4 a) show where the initial variables (combination of critical 
peak pair, temperature and organic co-solvent) are located with respect to the shown PC1 and 
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PC2. It can be seen that the change in selectivity for paclitaxel and docetaxel is almost 
independent of the applied separation conditions due to the small splitting of the loadings. In 
contrast, for the critical peak pairs doxorubicin/epirubicin and ifosfamide/cyclophosphamide a 
higher influence of the separation conditions can be observed because of the larger distribution 
of the loadings. Therefore, changing the separation conditions can improve the selectivity for 
these pairs. The difference in selectivity between paclitaxel/docetaxel and 
doxorubicin/epirubicin can be explained by a low and high contribution of the PC1, 
respectively. In contrast, the selectivity for ifosfamide/cyclophosphamide is almost independent 
of the PC1 and varies only in PC2. 
Looking now at the PCA score plot (Figure 2.4 b) of the columns it can be deduced which 
stationary phase is suitable for the individual critical peak pair from its position within the score 
plot compared to the loading plot (Figure 2.4 a). For example, the selectivity for 
paclitaxel/docetaxel is increased for columns that provide the possibility for π-π interactions 
[32, 33] because their scores are located nearby the loadings for this critical peak pair. This is 
consistent with the results shown in Table 2.3 and Figure 2.3 for the Restek Raptor Biphenyl 
column. The difference between biphenyl and phenyl hexyl is a result of the greater aromatic 
selectivity for the biphenyl column [30]. In contrast, the selectivity for doxorubicin/epirubicin 
can be increased using shorter alkyl chain length of the stationary phase. For 
ifosfamide/cyclophosphamide, the amide surface modification as well as longer alkyl chains 
yield a better selectivity. 
As highlighted by the dashed circle in Figure 2.4 b), most columns show almost the same 
selectivity. This could be expected because most of the columns have the same surface 
modification. Nevertheless, there are still selectivity differences although it is always C18 
moieties which are bonded on the silica surface. The resulting hydrophobicity depends on the 
carbon load of the stationary phase, which in turn depends on the packing density, pore size, 
ligand length and type of endcapping. These factors have an impact on the capability of the 
solutes to migrate between the chains of the stationary phase. This effect is known as shape 
selectivity or steric resistance depending on the type of bonding technology (monomeric, 
polymeric) [3, 24-26]. The varying sterical orientation and hydrodynamic diameter of the 
analytes could lead to a changed retention behavior and therefore to different separation results. 
In addition, other types of endcapping can result in different retention behavior for the target 
compounds. Especially, basic components are affected by free silanol groups at acidic pH, due 
to secondary interactions [1]. 
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Comparing the results of Figure 2.2 and Figure 2.3 with Figure 2.4, some similarities in terms 
of the selectivity can be observed. In Figure 2.2 and Figure 2.3, the correlations and resulting 
variances are a measure for the differences between the columns. Looking at the correlations, a 
higher similarity of the Restek Raptor ARC-18 and YMC Triart C18 could be found than for 
the Triart C18 and Restek Raptor Biphenyl. This statement is also confirmed by the PCA for 
the critical peak pairs. Therefore, this kind of representation (Figure 2.4) can also be applied to 
express selectivity differences with the additional advantage of all necessary information of all 
combinations in one plot, which allows for a targeted evaluation. 
There is also one column which shows a totally different selectivity for the critical peak pairs. 
The TCI Kaseisorb LC ODS-SAX Super column is a mixed-mode stationary phase with an 
anion exchange group in addition to the C18 chain. This column is the only one which provides 
a change in the retention order of the polar compounds 5-fluorouracil and gemcitabine, but is 
not suitable for the separation of the three critical peak pairs. Exemplarily, for gemcitabine it 
can be assumed that this analyte is positively charged at the applied pH, which causes a lower 
retention. The use of an anion exchange is unfavorable for this compound. In contrast to other 
target analytes both retention mechanisms cannot be exploited. As a consequence, the retention 
order of the polar compounds 5-fluorouracil and gemcitabine is reversed compared to classic 
C18 moieties. 
In order to substantiate the results of the PCA, the average α-values for the three critical pairs 
were calculated. The higher the average value, the greater the chance to achieve a separation 
for all critical peak pairs under the specific separation condition. Table-S 2.7 shows the 
calculated values for all investigated columns including all separation conditions. 
In order to determine the specific differences between particular stationary phases in 
combination with the applied mobile phase and temperature, the results of Table-S 2.6 and 
Table-S 2.7 as well as Figure 2.4 contain all necessary information. It can be concluded that for 
example the Supelco Ascentis Express C18 column is superior for the critical peak pairs 1 and 
2. In contrast, the Supelco Ascentis Express Phenyl-Hexyl phase is more suitable for the critical 
peak pair 3. The positioning of the column within the PCA score plot visualizes this result. The 
loading plot in Figure 2.4 a) shows that the selectivity using methanol as co-solvent leads to a 
decreased selectivity for paclitaxel/docetaxel on the phenyl hexyl stationary phase. 
Considering Table-S 2.7, the influence of the applied separation conditions on the selectivity 
can be evaluated. The impact of higher temperatures using acetonitrile seems to have a limited 
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effect on the average selectivity for these examples. The α-values comprises improvements as 
well as aggravations for the individual critical pairs because of the higher elution strength. In 
contrast, using methanol and elevated temperatures causes higher α-values for almost every 
column due to its protic character, specific interactions and lower elution strength. In terms of 
the α-values for the critical peak pairs, this separation condition seems to have the highest 
benefit. In general, the use of elevated temperatures has several advantages which can be 
exploited if α is constant. This concerns the acceleration of the analysis and the resulting 
backpressure which decreases when the temperature is increased [11].  
At this point it should be mentioned that the evaluation of the common average calculation of 
α could lead to wrong conclusions, because the impact of one high value for one α of one critical 
peak pair influences the average to a great extent. For this reason a weighting system on the 
basis of the importance to obtain a separation is applied. The separation of docetaxel and 
paclitaxel was deemed necessary because of ion suppression, although the mass spectrometer 
is able to differentiate between these substances. Therefore, α is multiplied with the factor of 
one. Ifosfamide and cyclophosphamide have one identical mass transition. The verification 
could be influenced at co-elution but the second mass transition still enables to separate these 
compounds using mass spectrometry. Therefore, the α-value is weighted by the factor of two. 
Doxorubicin and epirubicin are epimers, which differ only in the steric orientation of one 
hydroxyl group. An identification without a chromatographic separation is not possible because 
all mass transitions are equal. A chromatographic separation of this critical pair is mandatory, 
which is why the α-value is multiplied by three. The weighted average values are given in 
Table-S 2.7. The influence of the applied weighting system can be seen for the Restek Raptor 
Biphenyl column. Whereas the non-weighted average value implies a better α for the three 
critical peak pairs, the weighted approach clearly shows that the average selectivity is 
influenced by a higher value for the peak pair docetaxel and paclitaxel, of which 
chromatographic separation was defined as less important.  
In order to obtain a general statement about the influence of the applied separation conditions 
on the selectivity of the investigated critical peak pairs, the weighted average α-values over all 
columns can be calculated as shown in Table-S 2.7. Methanol leads to higher values than 
acetonitrile no matter which temperature is applied. For both organic modifiers, α can be 
improved by higher temperatures. This corroborates previous findings [10]. 
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To carry out a final evaluation which phase system provides the best results in terms of retention 
for the polar target compounds and the highest weighted average selectivity factor using a 
generic gradient, the resulting chromatograms for three different columns are shown in Figure 
2.5. The chromatograms are selected on the basis of the results of the retention factors for the 
polar compounds, PCA and weighted average α-values. As shown in Table-S 2.7, using 
methanol at 50 °C provides the highest weighted average α. Therefore, the separation 
conditions were kept constant for all shown chromatograms. 
Figure 2.5 a) depicts the separation for the twelve cytotoxic drugs on the Waters HSS T3 
column. This phase system was selected primarily because it provides an acceptable retention 
for the polar compounds under the selected separation conditions. This can be seen by the 
retention factor for 5-fluorouracil (k1=0.40) and gemcitabine (k2=1.35). In addition, the 
resulting separation for the three critical peak pairs is sufficient. 
Figure 2.5 b) represents the analysis on the Supelco Ascentis Express C8 column. The results 
of the PCA and average α indicate a suitable selectivity for all critical peak pairs. Looking at 
the score plot of the PCA in Figure 2.4 b), it can clearly be seen that the Ascentis Express C8 
column is characterized by a high PC1 and PC2. The comparison of the score plot (Figure 2.4 
b) and the loading plot (Figure 2.4 a) reveals that these properties are useful in order to separate 
all critical peak pairs. This can exactly be found in the shown chromatogram. As depicted, the 
separation of the three critical peak pairs (5/6 ifosfamide/cyclophosphamide, 9/10 
doxorubicin/epirubicin and 11/12 docetaxel/paclitaxel) is sufficient for a clear differentiation 
by mass spectrometry. However, the polar target compounds experience no retention due to the 
lower hydrophobicity of the stationary phase and elute with the column void volume. 
Figure 2.5 c) shows the separation on the YMC Triart C18 column. With respect to the PCA, it 
can be seen that this column is suitable for the separation of ifosfamide and cyclophosphamide 
as well as for doxorubicin and epirubicin, due to the contribution of PC1. The applied phase 
system also provides an acceptable compromise between retention for the polar compounds 
(k1=0.52, k2=1.14) and weighted average α for the critical peak pairs. Unfortunately, the 
separation for docetaxel/paclitaxel (compound 11/12) shows a partial co-elution, which can be 
expected due to the positioning of the column within the PCA. 
An additional criterion to evaluate the separation in terms of the application for routine 
operation is the analysis time. Higher run-times lead to a decreased sample throughput. For the 
shown examples, the run-time is decreased from 9.36 min to 8.04 min from Figure 2.5 a) to c). 
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This should also be considered for a final decision which phase system is finally selected, if a 
choice between two equally suitable phase systems has to be made. 
 
Figure 2.5: Resulting chromatograms for the analysis of the twelve cytotoxic drugs on a) Waters 
HSS T3 C18; b) Ascentis Express C8 and c) YMC Triart C18. Organic modifier: methanol; 
Temperature: 50 °C; Wavelength: (-) 254 nm; (---) 200 nm; Target compounds: (1) 5-fluorouracil, 
(2) gemcitabine, (3) methotrexat, (4) topotecan, (5) ifosfamide, (6) cyclophosphamide, (7) 
irinotecan, (8) etoposide, (9) doxorubicin, (10) epirubicin, (11) docetaxel, (12) paclitaxel. 
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2.4 Conclusion 
The applicability of the PCA to express selectivity differences in order to find a suitable phase 
system for the separation of critical peak pairs of twelve most important antineoplastic drugs 
could be shown. One advantage of this kind of data analysis is the availability and visualization 
of information about columns with similar selectivity, which can be applied as backup column 
for the analysis if needed. If the developed method should be applied over years the results of 
the PCA serve as an appropriate basis for the decision why a certain phase system has been 
chosen. In addition, it is a good starting point for future method development to choose a 
different selectivity. The introduction of the weighted average α calculation can be used to 
further validate the results. The definition of desired requirements is the key aspect and the first 
thing to do before a final phase system can be selected. The shown examples clearly show that 
several phase systems have benefits in dependence of the defined requirements which have to 
be achieved. After the final selection is made, the optimization of the column efficiency by 
variation of the particle diameter should be investigated in order to accomplish further 
improvements of the chromatographic separation. 
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2.7 Chapter appendix 
2.7.1 Mathematical Background for the calculations 
2.7.1.1 Neue et al. approach 
In order to accomplish the Neue et al. approach the retention factor must be calculated for each 
compound using Equation-S 2.1. 
𝑘 =
𝑡𝑅 − 𝑡0
𝑡0
 Equation-S 2.1 
where tR is the retention time and t0 the column void time. The obtained retention factor can be 
plotted as shown in Figure 2.2 and Figure 2.3. Afterwards, the correlation coefficient can be 
estimated using Equation-S 2.2. 
𝑅 =
𝑠𝑥𝑦
𝑠𝑥 ∙ 𝑠𝑦
 Equation-S 2.2 
where sxy is the covariance, sx and sy are the variances of the x and y data, respectively. The 
Neue et al. approach uses the squared R value because this is a characteristic for the explained 
variances of the data. The higher R², the higher is the similarity of the compared stationary 
phases. Now, the unexplained variances as a quantitative measure of column differences can be 
calculated using Equation-S 2.3. 
𝑠2 = 1 − 𝑅2 Equation-S 2.3 
where s2 is the unexplained variances of the data due to the column differences. The higher the 
s² value, the higher the differences of the compared stationary phases. 
2.7.1.2 Selectivity Factor 
For the calculation of the selectivity factor (α) for the critical peak pairs the ratio between the 
retention factors is estimated using Equation-S 2.4. 
𝛼 =
𝑘2
𝑘1
 Equation-S 2.4 
where k1 is the retention factor of the earlier eluting compound and k2 of the later eluting 
compound. Therefore, the selectivity factor is always higher than one. This value can be used 
to compare the selectivity of different stationary phases independently of the particle diameter. 
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2.7.1.3 Principal component analysis (PCA) 
The principal component analysis (PCA) is used to simplify large data sets without losing the 
most important information. Therefore, the original data matrix is transformed into a new 
coordinate system by data axis transformation showing the calculated principal components on 
the x- and y-axis, respectively, assuming a two-dimensional illustration. The first principal 
component (PC1) is calculated in order to illustrate the highest variance of the data. The second 
principal component (PC2) is arranged in an orthogonal direction to the PC1 displaying the 
next highest possible variance. All succeeding principal components are calculated in the same 
way. The strength of the PCA is as mentioned above the data reduction. This is possible because 
correlated data are condensed and principal components of higher order, which describe only a 
small portion of the variance, are not necessarily considered. As a consequence, the number of 
considered variables is often smaller than the number of initial variables. During PCA creation 
two characteristic values are calculated for each variable and data point. The loadings describe 
the direction of the initial variables with respect to the principal components. The scores are the 
values of the initial data points transformed into the new coordinate system. Besides the data 
reduction, the main intention of PCA is the illustration of correlations between the data which 
cannot be seen directly in classic data analysis. Nevertheless, in order to successfully apply the 
PCA some background knowledge about the data is desirable. In addition, PCA is sensitive with 
respect to the scaling of the data. Due to the reason that the PCA is a non-parametric approach, 
the results are independent of the data source and user [1, 2]. Further information about the PCA 
can be found in [3, 4]. 
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2.7.2 Additional tables 
A list of the investigated compounds is shown in Table-S 2.1. 
Table-S 2.1: List of the investigated compounds, including CAS number, sum formula, pKa and 
log D [5-7]. 
number compound CAS sum formula 
Purity / 
% 
provider 
pKa 
(T=25 °C) 
log D  
(T=25 °C, pH=3) 
(1) 5-fluorouracil 51-21-8 C4H3FN2O2 ≥ 99 Fluka 7.76 / 8.02 -0.65 
(2) gemcitabine 95058-81-4 C9H11F2N3O4 ≥ 98 Sigma 3.60 / 11.52 -3.34 
(3) methotrexate 59-05-2 C20H22N8O5 ≥ 98 Fluka 3.41 / 4.70 -2.95 
(4) topotecan 123948-87-8 C23H23N3O5 ≥ 98 Sigma 8.00 -3.36 
(5) irinotecan 97682-44-5 C33H38N4O6 ≥ 97 Sigma 11.71 -0.34 
(6) ifosfamide 3778-73-2 C7H15Cl2N2O2P ≥ 98 Sigma 13.24 0.75 
(7) cyclophosphamide 50-18-0 C7H15Cl2N2O2P ≥97 Sigma 12.78 0.50 
(8) doxorubicin 23214-92-8 C27H29NO11 ≥ 98 Sigma 9.53 -2.86 
(9) epirubicin 56420-45-2 C27H29NO11 ≥ 90 Sigma 9.53 -2.86 
(10) etoposide 33419-42-0 C29H32O13 ≥ 98 Sigma 9.33 0.28 
(11) paclitaxel 33069-62-4 C47H51NO14 ≥ 95 Sigma 10.36 3.95 
(12) docetaxel 114977-28-5 C43H53NO14 ≥ 97 Sigma 10.96 2.46 
 
Table-S 2.2 - Table-S 2.5 illustrates the calculated variances for all column combinations, 
organic modifier and temperatures whereas the selectivitiy factors for all critical peak pairs are 
shown in Table-S 2.6. The resulting average and weighted average selectivity factors for all 
columns, organic modifier and temperatures for the critical peak pairs are given in Table-S 2.7. 
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Table-S 2.2: Calculated variances for all column combinations using acetonitrile at 30 °C. Note: All investigated Supelco columns belong to the Ascentis 
Express series. 
 
s² ACN 
30 °C 
Supelco 
Ascenti
s C8 
Supelco 
Ascentis 
C18 
Supelco 
Ascenti
s CN 
Supelco 
Ascentis 
ES C18 
Supelco 
Ascentis 
RP-Amide 
Supelco 
Ascentis 
Phenyl 
Hexyl 
ChromaNik 
SunShell 
RP-Aqua 
Phenome
nex 
Kinetex 
C18 
Restek 
Raptor 
ARC-18 
Thermo 
Hypersil 
PFP 
Water
s BEH 
C18 
Waters 
HSS T3 
C18 
Waters 
Xbridge 
C18 
MN 
Nucleoshe
ll Rp18 
plus 
Phenomene
x Synergi 
Rppolar 
TCI 
Kaisersorb 
ODA-SAX 
Super 
Merck 
Chromoli
th RP18e 
Agilent 
Zorbax 
SB C18 
Restek 
Raptor 
Biphenyl 
YMC 
Triart 
C18 
Supelco 
Ascentis C8 
0 0.032 0.043 0.027 0.011 0.036 0.036 0.045 0.009 0.114 0.027 0.012 0.017 0.013 0.045 0.046 0.056 0.017 0.017 0.008 
Supelco 
Ascentis C18 
0.032 0 0.005 0.002 0.011 0.010 0.002 0.007 0.008 0.029 0.014 0.010 0.007 0.012 0.009 0.052 0.024 0.013 0.009 0.020 
Supelco 
Ascentis CN 
0.043 0.005 0 0.008 0.017 0.005 0.003 0.003 0.015 0.024 0.012 0.022 0.011 0.024 0.005 0.040 0.016 0.024 0.014 0.034 
Supelco 
Ascentis ES 
C18 
0.027 0.002 0.008 0 0.010 0.009 0.003 0.008 0.007 0.036 0.010 0.007 0.004 0.007 0.007 0.046 0.023 0.009 0.005 0.018 
Supelco 
Ascentis RP-
Amide 
0.011 0.011 0.017 0.010 0 0.019 0.014 0.022 0.004 0.064 0.018 0.008 0.008 0.007 0.022 0.051 0.042 0.011 0.008 0.005 
Supelco 
Ascentis 
Phenyl Hexyl 
0.036 0.010 0.005 0.009 0.019 0 0.004 0.002 0.013 0.042 0.003 0.018 0.006 0.021 0.006 0.021 0.006 0.021 0.014 0.034 
ChromaNik 
SunShell RP-
Aqua 
0.036 0.002 0.003 0.003 0.014 0.004 0 0.002 0.010 0.030 0.007 0.013 0.005 0.014 0.005 0.038 0.014 0.015 0.011 0.026 
Phenomenex 
Kinetex C18 
0.045 0.007 0.003 0.008 0.022 0.002 0.002 0 0.017 0.029 0.006 0.022 0.009 0.022 0.003 0.031 0.008 0.021 0.016 0.039 
Restek 
Raptor 
ARC-18 
0.009 0.008 0.015 0.007 0.004 0.013 0.010 0.017 0 0.065 0.011 0.003 0.003 0.005 0.019 0.038 0.029 0.008 0.006 0.007 
Thermo 
Hypersil 
PFP 
0.114 0.029 0.024 0.036 0.064 0.042 0.030 0.029 0.065 0 0.059 0.069 0.056 0.069 0.025 0.107 0.053 0.069 0.051 0.088 
Waters BEH 
C18 
0.027 0.014 0.012 0.010 0.018 0.003 0.007 0.006 0.011 0.059 0 0.015 0.004 0.015 0.010 0.015 0.007 0.015 0.013 0.029 
Waters HSS 
T3 C18 
0.012 0.010 0.022 0.007 0.008 0.018 0.013 0.022 0.003 0.069 0.015 0 0.004 0.004 0.023 0.048 0.035 0.007 0.009 0.008 
Waters 
Xbridge C18 
0.017 0.007 0.011 0.004 0.008 0.006 0.005 0.009 0.003 0.056 0.004 0.004 0 0.006 0.011 0.029 0.018 0.007 0.006 0.014 
MN 
Nucleoshell 
Rp18 plus 
0.013 0.012 0.024 0.007 0.007 0.021 0.014 0.022 0.005 0.069 0.015 0.004 0.006 0 0.021 0.051 0.038 0.001 0.008 0.008 
Phenomenex 
Synergi 
Rppolar 
0.045 0.009 0.005 0.007 0.022 0.006 0.005 0.003 0.019 0.025 0.010 0.023 0.011 0.021 0 0.036 0.013 0.020 0.011 0.040 
TCI 
Kaisersorb 
ODA-SAX 
Super 
0.046 0.052 0.040 0.046 0.051 0.021 0.038 0.031 0.038 0.107 0.015 0.048 0.029 0.051 0.036 0 0.014 0.049 0.042 0.066 
Merck 
Chromolith 
RP18e 
0.056 0.024 0.016 0.023 0.042 0.006 0.014 0.008 0.029 0.053 0.007 0.035 0.018 0.038 0.013 0.014 0 0.034 0.031 0.061 
Agilent 
Zorbax SB 
C18 
0.017 0.013 0.024 0.009 0.011 0.021 0.015 0.021 0.008 0.069 0.015 0.007 0.007 0.001 0.020 0.049 0.034 0 0.012 0.014 
Restek 
Raptor 
Biphenyl 
0.017 0.009 0.014 0.005 0.008 0.014 0.011 0.016 0.006 0.051 0.013 0.009 0.006 0.008 0.011 0.042 0.031 0.012 0 0.014 
YMC Triart 
C18 
0.008 0.020 0.034 0.018 0.005 0.034 0.026 0.039 0.007 0.088 0.029 0.008 0.014 0.008 0.040 0.066 0.061 0.014 0.014 0 
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Table-S 2.3: Calculated variances for all column combinations using acetonitrile at 50 °C. Note: All investigated Supelco columns belong to the Ascentis 
Express series. 
s² ACN 
50 °C 
Supelco 
Ascentis 
C8 
Supelco 
Ascentis 
C18 
Supelco 
Ascentis 
CN 
Supelco 
Ascentis 
ES C18 
Supelco 
Ascentis 
RP-
Amide 
Supelco 
Ascentis 
Phenyl 
Hexyl 
Chroma
Nik 
SunShell 
RP-Aqua 
Phenome
nex 
Kinetex 
C18 
Restek 
Raptor 
ARC-18 
Thermo 
Hypersil 
PFP 
Waters 
BEH C18 
Waters 
HSS T3 
C18 
Waters 
Xbridge 
C18 
MN 
Nucleosh
ell Rp18 
plus 
Phenome
nex 
Synergi 
Rppolar 
TCI 
Kaiserso
rb ODA-
SAX 
Super 
Merck 
Chromoli
th RP18e 
Agilent 
Zorbax 
SB C18 
Restek 
Raptor 
Biphenyl 
YMC 
Triart 
C18 
Supelco 
Ascentis C8 
0 0.025 0.023 0.018 0.004 0.007 0.015 0.035 0.006 0.103 0.004 0.011 0.007 0.007 0.036 0.039 0.043 0.007 0.012 0.008 
Supelco 
Ascentis 
C18 
0.025 0 0.007 0.001 0.011 0.010 0.002 0.005 0.010 0.032 0.012 0.008 0.008 0.010 0.006 0.048 0.017 0.011 0.008 0.029 
Supelco 
Ascentis CN 
0.023 0.007 0 0.006 0.009 0.014 0.005 0.020 0.016 0.039 0.018 0.016 0.013 0.016 0.016 0.070 0.038 0.018 0.012 0.023 
Supelco 
Ascentis ES 
C18 
0.018 0.001 0.006 0 0.007 0.006 0.000 0.008 0.006 0.040 0.008 0.005 0.004 0.007 0.008 0.044 0.019 0.008 0.006 0.021 
Supelco 
Ascentis 
RP-Amide 
0.004 0.011 0.009 0.007 0 0.003 0.005 0.021 0.004 0.070 0.004 0.007 0.004 0.004 0.022 0.044 0.033 0.006 0.007 0.011 
Supelco 
Ascentis 
Phenyl 
Hexyl 
0.007 0.010 0.014 0.006 0.003 0 0.006 0.015 0.001 0.070 0.002 0.004 0.002 0.005 0.017 0.025 0.019 0.005 0.006 0.015 
ChromaNik 
SunShell 
RP-Aqua 
0.015 0.002 0.005 0.000 0.005 0.006 0 0.011 0.005 0.046 0.006 0.004 0.003 0.005 0.011 0.046 0.022 0.006 0.005 0.017 
Phenomene
x Kinetex 
C18 
0.035 0.005 0.020 0.008 0.021 0.015 0.011 0 0.015 0.030 0.020 0.015 0.016 0.018 0.004 0.036 0.006 0.019 0.013 0.050 
Restek 
Raptor 
ARC-18 
0.006 0.010 0.016 0.006 0.004 0.001 0.005 0.015 0 0.073 0.000 0.002 0.001 0.003 0.018 0.026 0.020 0.002 0.006 0.013 
Thermo 
Hypersil 
PFP 
0.103 0.032 0.039 0.040 0.070 0.070 0.046 0.030 0.073 0 0.080 0.067 0.069 0.074 0.028 0.120 0.052 0.079 0.056 0.109 
Waters 
BEH C18 
0.004 0.012 0.018 0.008 0.004 0.002 0.006 0.020 0.000 0.080 0 0.002 0.001 0.002 0.021 0.028 0.024 0.002 0.006 0.010 
Waters HSS 
T3 C18 
0.011 0.008 0.016 0.005 0.007 0.004 0.004 0.015 0.002 0.067 0.002 0 0.002 0.004 0.017 0.032 0.020 0.003 0.007 0.014 
Waters 
Xbridge 
C18 
0.007 0.008 0.013 0.004 0.004 0.002 0.003 0.016 0.001 0.069 0.001 0.002 0 0.002 0.016 0.032 0.022 0.002 0.004 0.011 
MN 
Nucleoshell 
Rp18 plus 
0.007 0.010 0.016 0.007 0.004 0.005 0.005 0.018 0.003 0.074 0.002 0.004 0.002 0 0.021 0.039 0.026 0.000 0.007 0.013 
Phenomene
x Synergi 
Rppolar 
0.036 0.006 0.016 0.008 0.022 0.017 0.011 0.004 0.018 0.028 0.021 0.017 0.016 0.021 0 0.042 0.011 0.021 0.008 0.048 
TCI 
Kaisersorb 
ODA-SAX 
Super 
0.039 0.048 0.070 0.044 0.044 0.025 0.046 0.036 0.026 0.120 0.028 0.032 0.032 0.039 0.042 0 0.019 0.035 0.036 0.064 
Merck 
Chromolith 
RP18e 
0.043 0.017 0.038 0.019 0.033 0.019 0.022 0.006 0.020 0.052 0.024 0.020 0.022 0.026 0.011 0.019 0 0.025 0.022 0.062 
Agilent 
Zorbax SB 
C18 
0.007 0.011 0.018 0.008 0.006 0.005 0.006 0.019 0.002 0.079 0.002 0.003 0.002 0.000 0.021 0.035 0.025 0 0.008 0.012 
Restek 
Raptor 
Biphenyl 
0.012 0.008 0.012 0.006 0.007 0.006 0.005 0.013 0.006 0.056 0.006 0.007 0.004 0.007 0.008 0.036 0.022 0.008 0 0.022 
YMC Triart 
C18 
0.008 0.029 0.023 0.021 0.011 0.015 0.017 0.050 0.013 0.109 0.010 0.014 0.011 0.013 0.048 0.064 0.062 0.012 0.022 0 
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Table-S 2.4: Calculated variances for all column combinations using methanol at 30 °C. Note: All investigated Supelco columns belong to the Ascentis 
Express series. 
s² MeOH 
30 °C 
Supelco 
Ascentis 
C8 
Supelco 
Ascentis 
C18 
Supelco 
Ascentis 
CN 
Supelco 
Ascentis 
ES C18 
Supelco 
Ascentis 
RP-
Amide 
Supelco 
Ascentis 
Phenyl 
Hexyl 
Chroma
Nik 
SunShell 
RP-Aqua 
Phenome
nex 
Kinetex 
C18 
Restek 
Raptor 
ARC-18 
Thermo 
Hypersil 
PFP 
Waters 
BEH C18 
Waters 
HSS T3 
C18 
Waters 
Xbridge 
C18 
MN 
Nucleosh
ell Rp18 
plus 
Phenome
nex 
Synergi 
Rppolar 
TCI 
Kaiserso
rb ODA-
SAX 
Super 
Merck 
Chromoli
th RP18e 
Agilent 
Zorbax 
SB C18 
Restek 
Raptor 
Biphenyl 
YMC 
Triart 
C18 
Supelco 
Ascentis C8 
0 0.045 0.061 0.041 0.029 0.029 0.046 0.046 0.011 0.188 0.021 0.039 0.018 0.017 0.109 0.022 0.019 0.019 0.045 0.026 
Supelco 
Ascentis 
C18 
0.045 0 0.008 0.002 0.004 0.015 0.001 0.005 0.012 0.059 0.015 0.015 0.009 0.010 0.031 0.090 0.013 0.012 0.024 0.018 
Supelco 
Ascentis CN 
0.061 0.008 0 0.013 0.011 0.028 0.010 0.014 0.026 0.048 0.033 0.039 0.027 0.027 0.039 0.115 0.030 0.031 0.035 0.035 
Supelco 
Ascentis ES 
C18 
0.041 0.002 0.013 0 0.003 0.010 0.001 0.002 0.010 0.063 0.008 0.009 0.006 0.009 0.026 0.076 0.008 0.008 0.016 0.021 
Supelco 
Ascentis 
RP-Amide 
0.029 0.004 0.011 0.003 0 0.013 0.004 0.005 0.007 0.079 0.007 0.017 0.006 0.007 0.040 0.064 0.006 0.009 0.020 0.020 
Supelco 
Ascentis 
Phenyl 
Hexyl 
0.029 0.015 0.028 0.010 0.013 0 0.014 0.010 0.008 0.093 0.007 0.009 0.007 0.011 0.036 0.049 0.007 0.006 0.007 0.022 
ChromaNik 
SunShell 
RP-Aqua 
0.046 0.001 0.010 0.001 0.004 0.014 0 0.004 0.013 0.059 0.013 0.012 0.009 0.010 0.029 0.089 0.013 0.011 0.022 0.020 
Phenomene
x Kinetex 
C18 
0.046 0.005 0.014 0.002 0.005 0.010 0.004 0 0.014 0.058 0.008 0.012 0.009 0.013 0.020 0.074 0.008 0.011 0.013 0.030 
Restek 
Raptor 
ARC-18 
0.011 0.012 0.026 0.010 0.007 0.008 0.013 0.014 0 0.117 0.005 0.013 0.002 0.002 0.058 0.043 0.004 0.003 0.021 0.010 
Thermo 
Hypersil 
PFP 
0.188 0.059 0.048 0.063 0.079 0.093 0.059 0.058 0.117 0 0.106 0.096 0.104 0.111 0.034 0.238 0.107 0.109 0.084 0.126 
Waters 
BEH C18 
0.021 0.015 0.033 0.008 0.007 0.007 0.013 0.008 0.005 0.106 0 0.009 0.003 0.006 0.043 0.036 0.001 0.004 0.012 0.024 
Waters HSS 
T3 C18 
0.039 0.015 0.039 0.009 0.017 0.009 0.012 0.012 0.013 0.096 0.009 0 0.006 0.010 0.040 0.063 0.010 0.005 0.017 0.019 
Waters 
Xbridge 
C18 
0.018 0.009 0.027 0.006 0.006 0.007 0.009 0.009 0.002 0.104 0.003 0.006 0 0.002 0.048 0.047 0.002 0.001 0.017 0.011 
MN 
Nucleoshell 
Rp18 plus 
0.017 0.010 0.027 0.009 0.007 0.011 0.010 0.013 0.002 0.111 0.006 0.010 0.002 0 0.055 0.051 0.004 0.001 0.027 0.009 
Phenomene
x Synergi 
Rppolar 
0.109 0.031 0.039 0.026 0.040 0.036 0.029 0.020 0.058 0.034 0.043 0.040 0.048 0.055 0 0.128 0.045 0.048 0.032 0.082 
TCI 
Kaisersorb 
ODA-SAX 
Super 
0.022 0.090 0.115 0.076 0.064 0.049 0.089 0.074 0.043 0.238 0.036 0.063 0.047 0.051 0.128 0 0.038 0.046 0.055 0.076 
Merck 
Chromolith 
RP18e 
0.019 0.013 0.030 0.008 0.006 0.007 0.013 0.008 0.004 0.107 0.001 0.010 0.002 0.004 0.045 0.038 0 0.003 0.016 0.020 
Agilent 
Zorbax SB 
C18 
0.019 0.012 0.031 0.008 0.009 0.006 0.011 0.011 0.003 0.109 0.004 0.005 0.001 0.001 0.048 0.046 0.003 0 0.020 0.011 
Restek 
Raptor 
Biphenyl 
0.045 0.024 0.035 0.016 0.020 0.007 0.022 0.013 0.021 0.084 0.012 0.017 0.017 0.027 0.032 0.055 0.016 0.020 0 0.043 
YMC Triart 
C18 
0.026 0.018 0.035 0.021 0.020 0.022 0.020 0.030 0.010 0.126 0.024 0.019 0.011 0.009 0.082 0.076 0.020 0.011 0.043 0 
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Table-S 2.5: Calculated variances for all column combinations using methanol at 50 °C. Note: All investigated Supelco columns belong to the Ascentis 
Express series. 
s² MeOH 
50 °C 
Supelco 
Ascentis 
C8 
Supelco 
Ascentis 
C18 
Supelco 
Ascentis 
CN 
Supelco 
Ascentis 
ES C18 
Supelco 
Ascentis 
RP-
Amide 
Supelco 
Ascentis 
Phenyl 
Hexyl 
Chroma
Nik 
SunShell 
RP-Aqua 
Phenome
nex 
Kinetex 
C18 
Restek 
Raptor 
ARC-18 
Thermo 
Hypersil 
PFP 
Waters 
BEH C18 
Waters 
HSS T3 
C18 
Waters 
Xbridge 
C18 
MN 
Nucleosh
ell Rp18 
plus 
Phenome
nex 
Synergi 
Rppolar 
TCI 
Kaiserso
rb ODA-
SAX 
Super 
Merck 
Chromoli
th RP18e 
Agilent 
Zorbax 
SB C18 
Restek 
Raptor 
Biphenyl 
YMC 
Triart 
C18 
Supelco 
Ascentis C8 
0 0.056 0.065 0.063 0.029 0.049 0.057 0.068 0.023 0.221 0.040 0.051 0.037 0.047 0.127 0.039 0.040 0.033 0.064 0.036 
Supelco 
Ascentis 
C18 
0.056 0 0.011 0.003 0.006 0.013 0.000 0.006 0.013 0.068 0.018 0.009 0.009 0.013 0.024 0.086 0.012 0.013 0.019 0.019 
Supelco 
Ascentis CN 
0.065 0.011 0 0.022 0.013 0.032 0.013 0.027 0.033 0.061 0.049 0.035 0.033 0.036 0.041 0.124 0.037 0.036 0.041 0.035 
Supelco 
Ascentis ES 
C18 
0.063 0.003 0.022 0 0.011 0.010 0.002 0.001 0.014 0.071 0.012 0.006 0.006 0.013 0.017 0.076 0.007 0.011 0.012 0.023 
Supelco 
Ascentis 
RP-Amide 
0.029 0.006 0.013 0.011 0 0.014 0.006 0.014 0.007 0.102 0.016 0.013 0.008 0.013 0.045 0.065 0.010 0.010 0.023 0.015 
Supelco 
Ascentis 
Phenyl 
Hexyl 
0.049 0.013 0.032 0.010 0.014 0 0.012 0.011 0.006 0.108 0.008 0.005 0.005 0.019 0.032 0.048 0.006 0.005 0.006 0.015 
ChromaNik 
SunShell 
RP-Aqua 
0.057 0.000 0.013 0.002 0.006 0.012 0 0.005 0.013 0.069 0.017 0.008 0.008 0.012 0.022 0.084 0.010 0.012 0.018 0.019 
Phenomene
x Kinetex 
C18 
0.068 0.006 0.027 0.001 0.014 0.011 0.005 0 0.017 0.071 0.012 0.009 0.009 0.013 0.015 0.073 0.007 0.014 0.012 0.031 
Restek 
Raptor 
ARC-18 
0.023 0.013 0.033 0.014 0.007 0.006 0.013 0.017 0 0.134 0.005 0.007 0.002 0.013 0.051 0.037 0.005 0.002 0.016 0.009 
Thermo 
Hypersil 
PFP 
0.221 0.068 0.061 0.071 0.102 0.108 0.069 0.071 0.134 0 0.133 0.106 0.115 0.115 0.042 0.261 0.116 0.128 0.099 0.137 
Waters 
BEH C18 
0.040 0.018 0.049 0.012 0.016 0.008 0.017 0.012 0.005 0.133 0 0.006 0.003 0.013 0.043 0.030 0.002 0.004 0.012 0.021 
Waters HSS 
T3 C18 
0.051 0.009 0.035 0.006 0.013 0.005 0.008 0.009 0.007 0.106 0.006 0 0.002 0.013 0.034 0.055 0.005 0.003 0.012 0.010 
Waters 
Xbridge 
C18 
0.037 0.009 0.033 0.006 0.008 0.005 0.008 0.009 0.002 0.115 0.003 0.002 0 0.010 0.039 0.045 0.002 0.002 0.012 0.011 
MN 
Nucleoshell 
Rp18 plus 
0.047 0.013 0.036 0.013 0.013 0.019 0.012 0.013 0.013 0.115 0.013 0.013 0.010 0 0.037 0.064 0.008 0.009 0.034 0.023 
Phenomene
x Synergi 
Rppolar 
0.127 0.024 0.041 0.017 0.045 0.032 0.022 0.015 0.051 0.042 0.043 0.034 0.039 0.037 0 0.127 0.036 0.045 0.029 0.068 
TCI 
Kaisersorb 
ODA-SAX 
Super 
0.039 0.086 0.124 0.076 0.065 0.048 0.084 0.073 0.037 0.261 0.030 0.055 0.045 0.064 0.127 0 0.040 0.040 0.052 0.064 
Merck 
Chromolith 
RP18e 
0.040 0.012 0.037 0.007 0.010 0.006 0.010 0.007 0.005 0.116 0.002 0.005 0.002 0.008 0.036 0.040 0 0.003 0.013 0.018 
Agilent 
Zorbax SB 
C18 
0.033 0.013 0.036 0.011 0.010 0.005 0.012 0.014 0.002 0.128 0.004 0.003 0.002 0.009 0.045 0.040 0.003 0 0.017 0.008 
Restek 
Raptor 
Biphenyl 
0.064 0.019 0.041 0.012 0.023 0.006 0.018 0.012 0.016 0.099 0.012 0.012 0.012 0.034 0.029 0.052 0.013 0.017 0 0.033 
YMC Triart 
C18 
0.036 0.019 0.035 0.023 0.015 0.015 0.019 0.031 0.009 0.137 0.021 0.010 0.011 0.023 0.068 0.064 0.018 0.008 0.033 0 
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Table-S 2.6: Calculated selectivity factors for all columns, organic modifiers and separation temperatures that were used for the principal component 
analysis. IF / CP: ifosfamide / cyclophosphamide, Doxo / Epi: doxorubicin / epirubicin, Pac / Doc: paclitaxel / docetaxel. 
Columns 
Acetonitrile 30 °C Acetonitrile 50 °C Methanol 30 °C Methanol 50 °C 
IF / CP Doxo / Epi Pac / Doc IF / CP Doxo / Epi Pac / Doc IF / CP Doxo / Epi Pac / Doc IF / CP Doxo / Epi Pac / Doc 
Agilent Zorbax SB C18 1.023 1.026 1.028 1.029 1.027 1.020 1.047 1.027 1.013 1.056 1.035 1.013 
Chromanik SunShell RP-Aqua 1.024 1.028 1.018 1.031 1.034 1.015 1.047 1.027 1.012 1.052 1.032 1.014 
Merck Chromolith RP18e 1.023 1.017 1.014 1.031 1.020 1.006 1.045 1.029 1.016 1.050 1.031 1.018 
MN Nucleoshell Rp18 plus 1.023 1.027 1.026 1.029 1.032 1.018 1.047 1.031 1.015 1.059 1.032 1.017 
Phenomenex Kinetex C18 1.022 1.029 1.024 1.031 1.030 1.018 1.038 1.027 1.009 1.041 1.031 1.012 
Phenomenex Synergi Rppolar 1.015 1.024 1.048 1.018 1.016 1.044 1.025 1.023 1.025 1.030 1.023 1.027 
Restek Raptor Biphenyl 1.011 1.028 1.054 1.014 1.025 1.049 1.010 1.025 1.030 1.014 1.019 1.031 
Restek Raptor ARC-18 1.016 1.036 1.028 1.030 1.035 1.019 1.048 1.033 1.013 1.055 1.036 1.014 
Supelco Ascentis Express C18 1.028 1.034 1.019 1.032 1.035 1.011 1.052 1.031 1.016 1.056 1.035 1.018 
Supelco AscentisExpress C8 1.033 1.046 1.019 1.033 1.031 1.009 1.059 1.042 1.015 1.062 1.056 1.017 
Supelco Ascentis Express CN 1.024 1.030 1.039 1.032 1.038 1.036 1.031 1.037 1.019 1.037 1.042 1.019 
Supelco Ascentis Express ES C18 1.026 1.044 1.022 1.033 1.040 1.016 1.044 1.033 1.014 1.046 1.036 1.016 
Supelco Ascentis Express RP-Amide 1.032 1.033 1.040 1.038 1.038 1.031 1.052 1.031 1.000 1.066 1.036 1.000 
Supelco Ascentis Express Phenyl Hexyl 1.018 1.029 1.039 1.027 1.026 1.038 1.043 1.024 1.017 1.047 1.028 1.018 
TCI Kaisersorb ODS-SAX Super 1.013 1.013 1.023 1.017 1.015 1.018 1.035 1.027 1.000 1.041 1.030 1.000 
Thermo Hypersil PFP 1.035 1.034 1.031 1.033 1.027 1.027 1.035 1.035 1.011 1.048 1.041 1.010 
Waters Acquity BEH C18 1.019 1.020 1.014 1.030 1.029 1.007 1.017 1.026 1.011 1.047 1.028 1.014 
Waters HSS T3 C18 1.027 1.030 1.021 1.026 1.031 1.014 1.041 1.023 1.010 1.050 1.028 1.012 
Waters XBridge C18 1.031 1.026 1.015 1.033 1.031 1.000 1.051 1.028 1.014 1.056 1.031 1.017 
YMC Triart C18 1.030 1.032 1.034 1.034 1.035 1.025 1.056 1.028 1.005 1.062 1.032 1.009 
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Table-S 2.7: Resulting average and weighted average selectivity factors for all columns, organic 
modifier and separation temperatures for the three critical peak pairs 
ifosfamide/cyclophosphamide, doxorubicin/epirubicin and paclitaxel/docetaxel. Weighting factor: 
IF/CP:Doxo/Epi:Pac/Doc 2:3:1. 
Column 
Acetonitrile Methanol 
average 
a (30 °C) 
weighted 
average 
a (30 °C) 
average 
a (50 °C) 
weighted 
average 
a (50 °C) 
average 
a (30 °C) 
weighted 
average 
a (30 °C) 
average 
a (50 °C) 
weighted 
average 
a (50 °C) 
Agilent Zorbax SB C18 1.025 1.025 1.025 1.026 1.029 1.031 1.035 1.038 
ChromaNik Sunshell RP-Aqua 1.024 1.025 1.027 1.030 1.029 1.031 1.033 1.036 
Macherey Nagel Nucleoshell RP 18plus 1.025 1.025 1.027 1.029 1.031 1.033 1.036 1.038 
Merck Chromolith FastGradient RP 18e 1.018 1.018 1.019 1.021 1.030 1.032 1.033 1.035 
Phenomenex Kinetex C18 1.025 1.026 1.026 1.028 1.025 1.028 1.028 1.031 
Phenomenex Synergi RP polar 1.029 1.025 1.026 1.021 1.024 1.024 1.027 1.026 
Restek Raptor ARC-18 1.027 1.028 1.028 1.031 1.032 1.035 1.035 1.038 
Restek Raptor Biphenyl 1.031 1.027 1.030 1.025 1.022 1.021 1.021 1.019 
Supelco Ascentis Express C18 1.027 1.030 1.026 1.030 1.033 1.035 1.036 1.039 
Supelco Ascentis Express C8 1.033 1.037 1.024 1.028 1.039 1.043 1.045 1.052 
Supelco Ascentis Express CN 1.031 1.029 1.035 1.036 1.029 1.032 1.033 1.036 
Supelco Ascentis Express ES C18 1.031 1.034 1.030 1.033 1.030 1.033 1.033 1.036 
Supelco Ascentis Express RP-Amide 1.035 1.034 1.035 1.037 1.028 1.033 1.034 1.040 
Supelco Ascentis Express Phenyl-Hexyl 1.029 1.027 1.030 1.028 1.028 1.029 1.031 1.033 
TCI Kaseisorb LC ODS-SAX Super 1.016 1.014 1.017 1.016 1.021 1.025 1.024 1.029 
Thermo HypersilGold PFP 1.033 1.034 1.029 1.029 1.027 1.031 1.033 1.038 
Waters Acquity BEH C18 1.018 1.019 1.022 1.025 1.018 1.020 1.030 1.032 
Waters HSS T3 C18 1.026 1.028 1.024 1.026 1.025 1.027 1.030 1.033 
Waters Xbridge C18 1.024 1.026 1.021 1.027 1.031 1.033 1.034 1.037 
YMC Triart C18 1.032 1.032 1.031 1.033 1.030 1.034 1.034 1.038 
 
weighted average α 
(30 °C) 
weighted average α 
(50 °C) 
weighted average α 
(30 °C) 
weighted average α 
(50 °C) 
All columns (n=20) 1.027 1.029 1.031 1.035 
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Abstract 
The efficiency of miniaturized liquid chromatography columns with inner diameters between 
200 and 300 µm has been investigated using a dedicated micro-LC system. Fully porous, core-
shell and monolithic commercially available stationary phases were compared applying van 
Deemter as well as kinetic plot analysis. It was found that the sub-2 µm fully porous as well as 
the 2.7 µm core-shell particle packed columns showed superior efficiency and similar values 
for the minimum reduced plate heights (2.56-2.69) before correction for extra-column 
contribution compared to normal bore columns. Moreover, the influence of extra-column 
contribution was investigated to demonstrate the difference between apparent and intrinsic 
efficiency by replacing the column by a zero dead volume union to determine the band 
spreading caused by the system. It was demonstrated that 72% of the intrinsic efficiency could 
be reached. The results of the kinetic plot analysis indicate the superior performance of the sub-
2 µm fully porous particle packed column for ultra-fast liquid chromatography. 
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3.1 Introduction 
Currently, there is a renewed interest in miniaturized liquid chromatography [1]. Several groups 
and vendors are working on new developments and improvements in the field of micro-LC, 
nano-LC, and chip-LC [2, 3]. In particular, the advantages of increased separation speed at 
reduced solvent consumption as well as reduced cycle times are the main motivation for 
miniaturization. Regarding the separation speed, miniaturized separation techniques allow to 
use high linear velocities at low flow rates in the nL-µL min-1 range. In order to achieve similar 
linear velocities using conventional HPLC columns with an inner diameter (i.d.) between 
2.1 mm and 4.6 mm, flow rates in the mL min-1 range must be applied. This is an undisputed 
benefit of miniaturized LC columns with an i.d. between 50 µm and 300 µm. Furthermore, the 
need for increased detection sensitivity in combination with mass spectrometry (MS) favors 
miniaturized separation techniques because lower flow rates improve the ionization and ion 
desorption process [4-6]. 
In general, miniaturized columns are limited in terms of the injection volume. With decreasing 
i.d. of the column the maximum injection volume also decreases because of the reduced column 
volume. Therefore, nano-LC is mainly used in the field of proteomics and bioanalysis because 
the limited sample volume is less diluted by the column volume [1, 7]. While nano-LC requires 
dedicated detection capabilities like e.g. a nano-ESI source, micro-LC is compatible without a 
significant modification of conventional ion sources. Thus, micro-LC can also be used in other 
fields of application such as environmental and pharmaceutical analysis where the sample 
volume is not a limiting factor. It could be a suitable alternative to the established LC methods 
because micro-LC combines the advantages of increased separation speed with decreased 
resource consumption and sufficient sensitivity due to the decreased dilution by the column 
volume and higher loading capacity compared to nano-LC. Furthermore, in the field of multi-
dimensional LC separations, micro-LC can be used in the second dimension in order to 
accomplish very fast cycle times as has recently been demonstrated by Haun et al. (≤ 60 s) [8]. 
However, the prerequisite for the use of micro-LC in routine analysis are robust, reliable, and 
efficient LC columns. The common opinion is that such miniaturized columns cannot be packed 
adequately due to the decreased i.d. [1, 2, 9]. In addition, the negative influence of the extra-
column volume on the chromatographic efficiency is given as a reason why the intrinsic column 
efficiency cannot be utilized and therefore the obtained efficiencies are significantly lower 
compared to columns with an i.d. above 2.1 mm [10, 11]. This argument is also underlined by 
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Gritti et al. who characterized the efficiency of 500 µm i.d. columns packed with 3 µm fully 
porous and 2.7 µm core-shell particles [9]. It was found that the obtained plate heights are 
significantly higher compared to normal bore columns due to the extra-column volume 
contribution of the micro-LC system. 
Meanwhile, columns packed with fully porous and core-shell particles as well as monolithic 
columns are commercially available for an i.d. between 200 and 300 µm. Core-shell particle 
packed columns are increasingly being used instead of fully porous particle packed columns 
due to their reduced back pressure at a given flow rate [12]. Especially, monolithic columns are 
characterized by a very high permeability and recently published work by Hara et al. showed 
an increased pressure stability up to 800 bar [13, 14]. 
Therefore, this investigation focused on the question which efficiencies can be obtained with 
commercially available 200-300 µm i.d. micro-LC columns on a dedicated micro-LC system. 
For data evaluation, the van Deemter analysis as well as the kinetic plot method were applied 
[15]. Moreover, the influence of the extra-column volume on the performance of micro-LC 
columns was investigated by varying the i.d. of the connection tubings. Furthermore, the 
obtained apparent efficiencies were also compared to the intrinsic column efficiencies by 
correcting for the contribution of the extra-column volume. 
3.2 Materials and methods 
All measurements were performed on an Eksigent ExpressLC Ultra system (Sciex, Dublin, CA) 
with a standard micro-LC flow module (flow rate range: 1-10 µL min-1). The pneumatic pump 
offers the possibility to select six different mobile phases up to 690 bar for each solvent channel. 
The sample loop filling was done by an HTS PAL autosampler (CTC Analytics, Zwingen, 
Switzerland). The installed loop, made of fused-silica surrounded by polyetheretherketone 
(PEEKSil), has an inner diameter of 75 µm and a length of 10 cm and represents the standard 
configuration. The corresponding loop volume was 442 nL. The sample injection was done by 
a built-in six-port valve using the full loop injection mode of the software. The integrated static 
air column oven was used for temperature control of the stationary phase. For data acquisition, 
a built-in diode array detector (DAD) was employed with a cell volume of 100 nL. 
Chromatograms were recorded at 254 nm with a data acquisition rate of 10 Hz. 
All tubings prior to and after the column were made of 360 µm outer diameter (o.d.) fused-
silica capillaries with an i.d. of 25 µm and 50 µm with a length of 10 and 13 cm, respectively. 
Using sleeves, the o.d. was expanded to 1/32” for the connection to the columns and detector. 
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The lengths of the individual connections were adjusted using a diamond cutter. For data 
acquisition and analysis the Eksigent control software (Version 4.1 Patch for ekspert nanoLC 
400 and batch acquisition control) was used. Further data processing was done using Origin 
Lab v. 9.1 and Microsoft Office Excel 2010. Data fitting was done via least square method. For 
the measurement of the van Deemter curves, the flow rate was varied in a range between 2 and 
15 µL min-1. All measurements were done in triplicate. 
Table 3.1 presents an overview of the investigated columns. The column oven temperature was 
set to 30 °C. The retention factor k was calculated according to Equation 3.1 using the retention 
time of an unretained marker as column void time (t0). 
𝑘 =
𝑡𝑅 − 𝑡0
𝑡0
 Equation 3.1 
In order to obtain constant retention factors, the mobile phase composition was adjusted for 
every column. An overview can be found in the supporting information (Table-S 3.1). 
Table 3.1: List of the investigated columns. 
Description 
surface 
modification 
chromatographic 
support 
end 
capping 
L / 
mm 
i.d. / 
mm 
dp / µm pore diameter / Å 
ΔPmax/ 
bar 
Eksigent HALO C18 core-shell 
fully 
endcapped 
50 0.3 2.7 90 690 
Merck Chromolith CapRod C18 monolithic 
fully 
endcapped 
150 0.2 macro pores 2.0 meso pores130 218 
YMC Triart C18 
fully porous 
Multistage 
endcapped 
50 0.3 1.9 120 600 
YMC Triart C18 50 0.3 3.0 120 550 
i.d.: column inner diameter, L: column length, dp: particle diameter, ΔPmax: maximum backpressure 
Water (H2O) and acetonitrile (ACN) were used as mobile phase constituents. All solvents were 
purchased from Th. Geyer-Chemsolute (Renningen, Germany) with purity for LC-MS. Formic 
acid (FA), purchased from Sigma-Aldrich (Seelze, Germany), was used at 0.1% (v/v) as solvent 
additive to adjust the pH of the mobile phase and analyte mixture. 
Table 3.2 shows the selected substances including important physico-chemical properties, 
while the structural formulas are compiled in Figure-S 3.1. Naphthalene has been selected 
because there are numerous studies using this model compound [9, 16]. Due to its low 
molecular weight it has a high diffusion coefficient (Dm). Furthermore, its retention is not 
influenced by the mobile phase pH and exhibits only hydrophobic interactions with the 
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stationary phase. In contrast, etoposide has a higher molecular weight and thus lower diffusion 
coefficient. Moreover, etoposide is a pharmaceutical of interest in terms of routine analysis and 
was also part of a previous study we performed to investigate the selectivity of different 
stationary phases [17]. 
Table 3.2: List of the investigated compounds including CAS number, sum formula, molar mass 
and Dm calculated according to Wilke-Chang equation for a mobile phase composition of 
H2O/ACN 50/50 (v/v) and a temperature of 30 °C [18-21]. The viscosity was calculated according 
to [22]. 
number Compound CAS sum formula purity / % provider M / g mol-1 Dm / cm2 s-1 
(1) Etoposide 33419-42-0 C29H32O13 ≥ 98 Sigma 588.57 6.2 x 10-6 
(2) Naphthalene 91-20-3 C10H8 ≥ 98 Fluka 128.17 1.3 x 10-5 
 
The stock solution for the analyte etoposide was prepared using a mixture of 50/50 H2O/ACN 
(v/v). In contrast, naphthalene was dissolved in 100% ACN. For the micro-LC analysis the 
single standards were diluted with acidified water in the ratio of 1 to 10. The final concentration 
for etoposide and naphthalene was 0.1 mg mL-1 and 0.05 mg mL-1 with a composition of 95/5 
and 90/10 H2O/ACN + 0.1% FA (v/v), respectively. 
3.3 Results and discussion 
3.3.1 Determination of efficiency by van Deemter analysis 
The easiest and commonly used way to evaluate the column efficiency in isocratic separation 
is done by van Deemter analysis which is illustrated in Equation 3.2 [15, 23]. 
𝐻 = 𝐴 +
𝐵
𝑢0
+ 𝐶 ∙ 𝑢0 Equation 3.2 
where A is the eddy diffusion, B the longitudinal diffusion, C the mass transfer and u0 the linear 
velocity. For the determination of efficiency by van Deemter analysis the retention factor should 
be constant for all investigated columns. Thereby, the results are directly comparable because 
the influence of k on N can be neglected [24]. This is especially important for small i.d. columns. 
Figure 3.1 shows the comparison of the van Deemter curves for the different chromatographic 
supports at 30 °C for etoposide and naphthalene. 
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Figure 3.1: Van Deemter plots for a) etoposide and b) naphthalene at 30 °C. For mobile phase 
compositions, please refer to Table-S 3.1. 
Comparing the obtained van Deemter curves for etoposide and naphthalene on the columns 
packed with 1.9 µm and 3.0 µm fully porous particles it can be seen that decreasing the particle 
diameter leads to smaller values for H due to the decreased A-term. In addition, the slope in the 
C-term region of the van Deemter curve is much smaller because of the improved mass transfer 
for sub-2 µm particles. Decreasing the particle diameter from 3.0 µm to 1.9 µm improves the 
value of Hmin from 12.0 µm to 4.9 µm for etoposide and from 14.8 µm to 6.6 µm for 
naphthalene. This corresponds to a factor of 2.5 and 2.3 showing the poor packing of the 3.0 µm 
particle packed column because an improvement by a factor of 1.6 was expected. 
Considering Figure 3.1 a) it can be seen that the B-term region cannot be represented adequately 
for etoposide due to its higher molecular weight and decreased diffusion coefficient. However, 
the column packed with 1.9 µm fully porous particles shows superior efficiency over the entire 
flow rate range with Hmin of 4.9 µm when compared to all other columns. The column packed 
with 2.7 µm core-shell particles has a slightly higher Hmin compared to the 1.9 µm fully porous 
particle packed column for etoposide. The slope in the C-term region is comparable for the 
core-shell and the monolithic stationary phase. For the monolithic column it can be assumed 
that the minimum plate height is comparable to the column packed with 3.0 µm fully porous 
particles which has a larger Hmin due to the increased particle diameter, which is consistent with 
literature data [25]. In addition, the slope of the C-term for the column packed with 3.0 µm fully 
porous particles is much higher than for every other column due to a slower mass transfer and 
poor packing quality. 
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For the small molecule naphthalene in Figure 3.1 b), the core-shell as well as the column packed 
with 1.9 µm fully porous particles show comparable efficiencies. Again, the monolithic column 
and the column packed with 3.0 µm fully porous particles have an increased Hmin compared to 
the core-shell and sub-2 µm particle packed column. In general, the slope of the C-term is 
reduced for all columns because of the higher diffusion coefficient of the low molecular weight 
compound naphthalene. 
An overview about the minimum reduced plate heights hmin is given in Table 3.3 for the apparent 
efficiency of the investigated columns in order to compare the different particle diameters and 
chromatographic supports in terms of the packing quality using Equation 3.3 [26]. 
ℎ =
𝐻
𝑑𝑝
 𝑜𝑟 
𝐻
𝑑𝑑
 Equation 3.3 
For the calculation of hmin for monolithic columns the domain size (dd) is used instead of the 
particle diameter [25, 27]. 
Table 3.3: Comparison of the minimum reduced plate height hmin for etoposide (k=4) and 
naphthalene (k=11) for all investigated columns as well as the ratio between the column i.d. and 
particle diameter. 
chromatographic support 
Minimum reduced plate height hmin Aspect ratio 
Etoposide 
(k=4) 
Naphthalene 
(k=11) 
dc/dp 
fully porous, 3.0 µm 3.99 4.92 100 
fully porous, 1.9 µm 2.56 3.48 158 
monolithica) 4.49 3.79 - 
core-shell, 2.7 µm 3.02 2.69 111 
a) domain size: 3.38 µm [25, 27] 
⃰ Hmin not reached 
In Table 3.3 it can be seen that the obtained values for hmin strongly depend on the selected 
compound [26]. Comparing the minimum reduced plate height for the columns packed with 
1.9 µm and 3.0 µm fully porous particles, significant differences for hmin are observed. Due to 
its lower hmin, it can be assumed that sub-2 µm particles can be packed more efficiently in 
300 µm i.d. columns than the 3.0 µm particles. This seems surprising because the common 
opinion is that sub-2 µm particles are difficult to pack homogeneously [1]. One possible 
explanation for our results could be the aspect ratio between column i.d. and particle diameter 
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as shown in Table 3.3 which is more favorable for the 1.9 µm particles. In literature different 
results can be found for the influence of the aspect ratio on the reduced plate height when the 
column diameter is reduced at constant particle diameter. Whereas Eeltink et al. [28] found no 
influence of the aspect ratio for 75 - 150 µm columns, Kennedy et al. [29] and Patel et al. [3] 
found decreasing efficiency with increasing column diameter from 25 to 150 µm due to the 
increased radial diffusion time. To that end, decreasing the i.d. of the column to 300 µm has a 
negative influence on the achievable hmin when the particle diameter is constant compared to 
even smaller i.d. columns [11, 25]. However, the influence of the extra-column volume needs 
to be considered when different i.d. columns are compared on identical LC systems. 
Furthermore, the particle size distribution (psd) is a key parameter for the packing quality [6, 
30]. Considering the data included in Table 3.3, pronounced differences for hmin between the 
column packed with 3.0 µm fully porous particles and the 2.7 µm core-shell particle packed 
column can be observed although the aspect ratio is almost constant. Since the psd is higher for 
3.0 µm particles (d90/d10 = 1.54), the obtained packing quality could be negatively influenced 
compared to the 2.7 µm core-shell particles (d90/d10 = 1.16) [25]. Whereas Gritti et al. reported 
minor effects of psd for 4.6 mm i.d columns [31], Cabooter et al. found a clear relation between 
psd and column efficiency [32]. In general, the impact of large psd for decreased column i.d. 
could be more pronounced due to wall effects during the packing procedure. Commonly, a 
smaller psd is given as a reason why the packing of core-shell stationary phases is more uniform 
compared to fully porous particles leading to a reduced A-term contribution [6, 25, 33]. The 
efficiency of the monolithic column is comparable to 3.0 µm fully porous particles, which was 
also found by Olah et al. [25]. 
For well packed columns, the minimum reduced plate height should be between 2.0 and 2.5 
[34]. Fekete et al. reported hmin values between 2.2 - 3.1 for various fully porous particle 
diameters between 1.5 - 3.0 µm packed into 2 - 2.1 mm i.d. columns [26]. Diószegi et al. 
investigated the column performance of 300 µm i.d. columns packed with 2.7 µm core-shell 
particles. The obtained hmin was 6.69 [35]. This value is much higher compared to other reported 
values below 2 for conventional column i.d. for the same stationary phase material. Gritti et al 
reported an hmin of 6.5 for a 500 µm i.d column packed with 2.7 µm core-shell particles [9].  
In general, the column packed with 1.9 µm fully porous particles (hmin = 2.56) as well as the 
column packed with 2.7 µm core-shell particles (hmin = 2.69) are close to the optimal range for 
hmin considering the apparent efficiency. In addition, the hmin values obtained in our study are 
comparable to or even lower than the values reported by Fekete et al. for conventional column 
Chapter 3: Characterization of efficiency of microbore liquid chromatography columns by van 
Deemter and kinetic-plot analysis 78 
 
i.d. packed with fully porous particles and Gritti et al. for the 500 µm i.d. column packed with 
2.7 µm core-shell particles [9, 26]. Assuming a lower extra-column volume for the system used 
in our study, the apparent efficiency could be improved and therefore the value of hmin could be 
decreased. The influence of the extra-column volume will be discussed in more detail in the 
following section. Due to the superior performance (hmin = 2.56) of the column packed with 
fully porous 1.9 µm particles, the following investigations are focused on this column. 
3.3.2 Extra-column contribution of chromatographic system 
Over the last years, the influence of the extra-column volume in liquid chromatography on the 
obtained chromatographic efficiency has been extensively discussed in the literature when 
small i.d. columns became commercially available [5, 9, 36-39]. In general, the apparent 
column efficiency is always negatively affected by the total system variance (σ²v,ec) of the LC 
system including tubings (σ²v,ec,cap), injection valve and injection volume (σ²v,ec,inj) as well as the 
detector cell (σ²v,ec,det) and becomes more crucial when the peak volumes decrease [5]. The total 
band spreading due to the system volumes can be estimated using Equation 3.4. 
𝜎𝑣,𝑒𝑐
2 = 𝜎𝑣,𝑒𝑐,𝑖𝑛𝑗
2 + 𝜎𝑣,𝑒𝑐,𝑐𝑎𝑝
2 +  𝜎𝑣,𝑒𝑐,𝑑𝑒𝑡
2 =
𝑉𝑖𝑛𝑗
2
12
+ 𝜎𝑣,𝑒𝑐,𝑐𝑎𝑝
2 + 𝜎𝑣,𝑒𝑐,𝑑𝑒𝑡
2  Equation 3.4 
In order to determine the intrinsic efficiency the obtained efficiency values can be corrected for 
extra-column volume [38, 40]. This can be done by replacing the column by a zero dead volume 
(ZDV) union [36]. After this replacement, the flow-dependent experiments are repeated in order 
to determine the band spreading which is caused by the micro-LC system. The experimental 
extra-column volume, as depicted in Figure-S 3.3, was 0.0406 µL² at 15 µL min-1 without 
correcting for the injection plug.  
Figure 3.2 shows the comparison of the apparent and intrinsic efficiency for naphthalene on the 
column packed with 1.9 µm particles at 30 °C. The intrinsic efficiency (Nintrinsic) was calculated 
according to Equation 3.5 [38]. 
𝑁𝑖𝑛𝑡𝑟𝑖𝑛𝑠𝑖𝑐 = 16 ∙
[𝑡𝑅,𝑜𝑏𝑠 − 𝑡0,𝑒𝑐]
2
𝑤4𝜎,𝑜𝑏𝑠
2 − 𝑤4𝜎,𝑒𝑐
2  
Equation 3.5 
where tR,obs is the observed retention time, t0,ec the system void time, w4σ,obs the observed base 
peak width and w4σ,ec the observed extra-column peak width. 
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Figure 3.2: Comparison of the apparent and intrinsic van Deemter plots for naphthalene on the 
column packed with 1.9 µm fully porous particles. For mobile phase compositions, please refer to 
Table-S 3.1. 
Figure 3.2 demonstrates that the negative influence of the extra-column volume causes a 
substantial loss in efficiency when the linear velocity is higher than 2.25 mm s-1 even for a k of 
11. Comparing the values for H at 5.18 mm s-1 it can be calculated that only 72% of the intrinsic 
efficiency is achieved. 
To improve the apparent efficiency, the i.d. of the connection tubings was decreased from 
50 µm to 25 µm before and after the column. As can be seen from Figure-S 3.4, the influence 
of the tubing i.d. is negligible. One possible explanation could be the contribution of the 
injection valve and especially the influence of the injection volume. Considering Equation 3.4, 
the band broadening caused by the injection plug can be calculated. For an injection volume of 
442 nL the resulting σ²v,ec,inj is 1.63 10-2 µL² and therefore 40% of the total system variance. 
Consequently, the contribution of the injection volume is much more pronounced. Therefore, 
the injection volume should be decreased in order to represent the influence of the detection 
cell. Assuming an injection volume of 0.02 µL, the contribution of the injection plug can be 
reduced to σ²v,ec,inj = 3.3 10-5 µL² to achieve larger apparent efficiencies. 
3.3.3 Characterization of efficiency by kinetic plot analysis 
The fundamentals for the kinetic plot theory were first developed by Giddings et al. [41] and 
Poppe et al. [42], before Desmet et al. established several versions of the kinetic plot data 
evaluation strategy for isocratic separations [15]. Using this kind of data analysis allows for a 
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fair comparison of efficiency for different chromatographic supports. In addition, practical 
information about the achievable efficiency in a given time can be obtained. To that end, the 
van Deemter data are transformed into so-called fixed length kinetic plots. By replacing the 
actual pressure drop of the analysis by a defined maximum pressure (∆Pmax), the fixed length 
kinetic plot can be transformed into a variable length kinetic plot using Equation 3.6 and 
Equation 3.7 in order to create the kinetic plot limit (KPL) curve [43, 44]. The permeability 
(Kv0) was calculated according to Equation 3.8. 
𝑡0 =
∆𝑃𝑚𝑎𝑥
𝜂
∙ [
𝐾𝑣0
𝑢0
2 ]
𝑒𝑥𝑝
 Equation 3.6 
𝑁 =
∆𝑃𝑚𝑎𝑥
𝜂
∙ [
𝐾𝑣0
𝑢0 ∙ 𝐻
]
𝑒𝑥𝑝
 Equation 3.7 
𝐾𝑣0 =
𝑢0 ∙ 𝜂 ∙ 𝐿
(∆𝑃𝑡𝑜𝑡𝑎𝑙 − ∆𝑃𝑠𝑦𝑠𝑡𝑒𝑚)
 Equation 3.8 
where η is the mobile phase viscosity. This curve illustrates the maximum achievable efficiency 
which can be reached for each stationary phase material in a given time at ∆Pmax [45]. The 
comparison of the KPL curves allows for conclusions about the most efficient column and gives 
information about the corresponding column length. Figure 3.3 illustrates the resulting KPL 
curves for etoposide and naphthalene for a ∆Pmax of 600 bar which corresponds to the maximum 
pressure of the column packed with 1.9 µm fully porous particles as specified by the 
manufacturer. In addition, Hara et al. very recently showed increased pressure capabilities for 
monolithic columns in capillary column formats up to 800 bar [14]. Furthermore, this ∆Pmax is 
an appropriate assumption for a practically applied pressure drop.  
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Figure 3.3: Kinetic plot for a) etoposide (k=4) and b) naphthalene (k=11) assuming a ∆Pmax of 
600 bar. The viscosity was calculated according to [22]. For mobile phase compositions, please 
refer to Table-S 3.1. 
In the context of ultra-fast liquid chromatography, a column void time of 10 s maximum, which 
is highlighted by the dashed lines in Figure 3.3 a) and b), should be achieved. Within this region, 
the column packed with 1.9 µm fully porous particles shows superior efficiency compared to 
all other columns for etoposide and naphthalene. Even at a column void time of 1 s, the value 
of N is 1231 using a column length of 2.47 cm for naphthalene. All other columns have smaller 
values of N despite the longer corresponding column length. These results clearly show that 
sub-2 µm particles should be used for ultra-fast liquid chromatography. The first alternative for 
such applications is the column packed with 2.7 µm core-shell particles. At a column void time 
of 20 s, higher efficiency can be obtained using this stationary phase material for naphthalene. 
At this point it must be noted that these are extrapolated data and therefore should be interpreted 
with care. In addition, within this region the column length becomes very short, therefore extra-
column contribution must be considered. In contrast, for ultra-high efficiency, the monolithic 
column exhibits superior performance. However, the consequence is increased analysis times. 
For a k of approximately 4, all columns show similar maximum efficiencies. Only at a t0 larger 
than 104 s, the monolithic column outperforms all other stationary phases. 
In Table 3.4, the values of N and corresponding column length (L) are calculated for a t0 of 1 s 
and 10 s assuming three different scenarios for ∆Pmax. A ∆Pmax of 200 bar was chosen because 
it represents the maximum pressure of the monolithic column as specified by the manufacturer. 
In addition to the practical applied maximum pressure of 600 bar, a ∆Pmax of 1,000 bar has been 
chosen because most UHPLC systems can be used at this pressure drop. 
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Table 3.4: Comparison of the maximum achievable efficiency at 200, 600 and 1,000 bar and a 
column void time of 100 s and 101 s for etoposide (k=4) and naphthalene (k=11). The viscosity was 
calculated according to [22]. 
t0 / 
s 
chromatographic 
support 
compound 
etoposide k = 4 
200 bar 600 bar 1,000 bar efficiency gain 
N 
L / 
cm 
N 
L / 
cm 
N 
L / 
cm 
1,000 : 200 bar 
/ % 
100 
1.9 µm a) 591 1.38 596 2.39 597 3.08 0.90 
3.0 µm a) 163 2.00 165 3.46 166 4.46 2.35 
monolithic 193 4.62 198 8.00 199 10.33 3.15 
2.7 µm b) 319 1.93 322 3.33 323 4.30 1.38 
101 
1.9 µm a) 5383 4.37 5760 7.55 5842 9.75 8.53 
3.0 µm a) 1485 6.31 1571 10.93 1599 14.12 7.68 
monolithic 1723 14.60 1845 25.30 1887 32.66 9.52 
2.7 µm b) 2971 6.09 3110 10.54 3150 13.61 6.05 
t0 / 
s 
chromatographic 
support 
compound 
naphthalene k = 11 
200 bar 600 bar 1,000 bar efficiency gain 
N 
L / 
cm 
N 
L / 
cm 
N 
L / 
cm 
1,000 : 200 bar 
/ % 
100 
1.9 µm a) 1147 1.43 1231 2.47 1250 3.19 9.03 
3.0 µm a) 336 2.05 342 3.54 344 4.58 2.50 
monolithic 379 4.67 390 8.08 394 10.43 3.85 
2.7 µm b) 859 1.97 873 3.42 876 4.41 2.02 
101 
1.9 µm a) 6273 4.52 9393 7.82 10458 10.10 66.72 
3.0 µm a) 2877 6.47 3197 11.21 3280 14.47 14.00 
monolithic 3303 14.76 3588 25.55 3687 33.00 11.63 
2.7 µm b) 6988 6.24 8107 10.81 8377 13.96 19.88 
a) fully porous particles, b) core-shell particles 
Considering the data included in Table 3.4 it can be seen that for a t0 of 1 s an increased ∆Pmax 
results in almost no benefit on the achievable efficiency for etoposide with a k of approximately 
4. This observation is not valid for naphthalene. For a k of 11, the efficiency of the column 
packed with 1.9 µm fully porous particles can be increased by 9%. One possible explanation 
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for the almost constant efficiency for all applied ∆Pmax at a t0 of 1 s could be the influence of 
the extra-column volume [36]. However, assuming a t0 of 10 s, the increased ∆Pmax leads to 
higher efficiency for all columns. This is more pronounced for naphthalene due to the higher 
retention factor. Nevertheless, for all applied pressure drops the column packed with 1.9 µm 
fully porous particles outperforms all other columns regardless which k and ∆Pmax is adjusted. 
Therefore, the data contained in Table 3.4 support the results which can be derived from Figure 
3.3 that the sub-2 µm particle packed column should be used for ultra-fast liquid 
chromatography in isocratic elution. However, for ultra-high efficiencies, the monolithic 
column provides the highest number of theoretical plates. 
3.4 Conclusion 
The results of the van Deemter analysis clearly show the superior performance of 1.9 µm fully 
porous particles. The calculated hmin is comparable or even decreased compared to conventional 
normal bore columns packed with sub-2 µm fully porous particles and definitely lower 
compared to all other reported values for micro-LC columns despite the higher extra column 
volume compared to Gritti et. al. An increased hmin was found for the 3.0 µm fully porous 
particle packed column as well as for the column packed with 2.7 µm core-shell particles 
compared to literature data for normal bore i.d. columns. One possible explanation could be the 
aspect ratio between the column i.d. and particle diameter. Nevertheless, the packing quality of 
2.7 µm core-shell particles seems to be higher due to the narrower particle size distribution 
compared to 3.0 µm fully porous particles. Eliminating the extra-column band spreading and 
calculating the intrinsic efficiency, hmin is 2.1 for the 2.7 µm core-shell particle packed column 
which is within the optimum range as shown in Figure-S 3.5. 
Kinetic plot studies were done to evaluate the performance for ultra-fast liquid chromatography. 
The results indicate that a higher pressure has a limited benefit for the achievable efficiency at 
a t0 of 1 s especially when ∆Pmax is increased from 600 to 1,000 bar. In following studies the 
system design will be optimized by reducing the injection volume and decreasing the detector 
cell contribution in order to achieve higher apparent efficiencies. In addition, the investigations 
will be expanded to gradient elution experiments. 
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3.7 Chapter appendix 
3.7.1 Analyte structure 
Figure-S 3.1 shows the structural formulas of the investigated compounds. 
 
Figure-S 3.1: Structures of the investigated compounds: (1) etoposide and (2) naphthalene [1]. 
3.7.2 Mobile phase compositions 
For the adjustment of the retention factor (k), the mobile phase composition was varied for 
every column according to Table-S 3.1. 
Table-S 3.1: Overview of the mobile phase composition to adjust the retention factor for every 
column. 
column 
Mobile phase composition: water / acetonitrile (v/v) 
30 °C 
etoposide naphthalene 
Fully porous 
(50 x 0.3 mm, 1.9 µm) 
72.2 / 27.8 58.2 / 41.8 
Fully porous 
(50 x 0.3 mm, 3.0 µm) 
72.2 / 27.8 57.4 / 42.6 
Core-shell 
(50 x 0.3 mm, 2.7 µm) 
75.0 / 25.0 59.8 / 40.2 
Monolith 
(150 x 0.2 mm) 
78.5 / 21.5 68.8 / 31.2 
 
3.7.3 Peak shape study 
In general, the peak shape is crucial for the investigation of column efficiency. Therefore, an 
optimization and critical evaluation of the peak shape is necessary. In particular, the 
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connections between the different parts of the micro-LC system are decisive. Different fitting 
and capillary technology was tested to improve the peak shape. Figure-S 3.2 illustrates two 
different peak profiles for naphthalene before and after optimization. 
 
Figure-S 3.2: Comparison of a) the initial peak shape and b) optimized peak shape of naphthalene 
for a flow rate of 10 µL min-1. Both peak profiles were measured on the column packed with 
1.9 µm fully porous particles using the same injection volume. 
Although the peak shape in Figure-S 3.2 a) is acceptable, a slight tailing can be observed as 
highlighted by the dashed circle. In contrast, the peak shape in Figure-S 3.2 b) shows almost a 
symmetric peak profile when compared to the best Gaussian fit using optimized connections. 
This optimization allows for a determination of column efficiency at peak base width. 
3.7.4 Extra-column variance 
Figure-S 3.3 shows the experimentally determined system extra column volume (σ2v,ec) for a 
flow rate range between 10 to 50 µL min-1. For a flow rate of 15 µL min-1, σ2v,ec is 0.0406 µL2. 
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Figure-S 3.3: Experimentally determined system extra column volume (σ2v,ec) for a flow rate range 
between 10 to 50 µL min-1. 
3.7.5 Influence of the inner diameter of the connection tubing 
To improve the apparent efficiency, the i.d. of the connection tubings was decreased from 
50 µm to 25 µm before and after the column. Thereby, the extra-column volume contribution 
of the connection tubings was decreased by a factor of four. Figure-S 3.4 illustrates the 
comparison between the different tubing i.d. for naphthalene and etoposide at 30 °C. 
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Figure-S 3.4: Comparison of the van Deemter curves for a) etoposide and b) naphthalene at 30 °C 
on the column packed with 1.9 µm fully porous particles using 25 µm and 50 µm i.d. connection 
tubings. For mobile phase compositions, please refer to Table-S 3.1. 
As can be seen, varying the i.d. of the connection tubings has only a minor effect on the obtained 
efficiencies. Apparently, a slight loss of efficiency is only obtained if the flow rate is increased 
beyond the optimal linear velocity for the higher molecular weight compound. If the column is 
operated near uopt, the i.d. of the connection tubing does not have a negative influence on the 
band spreading. 
3.7.6 Intrinsic efficiency for 2.7 µm core-shell packed column 
Figure-S 3.5 illustrates the comparison between the apparent and intrinsic efficiency for 
naphthalene on the column packed with 2.7 µm core-shell particles. 
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Figure-S 3.5: Comparison of the apparent and intrinsic efficiency for naphthalene on the column 
packed with 2.7 µm core-shell particles at 30 °C. For mobile phase compositions, please refer to 
Table-S 3.1. 
By eliminating the influence of the extra-column volume contribution, the minimum reduced 
plate height (hmin) can be reduced from 2.69 to 2.10. 
3.7.7 References 
[1]  ChemSpider, http://www.chemspider.com, (accessed 09.06.2016) 
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Abstract 
The performance of micro-liquid chromatography columns with an inner diameter of 0.3 mm 
was investigated on a dedicated micro-LC system for gradient elution. Core-shell as well as 
fully porous particle packed columns were compared on the basis of peak capacity and gradient 
kinetic plot limits. The results for peak capacity showed the superior performance of columns 
packed with sub-2 µm fully porous particles compared to 3.0 µm fully porous and 2.7 µm core-
shell particles within a range of different gradient time to column void time ratios. For ultra-
fast chromatography a maximum peak capacity of 16 can be obtained using a 30 s gradient for 
the sub-2 µm fully porous particle packed column. A maximum peak capacity of 121 can be 
achieved using a 5 min gradient. In addition, the influence of an alternative detector cell on the 
basis of optical waveguide technology and contributing less to system variance was investigated 
showing an increased peak capacity for all applied gradient time / column void time ratios. 
Finally, the influence of pressure was evaluated indicating increased peak capacity for 
maximum performance whereas a limited benefit for ultra-fast chromatography with gradient 
times below 30 s was observed. 
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4.1 Introduction 
Gradient elution in high performance liquid chromatography is nowadays the predominant 
separation mode [1]. The possibility to separate compounds with different physico-chemical 
properties in a single chromatographic run within a reasonable time frame favors its application 
in reversed liquid chromatography. Especially, the advantage of peak focusing related to peak 
compression in gradient elution methods is considered advantageous compared to isocratic 
separations [2]. During the last decade, the development of both instrument and column 
technology offered the opportunity to achieve fast and highly efficient separations due to 
increasing pressure capabilities of the chromatographic system including the stationary phase 
up to 1,500 bar [3]. To achieve even faster separations at lower flow rates, which is a 
prerequisite for coupling with mass spectrometry (MS), the column inner diameter (i.d.) was 
subsequently decreased from 4.6 mm to 2.0 mm. Currently, this trend continues to even smaller 
column i.d.s of 1.0 mm to 0.3 mm [4]. At the same time stationary phase materials, such as sub-
2 µm fully porous particles with a minimum particle diameter (dp) of 1.5 µm as well as core-
shell particle packed columns with a dp of 1.3 µm, were introduced to accomplish highly 
efficient separations and attain increased peak capacities in shorter analysis times when using 
decreased column i.d. and length [5-7]. To take full advantage of such small i.d. columns and 
subsequently small peak volumes, the system contribution to extra-column band broadening 
needs to be further minimized [8-12]. Especially, for miniaturized columns with an i.d. of 
0.3 mm dedicated micro-LC systems have been developed. In particular, micro-LC systems are 
characterized by low gradient delay volumes allowing the use of fast cycle times of 30 s and 
smaller because of the immediate effectiveness of the solvent gradient. Due to the high linear 
velocities and decreased gradient delay volumes, fast separations and column re-equilibration 
can be achieved leading to reduced analysis cycle times, which is of utmost importance for 
routine analysis [7, 13]. These properties are also favorable for the applicability of micro-LC 
as a second dimension of an online comprehensive two-dimensional chromatography (LCxLC) 
system as has been recently shown by Haun and Leonhardt [14, 15]. In general, these benefits 
have been a major driver for implementing capillary columns - especially in combination with 
mass spectrometry - in different application areas [13, 16-18]. To circumvent possible column 
overloading, several investigations have explored means to overcome the limited loadability of 
small i.d. columns by temperature focusing, online solid phase extraction or direct large volume 
injection, illustrating the effort of optimizing this separation dimension [17, 19, 20]. 
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However, only little information about systematic efficiency characterization in gradient elution 
is available for miniaturized columns packed with commercially available state-of-the-art 
particles [21]. Therefore, this contribution focuses on the question, which peak capacity can be 
obtained using 300 µm i.d. micro-LC columns packed with various chromatographic supports 
on a dedicated micro-LC system. Furthermore, the influence of different chromatographic 
supports varying in dp is investigated with respect to applications requiring high peak capacities 
and therefore decreased gradient slopes. In addition, the range of ultra-fast chromatography 
with a maximum gradient time of 30 s for the applicability of online LCxLC and high 
throughput analysis is evaluated. Moreover, an alternative miniaturized detector cell based on 
optical waveguide technology was evaluated with respect to its influence on peak capacity to 
demonstrate the impact of reduced extra-column volume. For data evaluation, the peak capacity 
was determined and subsequently transformed into gradient kinetic plot limits. 
4.2 Materials and methods 
All experiments were performed on an Eksigent ExpressLC Ultra system (Sciex, Dublin, CA) 
with a micro-LC flow module (flow rate range: 5-50 µL min-1). The pneumatic pump was 
capable of 690 bar maximum pressure. Flow calibration was carried out at a flow rate of 
25 µL min-1. The sample was loaded by an HTS PAL autosampler (CTC Analytics, Zwingen, 
Switzerland). The installed fused-silica, surrounded by a polyetheretherketone (PEEKSil) 
sample loop, had an inner diameter of 75 µm and a length of 10 cm. The sample was injected 
through a built-in six-port valve using the full loop injection mode of the software injecting 
442 nL. An integrated static air column oven was used for temperature control of the stationary 
phase. For data acquisition, a built-in diode array detector (DAD) was employed with a cell 
volume of 100 nL as well as an alternative detector cell on the basis of optical waveguide 
technology with a cell volume of 6 nL (KNAUER, Berlin, Germany). Chromatograms were 
recorded at 272 nm with a data acquisition rate of 40 Hz and 50 Hz depending on the applied 
detector. 
Fused-silica capillaries with an outer diameter (o.d.) of 360 µm and an inner diameter (i.d.) of 
50 µm were used for the connection prior to and after the column with a length of 10 cm and 
13 cm. Using sleeves, the o.d. was expanded to 1/32” for the connection to the columns and 
detectors. For data acquisition and analysis the Eksigent control software (Version 4.2 Patch 
for ekspert nanoLC 400 and batch acquisition control) and ClarityChrom (V. 6.1.0) were used. 
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Further data processing was performed using Origin Lab V. 9.3 and Microsoft Office Excel 
2013. Table 4.1 presents an overview of the investigated columns. 
Table 4.1: List of the investigated columns. 
Description 
surface 
modification 
chromatographic 
support 
end 
capping 
L / 
mm 
i. d. / 
mm 
dp / µm pore diameter / Å 
ΔPmax/ 
bar 
Eksigent HALO C18 core-shell 
fully 
endcapped 
50 0.3 2.7 90 690 
YMC Triart C18 fully porous 
Multistage 
endcapped 
50 0.3 1.9 120 600 
YMC Triart C18 fully porous 
Multistage 
endcapped 
50 0.3 3.0 120 550 
i.d.: column inner diameter, L: column length, dp: particle diameter, ΔPmax: maximum backpressure 
Water and acetonitrile (ACN) were used as mobile phase constituents. In addition, acetone was 
used for the determination of the gradient delay volume. All solvents were purchased from Th. 
Geyer-Chemsolute (Renningen, Germany) with purity for LC-MS. Formic acid (FA), purchased 
from Sigma-Aldrich (Seelze, Germany), was used at 0.1% (v/v) as solvent additive to adjust 
the pH of the mobile phase and analyte mixture. 
Table 4.2 contains the selected compounds including important physico-chemical properties, 
while the structural formulas are compiled in Figure-S 4.1. All compounds except uracil are 
pharmaceuticals and have different log P values and thus different polarity to obtain a uniform 
distribution over the entire gradient window, which is of utmost importance for an appropriate 
determination of peak capacity [21]. 
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Table 4.2: List of the investigated compounds including CAS number, sum formula, molar mass 
and log P [22]. 
number Compound CAS sum formula purity  
/ % 
provider M /  
g mol-1 
Log P c /  
µg mL-1 
(1) 5-Fluorouracil 51-21-8 C4H3FN2O2 ≥ 99 Fluka 130.08 0.86 5 
(2) Uracil 66-22-8 C4H4N2O2 ≥ 99 Fluka 112.09 0.72 10 
(3) Methotrexate 59-05-2 C20H22N8O5 ≥ 98 Fluka 454.44 -0.24 20 
(4) Etoposide 33419-42-0 C29H32O13 ≥ 98 Sigma 588.56 1.16 50 
(5) Diclofenac 15307-86-5 C14H11Cl2NO2 ≥ 98.5 Sigma 296.15 4.26 10 
 
The stock solutions for all analytes were prepared using a mixture of 50/50 H2O/ACN (v/v) at 
a concentration of 1 mg mL-1. For the analysis the single standards were merged before dilution 
with acidified water. The final concentrations are given in Table 4.2 with a composition of 96/4 
H2O/ACN + 0.1% FA (v/v). 
For the determination of peak capacity, the flow rate was varied between 10 and 50 µL min-1 
in 5-µL steps using a linear gradient from 5% to 95% B. The influence of the gradient slope 
was analyzed using four different gradient times (tG). At a flow rate of 10 µL min
-1, tG was set 
to 0.5, 1.0, 3.0 and 5.0 min. The first two gradient times were chosen to mimic ultra-fast 
chromatography whereas the latter two represent applications requiring high peak capacity. In 
order to ensure the same mobile phase history, the ratio between tG and the column void time 
(t0) needed to be kept constant. Therefore, the t0 values were determined using uracil as column 
void marker at a mobile phase composition of 10/90 H2O/ACN + 0.1% FA (v/v). Afterwards, 
the obtained t0 times were corrected for the system void time (t0,sys) by replacing the column by 
a zero-dead volume (ZDV) union. The gradient time was adjusted to ensure constant elution 
volumes resulting in gradient times between 5 s and 5 min depending on the column t0 and flow 
rate (see Table-S 4.1 - Table-S 4.4). In addition, the ratio between the delay time (td) and t0 had 
to be kept constant to obtain comparable results. Consequently, the gradient delay volume had 
to be determined. Therefore, the column was replaced by a ZDV union using water as mobile 
phase for both solvent channels. In order to illustrate the gradient profile, 0.1% acetone was 
added to the water of solvent channel B. The use of acetone was not considered critical because 
no on-line degasser was used. The gradient delay volume was determined at three different flow 
rates (10, 20 and 40 µL min-1) using a plateau of 0.5 min followed by a 1.0 min linear gradient 
from 5% to 95% B. Afterwards, the gradient delay volume was corrected for the volumes of 
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the connection capillary after the column (Vcap = 255 nL) as well as for the detector cell volume 
(Vdet = 100 nL). Since t0 differed for all columns, an additional isocratic plateau (tp) was added 
at the beginning of the analysis to obtain a constant ratio of td to t0 of 2. In the following, td will 
be used as the sum of the gradient delay time (tdwell) and tp. All measurements were performed 
in triplicate at a column temperature of 30 °C. 
4.3 Results and discussion 
4.3.1 Determination of the gradient delay volume and retention 
factor 
Since the ratio of td/t0 had to be kept constant in order to provide comparable results, the gradient 
delay volume needed to be determined. This was achieved according to the procedure described 
in Chapter 4.2. Figure-S 4.2 shows the resulting gradient profile including the determination of 
the gradient delay volume for a flow rate of 40 µL min-1. In order to characterize tdwell, several 
determination strategies can be applied [23]. As can be identified in Figure-S 4.2, the point of 
intersection between the linear regressions of the isocratic plateau and linear gradient was used. 
Thereby, tdwell is estimated to 0.06 min. After multiplication by the flow rate, the experimentally 
determined gradient delay volume (Vd,exp) needs to be corrected for the corresponding volumes 
of the capillary after the column (Vcap) as well as the detector cell volume (Vdet) according to 
Equation 4.1 to obtain the corrected gradient delay volume (Vd,cor). Compared to conventional 
HPLC systems, this correction is mandatory due to the higher influence of these additional 
volumes. 
𝑉𝑑,𝑐𝑜𝑟 = 𝑉𝑑,𝑒𝑥𝑝 − 𝑉𝑐𝑎𝑝 − 𝑉𝑑𝑒𝑡 Equation 4.1 
After this correction, the final gradient delay volume amounted to 2 µL ± 4.3%, which is far 
below the gradient delay volume of conventional HPLC and UHPLC systems [24]. 
Another important parameter to ensure comparable results is the retention factor (k) of the first 
and last eluting compound. Broeckhoven et al. underlined the necessity of keeping these k 
values constant [25, 26]. Therefore, the retention factor at the point of elution (ke) was calculated 
according to Equation 4.2 [27]. 
𝑘𝑒 =
𝑡𝑅 − 𝑡0
𝑡0
 Equation 4.2 
Although Equation 4.2 is usually applied for isocratic elution, it can be used to verify if the 
adjustments of the gradient time depending on the column void time is appropriate. Further 
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explanations can be found in Chapter 4.7.2. When ke is not constant for the analytes on different 
columns, the gradient profile can be modified to obtain similar values for ke. Figure-S 4.3 
exemplarily shows the ke values obtained for the different columns, analytes and detector cells. 
As can be seen, no adjustment of the gradient slope is necessary since all analytes show similar 
retention behavior. 
4.3.2 Determination of peak capacity 
For the determination of peak capacity the compounds methotrexate, etoposide and diclofenac 
were used. The peak capacity (np,exp) was calculated according to the well-established Equation 
4.3, using the gradient time (tG) and the average peak width (w̅) at the base [28, 29]. 
𝑛𝑝,𝑒𝑥𝑝 = 1 +
𝑡𝐺
?̅?
 Equation 4.3 
After the determination of peak capacity, the obtained np,exp can be plotted versus gradient time 
to evaluate the performance in gradient elution for the chromatographic support. Figure 4.1 a) 
shows the resulting plot of np versus tG for the column packed with 3 µm fully porous particles 
using a tG/t0 ratio of 12 as illustrated by the squares. 
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Figure 4.1: Comparison of the experimentally determined peak capacity and gradient kinetic plot 
limits for a maximum pressure of 600 bar for the column packed with 3 µm fully porous particles 
using a tG/t0 ratio of 12. a) experimentally obtained peak capacity (squares) and gradient kinetic 
plot limits (circles) versus the gradient time, the curved arrow illustrates the increase in flow rate, 
b) experimentally obtained peak capacity (squares) and gradient kinetic plot limits (circles) versus 
the column length, whereas the dashed arrow represents the corresponding column length for a 
flow rate of 10 µL min-1, the full line arrow demonstrates the length elongation at a flow rate of 
45 µL min-1 (n=3). 
At a flow rate of 10 µL min-1 and a tG of 2.98 min a peak capacity of 51 can be experimentally 
achieved. With increasing flow rate and thus decreasing tG, the value for np,exp decreases to 31 
at a tG of 0.65 min and a flow rate of 45 µL min
-1 resulting in a ΔPmax of 469 bar as indicated 
by the arrow. 
4.3.3 Transformation of peak capacity into gradient kinetic plots 
In order to apply the kinetic plot analysis to gradient elution, the analytes have to experience 
the same relative mobile phase history [28, 29]. Therefore, the ratios between tG/t0 as well as 
td/t0 must be kept constant. To demonstrate that the gradient kinetic plot method can also be 
applied to miniaturized columns, the transformation of np,exp values into gradient kinetic plots 
limits (np,KPL) is shown in Figure 4.1 a) for the column packed with 3.0 µm fully porous particles 
for a tG/t0 ratio of 12 at a maximum backpressure (ΔPmax) of 600 bar as illustrated by the circles. 
The transformation was computed according to the Equation 4.4 - Equation 4.7 [28] introducing 
the length-elongation factor (λ). 
𝜆 =
∆𝑃𝑚𝑎𝑥
∆𝑃𝑒𝑥𝑝 − ∆𝑃𝑒𝑐
 Equation 4.4 
𝑛𝑝,𝐾𝑃𝐿 = 1 + √𝜆 ∙ (𝑛𝑝,𝑒𝑥𝑝 − 1) Equation 4.5 
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𝑡𝐺,𝐾𝑃𝐿 = 𝜆 ∙ 𝑡𝐺,𝑒𝑥𝑝 Equation 4.6 
𝐿𝐾𝑃𝐿 = 𝜆 ∙ 𝐿𝑒𝑥𝑝 Equation 4.7 
where ΔPexp is the experimental pressure drop, ΔPec the extra-column backpressure both at 
maximum viscosity, tG,exp and Lexp the experimental gradient time and column length, tG,KPL and 
LKPL the corresponding gradient time and column length of the gradient kinetic plot. As can be 
seen from Figure 4.1 a), the maximum peak capacity np,KPL can be increased to 130 using a 
gradient time of approximately 20 min but at the same time the column length needs to be 
increased to 34 cm as indicated by the dashed arrow in Figure 4.1 b) where the peak capacity 
is plotted against the column length. The peak capacity can thus be increased by a factor of 2.6 
by maximizing the column length until the maximum pressure is obtained. At the same time, 
the gradient time increases by a factor of 6.8, which reduces sample throughput. On the other 
hand for an increased flow rate of 45 µL min-1, np,KPL is 38 and thus 20% higher compared to 
np,exp as demonstrated by the full line arrow because the maximum pressure of 550 bar is not 
achieved during the experiments at the applied flow rate as shown above. At this point, it must 
be noted that the packing of such columns length is challenging. However it would be possible 
to couple already available column lengths like three times 10 cm and one 5 cm long column 
in order to obtain a column length of 35 cm. 
4.3.4 Comparison of chromatographic supports for maximum 
peak capacity 
For the investigation of maximum peak capacity depending on the applied chromatographic 
support, the results for the flattest gradient slope of 18% B min-1 resulting in a tG/t0 ratio of 20 
are evaluated. Figure 4.2 shows the peak capacities np,exp and np,KPL obtained for a ΔPmax of 
600 bar. The results for all remaining tG/t0 ratios are given in the supplementary material 
(Figure-S 4.4 - Figure-S 4.6). 
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Figure 4.2: Comparison of peak capacity for the different chromatographic supports at tG/t0 of 20. 
a) experimentally obtained peak capacities and b) gradient kinetic plot limits for a maximum 
pressure of 600 bar. The full line arrows are used for the comparison of the peak capacity achieved 
for the 1.9 µm and 3.0 µm fully porous particle packed column (n=3). 
It can be recognized from Figure 4.2 a) that the column packed with 1.9 µm fully porous 
particles is superior to the other stationary phase materials over the gradient time between 2 min 
to 5 min with a maximum pressure of 472 bar at 25 µL min-1. By changing the particle diameter 
from 3.0 µm to 1.9 µm, the maximum peak capacity np,exp can be increased from 76 to 121, thus 
by 59%, in the same tG as indicated by the arrows. The result is different when considering 
np,KPL in Figure 4.2 b). By maximizing the column length until the maximum pressure is 
obtained, the increase in peak capacity when using the 1.9 µm instead of the 3.0 µm fully porous 
particles is only 12.7%. In order to obtain such a high peak capacity for the 3.0 µm fully porous 
particles, the gradient time needs to be increased by a factor of 2 indicating a higher peak 
capacity production rate for the 1.9 µm fully porous particle packed column which is specified 
in Equation 4.8. Therefore, sub-2 µm particles should be chosen for the applied tG/t0 ratio. The 
column packed with 2.7 µm core-shell particles shows similar values for np.exp as well as for 
np,KPL compared to the 3.0 µm fully porous particle packed column. This is rather unexpected, 
since several studies showed similar performance of 2.7 µm core-shell particles to sub-2 µm 
fully porous particle and superior efficiency compared to 3.0 µm fully porous particle packed 
columns under gradient elution conditions for normal bore inner diameter columns [30, 31]. In 
addition, the performance and packing quality was investigated for isocratic elution in a 
previous study, indicating a more homogenous packing quality of the core-shell column 
compared to the 3.0 µm fully porous particle packed column [32]. One possible reason could 
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be the influence of the extra-column volume due to the reduced internal volume of 1.84 µL for 
the 2.7 µm core-shell particle packed column compared to 2.43 µL for the 3.0 µm fully porous 
particle packed column indicating a more favourable extra-column to column volume ratio for 
the fully porous particle packed column. However, Vaast et al. also found comparable peak 
capacities for 2.7 µm core-shell and 3.0 µm fully porous particle packed columns with an i.d. 
of 0.1 mm using the same tG/t0 ratio [21]. In addition, the peak capacity obtained in that study 
is comparable to the 3.0 µm fully porous particles for a tG/t0 of 20 of our study. Furthermore, 
the obtained peak capacity can be compared to conventional column i.d. to evaluate the 
performance of already established column dimensions. As a tool for better comparison, the 
peak capacity production rate (ξ) is calculated according to Equation 4.8 [21]. 
𝜉 =
𝑛𝑝
𝑡𝐺
 Equation 4.8 
Zhang et al. reached a ξ of 0.42 s-1 and 0.58 s-1 for a 50 x 2.1 mm column packed with 1.7 µm 
fully porous and 2.7 µm core-shell particles [33]. The peak capacity production rate for the 
miniaturized column packed with 1.9 µm fully porous particles amounts to 0.41 s-1 and 
becomes therefore very close to the even smaller fully porous particles of 1.7 µm used in that 
study. In contrast, the 0.3 mm i.d. column packed with 2.7 µm core-shell particles shows a ξ of 
only 0.33 s-1 and therefore less efficiency compared to the normal bore i.d. column underlining 
the above statement of poor performance in gradient elution. 
Due to the superior peak capacity of the column packed with 1.9 µm fully porous particles, this 
column was selected for the following investigations. In particular, the influence of the gradient 
slope was a goal of the analyses to demonstrate the potential for faster analysis times, which is 
of utmost importance for routine analysis to increase sample throughput as well as for online 
comprehensive two-dimensional chromatography. 
4.3.5 Influence of the gradient slope 
For the evaluation of the influence of the gradient slope on peak capacity, the results for the 
different tG/t0 ratios are shown in Figure 4.3 for the column packed with 1.9 µm fully porous 
particles, whereas the results for all other chromatographic supports can be found in the 
supplementary material (Figure-S 4.7 - Figure-S 4.8). A tG/t0 of 12 and 20 was assumed for high 
peak capacity requiring applications whereas the range of ultra-fast chromatography is 
represented by a tG/t0 of 2 and 4. 
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Figure 4.3: Influence of the gradient slope on peak capacity for four different tG/t0 ratios a) 
experimentally obtained peak capacities and b) gradient kinetic plot limits for a maximum 
pressure of 600 bar for the column packed with 1.9 µm fully porous particles. 
Figure 4.3 a) shows the resulting np,exp values for tG/t0 ratios of 2, 4, 12 and 20. As expected, 
higher peak capacities can be achieved with decreasing gradient slope. Within a 5 min gradient 
a peak capacity of 121 can be obtained at the lowest flow rate. The value of np,exp decreases 
subsequently to 27 using a 1 min gradient time at the same flow rate. However, even at a tG of 
30 s, a peak capacity of 16 can still be achieved at a flow rate of 10 µL min-1. Considering the 
gradient kinetic plot in Figure 4.3 b) for a ΔPmax of 600 bar, the maximum peak capacity can be 
increased to 225, whereas the value of np,KPL can be raised to almost 30 compared to an np,exp of 
16 for a tG/t0 of 2 by maximizing the column length until the maximum pressure is obtained. 
In particular, the tG/t0 ratio of 2 is of interest for ultra-fast chromatography and high throughput 
analysis as well as for online LCxLC. Therefore, one opportunity to increase peak capacity is 
evaluated by reducing the extra-column volume after the column, since the performance in 
gradient elution is mainly affected by this dispersion assuming sufficient retention for the 
investigated analytes. This was investigated using an alternative detector cell with less 
contribution to system variance. 
4.3.6 Influence of the detector cell contribution 
As mentioned above, micro-LC can be used as the second dimension of online LCxLC systems 
[14]. One prerequisite is a very fast cycle time in the second dimension. To achieve such fast 
cycle times, a maximum gradient time of 30 s is required which is represented by a tG/t0 ratio 
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of 2 at a flow rate of 10 µL min-1. For such steep gradients with a gradient slope of 3.0% B s-1 
at 10 µL min-1 to 7.6% B s-1 at 25 µL min-1, the optimization of the extra-column band 
broadening is mandatory due to the small resulting peak volumes and peak widths to ensure 
highly efficient separations. The built-in UV detector with a volume of 100 nL was hence 
replaced by an alternative UV detector on the basis of an optical waveguide with an i.d. of 
50 µm and a cell volume of only 6 nL. Thereby the extra-column contribution can be 
significantly reduced but at the same time the signal-to-noise ratio decreases by the factor 
approximately 130. Figure 4.4 shows the resulting peak capacities for a tG/t0 ratio of 2 whereas 
all other ratios can be found in the supplementary material (Chapter 4.7.5). 
 
Figure 4.4: Comparison of peak capacity for the built-in and alternative UV detector for the 
column packed with 1.9 µm fully porous particles at a tG/t0 of 2. a) experimentally obtained peak 
capacity, b) gradient kinetic plot limits (n=3). Best fit lines are displayed as well. 
As can be seen, the use of the alternative detector cell has a positive effect on the experimentally 
obtained peak capacity for all investigated tG/t0 ratios (see also Figure-S 4.9 - Figure-S 4.11 a). 
In addition, the influence is more pronounced for tG/t0 2 and 4 as the peak width for the increased 
gradient slopes is smaller and the generated bands are thus more vulnerable to extra-column 
band broadening compared to the bands generated at flatter gradient slopes. Moreover, it can 
be noted that the increase in np,exp decreases at elevated flow rates. This is attributed to the fact 
that the band broadening in the connection tubing depends on the flow rate [9]. When 
comparing the maximum peak capacities for the different gradient slopes, an increase of 30% 
can be achieved for the highest gradient slope (Figure 4.4 a), whereas for the flatter slope 
(Figure-S 4.11 a) only an improvement of 21% can be obtained. For the different flow rates 
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within the tG/t0 2 ratio, the improvement in peak capacity decreased from 30% to 11%. For the 
flatter slope, the increase is only 6% at the highest flow rate (Figure-S 4.11 a). However, it can 
be clearly demonstrated that a minimization of the extra-column volume is also necessary for 
gradient elution, especially when steep gradient slopes are applied. The same result was also 
observed by Vanderlinden et al. for a 2.1 mm i.d column packed with 1.3 µm core-shell 
particles [9]. 
Finally, the experimentally obtained peak capacities of Figure 4.4 a) are transformed into np,KPL 
at a maximum pressure of 600 bar to demonstrate the potential of the chromatographic support 
at ΔPmax illustrated in Figure 4.4 b). The same trends can be identified for the gradient kinetic 
plots. At a ΔPmax of 600 bar, the maximum achievable peak capacity is 263 for a tG/t0 ratio of 
20 using the alternative detector cell (Figure-S 4.11 b). For the highest gradient slope in Figure 
4.4 b), a maximum np,KPL of 37 can be obtained for the detector cell based on optical waveguide 
technology and a column length of 16.4 cm. Yet, the resulting tG is 1.6 min and thus three times 
larger than specified for the maximum gradient time in the second dimension for online LCxLC. 
Considering a maximum tG of 30 s, the comparison between Figure 4.4 a) and b) clearly shows 
that no benefit on peak capacity can be achieved at a ΔPmax of 600 bar despite the longer column 
length of 8.4 cm compared to the 5 cm column as indicated by the dashed lines and full lined 
arrows. However, the same peak capacity can be achieved at a higher flow rate and thus at a 
higher linear velocity. Whereas the flow rate is 10 µL min-1 for the 5 cm column, the flow rate 
can be increased to 18 µL min-1 for a 8.4 cm column. Although no benefit can be obtained with 
respect to the efficiency, the increased flow rate leads to a decreased gradient delay and column 
equilibration time, which is favourable for faster analysis cycle times. As a consequence, the 
sample throughput can be increased. At last, the influence of pressure on np,KPL will be 
investigated for the tG/t0 2 using the alternative detector cell. 
4.3.7 Investigation of pressure for ultra-fast chromatography 
Another approach to increase the maximum peak capacity is the increase of ΔPmax [8]. 
Therefore, the influence of an increased ΔPmax is evaluated. In Figure 4.5 the resulting np,KPL 
are depicted for a ΔPmax of 600, 1,000 and 1,500 bar using the alternative UV detector cell. A 
ΔPmax of 600 bar represents the maximum backpressure of the column packed with 1.9 µm fully 
porous particles as specified by the manufacturer. Increased pressure limits, i.e. 1,000 and 
1,500 bar were used, since several UHPLC systems allow the use of such high pressures [3]. 
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Figure 4.5: Comparison of the resulting gradient kinetic plot limits for a tG/t0 of 2 and a maximum 
pressure of 600, 1,000 and 1,500 bar on the column packed with 1.9 µm fully porous particles using 
the alternative detector cell. Best fit lines are displayed as well. 
As can be recognized from Figure 4.5, the maximum np,KPL can be increased due to the larger 
tG and column length as indicated by the dashed arrows. Identical results were found by De Vos 
et al. [3, 8]. At a tG,KPL of 30 s, the influence is limited despite the longer column, which 
increases from 8.4 cm for a ΔPmax of 600 bar to 11.8 cm for a maximum pressure of 1000 bar 
and 14.5 cm for a ΔPmax of 1500 bar, as highlighted by the dashed lines. The only advantage is 
attributed to the higher linear velocity as already discussed above. At this point it should be 
noted that temperature effects due to frictional heating should be taken into account [34]. While 
the influence of frictional heating is reduced for miniaturized columns due to increased heat 
dissipation [4, 18, 35], the influence needs to be further analyzed. Nevertheless, it can be 
demonstrated that the influence of a very high inlet pressure for ultra-fast chromatography is 
limited for gradient times below 1.5 min. The same result was also obtained for the efficiency 
of isocratic separations at a column void time of 1 s [32]. 
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4.4 Conclusion 
The peak capacity as well as the results of the gradient kinetic plot limits indicate the superior 
performance of sub-2 µm fully porous particles for all applied tG/t0 ratios compared to all other 
chromatographic supports. In general, flatter gradient slopes in combination with low flow rates 
lead to increased peak capacity. Compared to normal bore i.d. columns, similar peak capacity 
production rates can be obtained for sub-2 µm fully porous particles. However, the performance 
of 2.7 µm core-shell particles is comparable to 3.0 µm fully porous particles and is therefore 
decreased when compared to conventional column i.d. For the range of ultra-fast 
chromatography with a tG of 30 s, the sub-2 µm fully porous particle packed column provides 
a peak capacity of 16. When reducing the extra-column volume by decreasing the detector cell 
volume, an increase of 30% can be achieved. In general, the influence of the extra-column 
volume contribution can also be demonstrated for gradient elution, especially when sharp peak 
profiles with peak widths below 2 s are obtained due to increased gradient slopes. The results 
of the gradient kinetic plot limits clearly demonstrate that increased pressure capabilities are 
beneficial for the increase in maximum peak capacity due to the longer column length for all 
tG/t0 ratios. However, the gain in peak capacity is limited for the range of ultra-fast 
chromatography (tG below 30 s). In future studies, the system design will be optimized and 
expanded to temperature depending gradient kinetic plots to further improve peak capacity. 
Thereby, the pressure drop can be significantly reduced allowing the use of longer columns at 
the maximum pressure [36]. 
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4.7 Chapter appendix 
4.7.1 Structural formula of the investigated analytes 
The chemical structures of the analytes are depicted in Figure-S 4.1. 
 
Figure-S 4.1: Chemical structures of the investigated analytes. (1) 5-fluorouracil, (2) uracil, (3) 
methotrexate, (4) etoposide and (5) diclofenac [1]. 
Whereas uracil is often used as column void marker in reversed liquid chromatography, the 
remaining compounds are pharmaceuticals analyzed within our routine analysis. All analytes 
differ in polarity which is of utmost importance for the characterization of peak capacity to 
obtain a uniform distribution across the gradient window. 
4.7.2 Determination of the gradient times, gradient delay volume 
and retention factor 
Table-S 4.1 - Table-S 4.4 show the resulting gradient times (tG) depending on the flow rate and 
column. 
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Table-S 4.1: Resulting gradient times depending on the flow rate and column for a tG/t0 of 2. 
tG/t0 = 2 Gradient times (tG) / min 
Flow rate / µL min-1 1.9 µm fully porous 3.0 µm fully porous 2.7 µm core-shell 
10 0.49 0.49 0.38 
15 0.32 0.32 0.25 
20 0.24 0.24 0.18 
25 0.20 0.20 0.15 
30  0.16 0.12 
35  0.14 0.10 
40  0.12 0.09 
45  0.11  
 
Table-S 4.2: Resulting gradient times depending on the flow rate and column for a tG/t0 of 4. 
tG/t0 = 4 Gradient times (tG) / min 
Flow rate / µL min-1 1.9 µm fully porous 3.0 µm fully porous 2.7 µm core-shell 
10 0.99 0.99 0.75 
15 0.65 0.65 0.50 
20 0.48 0.48 0.37 
25 0.39 0.39 0.29 
30  0.32 0.24 
35  0.28 0.21 
40  0.24 0.18 
45  0.22  
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Table-S 4.3: Resulting gradient times depending on the flow rate and column for a tG/t0 of 12. 
tG/t0 = 12 Gradient times (tG) / min 
Flow rate / µL min-1 1.9 µm fully porous 3.0 µm fully porous 2.7 µm core-shell 
10 2.97 2.98 2.29 
15 1.99 1.98 1.53 
20 1.48 1.44 1.14 
25 1.18 1.15 0.89 
30  0.96 0.74 
35  0.82 0.62 
40  0.71 0.54 
45  0.65  
 
Table-S 4.4: Resulting gradient times depending on the flow rate and column for a tG/t0 of 20. 
tG/t0 = 20 Gradient times (tG) / min 
Flow rate / µL min-1 1.9 µm fully porous 3.0 µm fully porous 2.7 µm core-shell 
10 4.94 4.96 3.82 
15 3.32 3.30 2.55 
20 2.47 2.44 1.90 
25 1.97 1.95 1.49 
30  1.62 1.23 
35  1.39 1.03 
40  1.22 0.90 
45  1.08  
 
Figure-S 4.2 exemplarily illustrates the obtained gradient profile at a flow rate of 40 µL min-1 
including the determination of the gradient delay volume. For the determination, the 
intersection between the linear regressions are used as illustrated by the dashed lines. 
 
Chapter 4: Characterization of peak capacity of microbore liquid chromatography columns 
using gradient kinetic plots  113 
 
 
Figure-S 4.2: Illustration for the determination of the gradient delay volume at a flow rate of 
40 µL min-1. 
The gradient retention factor (k*) should be constant for the first and last eluting compound in 
order to obtain comparable results. For an appropriate adjustment of the gradient retention 
factor, Snyder’definition of k* can be used which is shown in Equation 4.1. 
𝑘∗ =
0.87 ∙ 𝑡𝐺 ∙ 𝐹
𝑉𝑚 ∙ ∆𝛷 ∙ 𝑆
 Equation-S 4.1 
The gradient retention factor depends on the gradient time, flow rate, column volume, gradient 
range and the slope within the linear solvent strength theory (S). By replacing the column 
volume by Equation-S 4.2, Equation 4.3 can be obtained. 
𝑉𝑚 = 𝐹 ∙ 𝑡0 Equation-S 4.2 
𝑘∗ =
0.87 ∙ 𝑡𝐺
𝑡0 ∙ ∆𝛷 ∙ 𝑆
 Equation-S 4.3 
Now the gradient retention factor only depends on the gradient time and column void time since 
the gradient range as well as S are constant for a given solute. Because the column void time 
depends on the column, an adjustment of the gradient time needs to be done to achieve a 
constant ratio for tG/t0 and consequently k*. By calculating the retention factor at the time of 
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elution (ke), it can be verified whether the adjustment of the gradient time depending on the 
column void time was appropriate [2]. One example of the obtained retention factors at time of 
elution is depicted in Figure-S 4.3 for a tG/t0 ratio of 20 at a flow rate of 20 µL min
-1 for all 
columns, analytes and detector cells. 
 
Figure-S 4.3: Comparison of the resulting retention factors for all analytes and detector cells on 
the different stationary phases at a flow rate of 20 µL min-1 (n=3). 
4.7.3 Comparison of chromatographic support 
Figure-S 4.4 shows the resulting experimentally obtained peak capacities (np,exp) as well as the 
gradient kinetic plot (np,KPL) for a ratio of the gradient time (tG) to the column void time (t0) of 
2 obtained on the three different chromatographic supports. For np,KPL a maximum pressure of 
600 bar was used. 
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Figure-S 4.4: Comparison of peak capacity for the different chromatographic supports at tG/t0 of 
2. a) experimentally obtained peak capacities, b) gradient kinetic plots for a maximum pressure 
of 600 bar (n=3). 
Figure-S 4.5 illustrates the comparison of the chromatographic supports for a tG/t0 of 4. 
 
Figure-S 4.5: Comparison of peak capacity for the different chromatographic supports at tG/t0 of 
4. a) experimentally obtained peak capacities, b) gradient kinetic plots for a maximum pressure 
of 600 bar (n=3). 
In Figure-S 4.6, the results for np,exp as well as np,KPL are depicted for a tG/t0 of 12. 
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Figure-S 4.6: Comparison of peak capacity for the different chromatographic supports at tG/t0 of 
12. a) experimentally obtained peak capacities, b) gradient kinetic plots for a maximum pressure 
of 600 bar (n=3). 
4.7.4 Influence of the gradient slope on peak capacity 
Figure-S 4.7 illustrates the influence of the gradient slope for the column packed with 3.0 µm 
fully porous particles. 
 
Figure-S 4.7: Influence of the gradient slope on np,exp as well as np,KPL for the column packed with 
3.0 µm fully porous particles. a) experimentally obtained peak capacity, b) gradient kinetic plots 
(n=3). 
Figure-S 4.8 shows the influence of the gradient slope for the 2.7 µm core-shell particle packed 
column. 
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Figure-S 4.8: Influence of the gradient slope on np,exp as well as np,KPL for the column packed with 
2.7 µm core-shell particles. a) experimentally obtained peak capacity, b) gradient kinetic plots 
(n=3). 
4.7.5 Influence of the detector cell 
Figure-S 4.9 illustrates the influence on the obtained np,exp as well as np,KPL for the alternative 
detector cell using the column packed with 1.9 µm fully porous particles for tG/t0 of 4. 
 
Figure-S 4.9: Comparison of peak capacity for the built-in and alternative UV detector for the 
column packed with 1.9 µm fully porous particle packed column at a tG/t0 of 4. a) experimentally 
obtained peak capacity, b) gradient kinetic plots (n=3). 
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Figure-S 4.10 shows the resulting values for tG/t0 of 12 on the same stationary phase. 
 
Figure-S 4.10: Comparison of peak capacity for the built-in and alternative UV detector for the 
column packed with 1.9 µm fully porous particle packed column at a tG/t0 of 12. a) experimentally 
obtained peak capacity, b) gradient kinetic plots (n=3). 
Figure-S 4.11 shows the resulting peak capacities for a tG/t0 of 20 on the column packed with 
1.9 µm fully porous particles. 
 
Figure-S 4.11: Comparison of peak capacity for the built-in and alternative UV detector for the 
column packed with 1.9 µm fully porous particle packed column at a tG/t0 of 20. a) experimentally 
obtained peak capacity, b) gradient kinetic plots (n=3). 
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Abstract 
The influence of temperature on the performance of micro liquid chromatography columns with 
an inner diameter of 300 µm has been investigated using a dedicated micro-LC system. Core-
shell as well as fully porous particle packed stationary phases are compared on the basis of 
temperature depending van Deemter and kinetic plot analysis both at isocratic and gradient 
elution. For isocratic separations the minimum of the van Deemter curve was found to shift to 
higher linear velocities allowing for faster separations without significant loss of efficiency 
whereas the absolute minimum remained constant. The results of the kinetic plot analysis 
indicate higher efficiency with increasing temperature as well as extended pressure capabilities 
due to the decrease in mobile phase viscosity, which may allow to increase column length. 
Moreover, the influence of elevated temperature is more pronounced compared to increased 
pressure capabilities for column void times below 10 s. However, maximum efficiency can be 
achieved at maximum temperature and pressure in isocratic elution. For gradient elution, the 
peak capacity can be increased by 25% using a 30 s gradient when rising temperature from 30 
to 70 °C. Using a UV detector with less contribution to extra-column variance, the rise in peak 
capacity is about 40%. 
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5.1 Introduction 
One fundamental aim in liquid chromatography is to achieve more efficient and faster analysis 
with reduced resource consumption [1, 2]. To that end, particle diameter (dp) as well as column 
inner diameter and column length were continuously decreased. Nowadays, core-shell particles 
with a diameter of 1.3 µm and fully porous particles with a diameter of 1.5 µm are commercially 
available [3, 4]. However, the decrease in particle diameter inevitably leads to a drastic increase 
in column back pressure [5]. To overcome this problem, the pressure capabilities of LC systems 
were enlarged by introducing systems with maximum pressures of 1,500 bar [6]. However, 
working at such high pressure leads to frictional heating, which can negatively affect column 
performance due to the formation of temperature gradients within the column [7]. As a 
consequence, the column inner diameter needs to be decreased for faster heat dissipation [8, 9]. 
Today, column inner diameters of less than 1.0 mm are available [10]. Moreover, microbore 
columns with an inner diameter of 300 µm have been introduced for micro liquid 
chromatography [11, 12]. For such a small column inner diameter, the influence of frictional 
heating on column performance has been reported to be negligible [13, 14]. Another approach 
to reduce column back pressure uses elevated temperatures leading to the reduction of mobile 
phase viscosity [15]. Thereby, the column back pressure is significantly decreased at constant 
linear velocities [16]. In addition, higher flow rates can be applied leading to faster analysis 
times [17]. Moreover, molecular diffusion coefficients increase at elevated temperatures [18]. 
As a consequence, the slope in the mass transfer region of the van Deemter curve can be reduced 
enabling to work at high linear velocities without compromising separation efficiency [19]. For 
gradient elution, commonly the peak capacity is considered as a measure of column 
performance [20, 21]. Several studies reveal the benefit of elevated temperature to increase 
peak capacity [22-24]. 
To achieve fast analysis times, high linear velocities are mandatory. Microbore columns with 
an inner diameter of 300 µm are ideally suited to achieve high linear velocities at flow rates in 
the low µL min-1 range [25]. Thereby, micro-LC allows for high-throughput analysis as well as 
for very fast second dimension separations in LCxLC [26, 27]. As mentioned above, even faster 
analysis can be accomplished using elevated temperatures. Therefore, the aim of this study 
focuses on the investigation of the influence of temperature on the efficiency of micro-LC 
columns to further increase separation speed. Core-shell as well as fully porous particle packed 
columns were analyzed using van Deemter as well kinetic plot analysis in case of isocratic 
experiments. In addition, peak capacity and gradient kinetic plots were examined for gradient 
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elution. Moreover, the influence of temperature at decreased extra-column variance was 
determined using a low volume UV detector on the basis of an optical waveguide. 
5.2 Materials and methods 
All measurements were performed on an Eksigent ExpressLC Ultra system (Sciex, Dublin, CA) 
with two different standard micro-LC flow modules (flow rate range: 1-10 µL min-1, 5-
50 µL min-1). Whereas the first one is specified in the following as “small flow module”, the 
latter is called “large flow module”. The pneumatic pumps offer the possibility of generating 
690 bar maximum pressure. Flow calibration was carried out at a flow rate of 5 µL min-1 for 
the small flow module whereas the large flow module was calibrated at a flow rate of 
25 µL min-1. The applied sample loop is made of fused-silica surrounded by 
polyetheretherketone (PEEKSil) with an inner diameter of 75 µm and a length of 10 cm. The 
corresponding loop volume was 442 nL. For sample loop filling, an HTS PAL autosampler 
(CTC Analytics, Zwingen, Switzerland) was used. The built-in six port valve was used for 
sample injection using the full loop injection. A static air column oven was used for temperature 
control of the stationary phase. For data acquisition two different UV detectors were applied. 
The built-in diode array detector (DAD) was employed with a cell volume of 100 nL as well as 
an alternative detector cell on the basis of optical waveguide technology with a cell volume of 
6 nL (KNAUER, Berlin, Germany). Fused-silica capillaries with an inner diameter (i.d.) of 
50 µm and an outer diameter (o.d.) of 360 µm were used for the connection prior to and after 
the column with a length of 10 cm and 13 cm, respectively. The o.d. was expanded to 1/32” 
using sleeves for the connection to the columns and detectors. For data acquisition and analysis 
the ClarityChrom (V. 6.1.0) as well as the Eksigent control software (Version 4.2 Patch for 
ekspert nanoLC 400 and batch acquisition control) were used. Further data processing was 
performed using Origin Lab V. 9.3 and Microsoft Office Excel 2013. Table 5.1 presents an 
overview of the investigated columns. 
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Table 5.1: List of investigated columns including column dimensions, particle and pore diameter, 
maximum pressure as well as temperature. 
description 
surface 
modification 
chromatographic 
support 
end capping 
L / 
mm 
i. d. / 
mm 
dp / 
µm 
pore 
diameter / Å 
ΔPmax/ 
bar 
maximum 
temperature 
/ °C 
Eksigent HALO C18 core-shell 
fully 
endcapped 
50 0.3 2.7 90 690 60 
YMC Triart C18 fully porous 
Multistage 
endcapped 
50 0.3 1.9 120 600 
70 (pH 1-7) 
50 (pH 7-12) 
YMC Triart C18 fully porous 
Multistage 
endcapped 
50 0.3 3.0 120 550 
70 (pH 1-7) 
50 (pH 7-12) 
i.d.: column inner diameter, L: column length, dp: particle diameter, ΔPmax: maximum backpressure 
Water (H2O) and acetonitrile (ACN) were used as mobile phase constituents. Moreover, acetone 
was used for the determination of the gradient delay volume. All solvents were purchased from 
Th. Geyer-Chemsolute (Renningen, Germany) with LC-MS grade purity. Formic acid (FA), 
purchased from Sigma-Aldrich (Seelze, Germany), was used at 0.1% (v/v) as solvent additive 
to adjust the pH of the mobile phase and analyte mixture. 
Table 5.2 shows the selected substances including important physico-chemical properties, 
while the structural formulas are compiled in Figure-S 5.1. 
Table 5.2: List of the selected compounds including CAS number, sum formula, molar mass and 
log P [28]. 
number Compound CAS sum formula purity 
/ % 
provider M / 
g mol-1 
Log P c / 
µg mL-1 
(1) 5-Fluorouracil** 51-21-8 C4H3FN2O2 ≥ 99 Fluka 130.08 0.86 5 
(2) Uracil*,** 66-22-8 C4H4N2O2 ≥ 99 Fluka 112.09 0.72 10 
(3) Methotrexate** 59-05-2 C20H22N8O5 ≥ 98 Fluka 454.44 -0.24 20 
(4) Etoposide*,** 33419-42-0 C29H32O13 ≥ 98 Sigma 588.56 1.16 100*, 50** 
(5) Diclofenac** 15307-86-5 C14H11Cl2NO2 ≥ 98.5 Sigma 296.15 4.26 10 
(6) Naphthalene* 91-20-3 C10H8 ≥ 98 Fluka 128.17 2.96 50 
* isocratic measurements, ** gradient experiments 
5.2.1 Isocratic measurements 
For the isocratic measurements, the built-in diode array detector (DAD) was employed with a 
cell volume of 100 nL having a light path length of 5 mm. Chromatograms were recorded at 
254 nm with a data acquisition rate of 10 Hz. For the determination of the van Deemter curves, 
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the flow rate was varied in a range between 2 and 50 µL min-1. Data fitting was performed via 
the least square method. All measurements were carried out in triplicate. To investigate the 
influence of temperature, the column oven temperature was varied between 30, 50 and 70 °C 
depending on the individual maximum temperature as specified by the column manufacturer. 
For the isocratic kinetic plots, maximum pressures (ΔPmax) of 600 and 1,000 bar were used. The 
retention factor k was calculated according to Equation 5.1 using the retention time of uracil as 
column void time (t0). 
𝑘 =
𝑡𝑅 − 𝑡0
𝑡0
 Equation 5.1 
The mobile phase composition was adjusted for every column and temperature in order to 
obtain constant retention factors. An overview can be found in the supporting information 
(Table-S 5.1 - Table-S 5.3). 
For the determination of the van Deemter plots, the compounds naphthalene and etoposide were 
used. Naphthalene was selected because it is often used as model compound [29, 30]. It has a 
high diffusion coefficient (Dm) due to its low molecular weight. Moreover, it exhibits only 
hydrophobic interactions with the stationary phase and retention is not influenced by the mobile 
phase pH. In contrast, etoposide has a higher molecular weight and a lower diffusion 
coefficient. Furthermore, etoposide is a pharmaceutical of interest in terms of routine analysis. 
It was also part of a previous study to investigate the selectivity of different stationary phases 
[31]. 
For the analyte etoposide, the stock solution was prepared using a mixture of 50/50 H2O/ACN 
(v/v). In contrast, naphthalene was dissolved in 100% ACN. For the analysis the single 
standards were diluted with acidified water in the ratio of 1 to 10. The final concentration for 
etoposide and naphthalene were 0.1 mg mL-1 and 0.05 mg mL-1 with a composition of 95/5 and 
90/10 H2O/ACN + 0.1% FA (v/v), respectively. 
5.2.2 Gradient experiments 
For the gradient experiments, the built-in UV detector with a cell volume of 100 nL as well as 
the optical-waveguide based UV detector with a cell volume of 6 nL (KNAUER, Berlin, 
Germany) were used. Detection was carried out at 272 nm with a data acquisition rate of 40 Hz 
and 50 Hz depending on the applied detector. The gradient experiments were performed in the 
flow rate range between 10 and 50 µL min-1 in 5-µL steps using a linear gradient from 5% to 
95% B. For all measurements, the large flow module was used. For the gradient kinetic plots a 
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ΔPmax of 600 bar was considered because increased pressure capabilities showed a limited effect 
on peak capacity for the range of ultra-fast chromatography with gradient times < 100 s as was 
demonstrated by Wang et al [24] (see also Figure 4.5). 
Uracil is used as column void time marker. All other compounds are pharmaceuticals and have 
different log P values and therefore different polarity as can be seen from Table 5.2. This is of 
utmost importance to obtain a uniform distribution over the entire gradient window for an 
appropriate determination of peak capacity [32]. All stock solutions were prepared at a 
concentration of 1 mg mL-1 using a mixture of 50/50 H2O/ACN (v/v). For the micro-LC 
analysis, the single standards were merged and afterwards diluted with acidified water. The 
final concentrations are given in Table 5.2 with a composition of 96/4 H2O/ACN + 0.1% FA 
(v/v). Four different gradient times (tG) were used to analyze the influence of the gradient slope. 
Gradient times were set to 0.5, 1.0, 3.0 and 5.0 min at a flow rate of 10 µL min-1 for all 
investigated temperatures. Whereas the first two gradient times were chosen to mimic ultra-fast 
chromatography, the latter two represent applications requiring higher peak capacity. For an 
appropriate determination of peak capacity the analytes have to experience the same mobile 
phase history. Therefore, the ratio between tG and the column void time (t0) needed to be kept 
constant [33, 34]. Therefore, the t0 values were determined using uracil as column void marker 
at a mobile phase composition of 10/90 H2O/ACN + 0.1% FA (v/v). Subsequently, the 
experimentally obtained t0 times were corrected for the system void time (t0,sys) by replacing the 
column by a zero-dead volume (ZDV) union. The gradient time was adjusted to ensure constant 
elution volumes resulting in gradient times between 5 s and 5 min depending on the column t0, 
flow rate and temperatures (see Table-S 5.4 - Table-S 5.15). Additionally, the ratio between the 
delay time (td) and t0 had to be kept constant to obtain comparable results. The gradient delay 
volume was 2 µL ± 4.3% [11]. At the beginning of the analysis, an additional isocratic plateau 
(tp) was added to obtain a constant ratio of td to t0 of 2 since t0 differed for all columns. In the 
following, td will be used as the sum of the gradient delay time (tdwell) and tp. All measurements 
were performed in triplicate for each temperature. 
5.3 Results and discussion 
5.3.1 Temperature depending Deemter analysis 
The van Deemter analysis is one of the most common approaches to analyze column 
performance in isocratic separations [32, 34]. The corresponding van Deemter equation is given 
in Equation 5.2. 
Chapter 5: The influence of temperature on efficiency of microbore liquid chromatography 
columns  126 
 
𝐻 = 𝐴 ∙ 𝑑𝑝 +
𝐵 ∙ 𝐷𝑚
𝑢0
+ 𝐶 ∙
𝑑𝑝
2 ∙ 𝑢0
𝐷𝑚
 Equation 5.2 
where H is the plate height, A the eddy diffusion, B the longitudinal diffusion, C the mass 
transfer, u0 the linear velocity, Dm the molecular diffusion coefficient and dp the particle 
diameter. According to Equation 5.2, the plate height depends on the molecular diffusion 
coefficient. For the calculation of the temperature dependent diffusion coefficient, the Wilke-
Chang equation (Equation 5.3) can be used [35]. 
𝐷𝑚 = 7.4 ∙ 10
−8
(𝜙𝐵 ∙ 𝑀𝐵)
1
2⁄ ∙ 𝑇
𝜂𝐵 ∙ 𝑉𝐴
0.6  
Equation 5.3 
where MB is the molecular weight of solvent B, T the temperature, ϕB the association factor of 
solvent B, ηB the viscosity of solvent B and VA the molar volume of solute A. In addition to the 
direct dependence of diffusion coefficients on temperature, the mobile phase viscosity also 
changes with temperature. The mobile phase viscosity was calculated according to Equation 
5.4 [36]. 
𝜂𝜙,𝑇 = 𝑒𝑥𝑝 [𝜙 (−3.476 +
726
𝑇
) + (1 − 𝜙) (−5.414 +
1566
𝑇
)
+ 𝜙(1 − 𝜙) (−1.762 +
929
𝑇
)] 
Equation 5.4 
where ηϕ,T is the mobile phase viscosity at the temperature (T) and portion of organic solvent 
(ϕ) within the mobile phase. To investigate the influence of temperature for miniaturized 
columns with an i.d. of 300 µm, the column oven temperature was varied for the individual 
columns. Figure 5.1 shows the resulting temperature dependent van Deemter curves for 
naphthalene on the three investigated columns whereas the corresponding curves for etoposide 
can be found in the supporting information (Figure-S 5.2). 
  
Chapter 5: The influence of temperature on efficiency of microbore liquid chromatography 
columns  127 
 
 
Figure 5.1: Resulting van Deemter curves at 30, 50 and 70 °C for naphthalene for the columns 
packed with a) 1.9 µm fully porous particles, b) 3.0 µm fully porous particles (1.68, 0.72, 0.16) and 
c) 2.7 µm core-shell particles (0.62, 0.31, not specified). Data fitting was performed via the least 
square method. Data were recorded using the small flow module. The numbers in brackets 
represent the slope of the C-term region at the different temperatures (30 °C, 50 °C, 70 °C). For 
the column packed with 1.9 µm fully porous particles, please refer to Figure 5.2. 
As expected from theory, the value for the plate height at constant linear velocity increases in 
the B-term region due to the higher diffusion coefficient at higher temperature [22]. In contrast, 
the slope in the C-term region decreases as can be identified from Figure 5.1 b) and c) according 
to Equation 5.2. For the column packed with 3.0 µm fully porous particles, the slope decreases 
by a factor of approximately 10 from 1.68 at 30 °C to 0.16 at 70 °C, whereas a reduction by a 
factor of 2 from 0.62 to 0.31 can be observed for the 2.7 µm core-shell particle packed column 
between 30 and 50 °C. As a consequence, the optimum linear velocity (uopt) shifts to higher 
linear velocities with increasing temperature because of the increased diffusion at higher 
temperatures [15], whereas the value of Hmin is almost constant over the entire temperature 
range. Thereby faster analysis can be performed at increased linear velocities without 
significant loss of efficiency which is of utmost importance for routine applications and LCxLC 
[25, 27]. The results clearly show that micro-LC columns can be used at elevated temperatures 
and behave like conventional LC columns. However, it can be seen from Figure 5.1 a) that the 
influence of increased temperature cannot be visualized for the minimum plate height as well 
as the C-term region within the applied flow rate range for the 1.9 µm fully porous particle 
packed column. 
5.3.2 Investigation of increased flow rates and temperatures 
In order to investigate the efficiency for high linear velocities, the large flow module was 
installed. After flow calibration, the flow-dependent experiments were performed and 
compared to the results of the small flow module. Figure 5.2 a) shows the van Deemter curves 
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obtained for naphthalene at 30 °C on the column packed with 1.9 µm fully porous particles 
using both flow modules. 
 
Figure 5.2: Comparison of the resulting van Deemter curves at a) 30 °C (0.46) and b) 70 °C (0.18) 
using the small (black squares) and large (red circles) flow module for naphthalene on the column 
packed with 1.9 µm fully porous particles. Data fitting was performed via least square method. 
The number in brackets represent the slope of the C-term region at the corresponding 
temperature using the curve obtained for the large flow module. 
As can be seen the curves almost overlap. For practical purposes, the use of the larger flow 
module is more favourable since a higher flow rate range can be applied. Mainly, small 
deviations can be observed in the lower velocity range. This can be explained by the technical 
characteristics of the large flow module, the use of which should be restricted to the range 
between 5-50 µL min-1 according to manufacturer’s specifications. Therefore, larger deviations 
at low flow rates between 3-5 µL min-1 (up to 2 mm s-1) are expected. Nevertheless, the 
influence of increased linear velocities on H can still be evaluated. Even at a linear velocity of 
10 mm s-1, H is found to be below 10 µm. Figure 5.2 b) illustrates the effect of elevated 
temperature at increased linear velocities on the plate height. Even at 70 °C, the resulting van 
Deemter curves appear almost identical between the different flow modules. When comparing 
the C-term regions, the slope decreases from 0.46 at 30 °C (Figure 5.2 a) to 0.18 at 70 °C 
(Figure 5.2 b). By increasing the temperature to 70 °C a linear velocity of 11 mm s-1 and a plate 
height of 8.4 µm can be achieved at a ΔPmax of 280 bar. This corresponds to a flow rate of only 
30 µL min-1. When comparing the slopes of the C-term region for all applied particle 
morphologies and diameters, it can be seen that the increase of temperature leads to a 
0 2 4 6 8 10 12
0
10
20
30
40
50
H
 /
 µ
m
u
0
 / mm s
-1
 30 °C small flow module
 30 °C large flow module
a)
0 2 4 6 8 10 12
0
10
20
30
40
50
 70 °C small flow module
 70 °C large flow module
H
 /
 µ
m
u
0
 / mm s
-1
b)
Chapter 5: The influence of temperature on efficiency of microbore liquid chromatography 
columns  129 
 
pronounced reduction of the slope within this region. To that end, faster analysis can be 
performed without significant loss of efficiency. 
To investigate the performance at different temperatures at maximum pressure and therefore at 
maximum efficiency, the results of the van Deemter analysis shall be transformed into kinetic 
plots. 
5.3.3 Temperature depending kinetic plots 
In a previous study, it was shown that the sub-2 µm fully porous particles should be used for 
ultra-fast chromatography with a maximum column void time of 10 s [12]. That is why the 
following investigations are focussed on this column using naphthalene as reference compound. 
The data transformation into kinetic plots was achieved according to Equation 5.5 - Equation 
5.7 [37]. 
𝑡0 =
∆𝑃𝑚𝑎𝑥
𝜂
∙ [
𝐾𝑣0
𝑢0
2 ]
𝑒𝑥𝑝
 Equation 5.5 
𝑁 =
∆𝑃𝑚𝑎𝑥
𝜂
∙ [
𝐾𝑣0
𝑢0 ∙ 𝐻
]
𝑒𝑥𝑝
 Equation 5.6 
𝐾𝑣0 =
𝑢0 ∙ 𝜂 ∙ 𝐿
(∆𝑃𝑡𝑜𝑡𝑎𝑙 − ∆𝑃𝑠𝑦𝑠𝑡𝑒𝑚)
 Equation 5.7 
where t0 is the column void time, N the number of theoretical plates, ΔPtotal the total 
backpressure, ΔPsystem the system backpressure and Kv0 the permeability. All other symbols are 
used as above. Mobile phase viscosity was calculated according to Equation 5.4 whereas the 
permeability was calculated according to Equation 5.7 [37]. In general, the kinetic plot limit 
(KPL) curve illustrates the maximum achievable efficiency at each temperature in a given time 
at ∆Pmax [34, 38]. The comparison of the KPL curves allows for conclusions about the most 
efficient combination of temperature and pressure for a given chromatographic support and 
reveals information about the corresponding column length. At first, the influence of pressure 
is evaluated at constant temperatures of 30, 50 and 70 °C. The corresponding kinetic plots are 
depicted in Figure 5.3. 
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Figure 5.3: Kinetic plots for naphthalene on the column packed with 1.9 µm fully porous particles 
at a temperature of a) 30, b) 50 and c) 70 °C and varying pressure of 600 (black squares) and 
1,000 bar (red circles). 
Within the range of ultra-fast chromatography with a column void time between 1 and 10 s 
which is highlighted by the dashed lines, almost no difference in terms of efficiency can be 
achieved between 600 and 1,000 bar at each temperature. However, the maximum efficiency 
rises with increasing temperature between 30 °C and 70 °C from 38,800 to 53,800 theoretical 
plates for 600 bar and from 64,600 to 89,700 theoretical plates at a ΔPmax of 1,000 bar as can 
be recognized by following the full lines in Figure 5.3. Both effects are attributed to the 
possibility of using longer column lengths at increased pressure and temperature. As a 
consequence, high pressure in combination with elevated temperatures is recommended to 
maximize column efficiency. For a better visualization and to further analyze the range of ultra-
fast chromatography the data of Figure 5.3 are rearranged to demonstrate the potential of 
increased temperature at constant pressure. The resulting kinetic plots are included in Figure 
5.4. 
 
Figure 5.4: Kinetic plots for naphthalene on the column packed with 1.9 µm fully porous particles 
at constant pressures of a) 600 and b) 1,000 bar at temperatures of 30 (black squares), 50 (red 
circles) and 70 °C (green triangles). 
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It can be seen that at constant pressure an increase of temperature leads to higher efficiency 
even in the range of ultra-fast chromatography. When considering the maximum efficiency, the 
increase in performance is limited when the column temperature is increased from 50 to 70 °C 
despite the possibility of using longer column length at 70 °C due to the improved pressure 
characteristic. Data of the kinetic plot analysis for the three different temperatures used are 
summarized in Table 5.3. 
Table 5.3: Achievable efficiency in the range of ultra-fast chromatography with a column void 
time of 100 and 101 s for different temperatures and pressures. In addition, the corresponding 
column lengths (L) as well as efficiency gain are given. 
Temperature / °C Pressure / bar 
30 600 1,000 
Column void time / s N L / cm N L / cm 
100 1231 2.47 1250 3.19 
101 9393 7.82 10458 10.10 
Temperature / °C Pressure / bar 
50 600 1,000 
Column void time / s N L / cm N L / cm 
100 1651 3.10 1690 4.00 
101 11901 9.81 13446 12.66 
Temperature / °C Pressure / bar 
70 600 1,000 
Column void time / s N L / cm N L / cm 
100 2078 3.64 2149 4.70 
101 13788 11.51 15972 14.86 
 
The data of Table 5.3 reveal that it is more efficient to increase the temperature at constant 
pressure than vice versa. By increasing the temperature from 30 to 70 °C, the decrease in mobile 
phase viscosity allows for using even longer columns (47%), which cannot be attained through 
augmenting the pressure from 600 to 1,000 bar at 30 °C (29%). In addition, the slope of the van 
Deemter curve in the C-term region decreases with rising temperature leading to higher 
efficiency at increased linear velocities using smaller column length. However, the maximum 
efficiency in the range of ultra-fast chromatography can be achieved at maximum temperature 
and pressure. 
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5.3.4 Temperature depending peak capacity and gradient kinetic plots 
For gradient elution, the plate height can no longer be taken as the measure of choice for the 
evaluation of performance. Commonly the peak capacity is considered to evaluate the 
separation power of a given chromatographic support [20, 21]. The peak capacity (np,exp) can 
be calculated according to Equation 5.8 assuming a constant peak width across the gradient 
window [33, 34, 39]. 
𝑛𝑝,𝑒𝑥𝑝 = 1 +
𝑡𝐺
?̅?
 Equation 5.8 
where tG is the gradient time and w̅ the average peak width at the base. For the determination 
of peak capacity the compounds methotrexate, etoposide and diclofenac were used. As 
mentioned in Chapter 5.2.2, the analytes have to experience the same relative mobile phase 
history for an appropriate determination of the peak capacity [33]. Therefore, the ratio of tG/t0 
as well as td/t0 should be constant for every column and flow rate. Figure 5.5 a) illustrates the 
peak capacity experimentally determined for the column packed with 3.0 µm fully porous 
particles for a tG/t0 of 2. The tG/t0 ratio of 2 is of interest for ultra-fast chromatography and high 
throughput analysis as well as for online LCxLC [25, 27]. The results for all other 
chromatographic supports and tG/t0 ratios at elevated temperature can be found in the 
supplementary material (see Figure-S 5.3 to Figure-S 5.6). 
 
Figure 5.5: Comparison of peak capacity at tG/t0 of 2 for the column packed with 3.0 µm fully 
porous particles at 30 (black squares), 50 (red circles), 70 °C (green triangles). a) experimentally 
obtained peak capacities, b) gradient kinetic plots for a maximum pressure of 600 bar (n=3). The 
full line arrow illustrates the difference in peak capacity between 30 and 70 °C at a gradient time 
of 3.3 min, whereas the dashed arrows demonstrate the increase of maximum peak capacity with 
rising temperature. 
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As depicted in Figure 5.5 a), the experimentally determined peak capacity rises with increasing 
temperature. By changing the temperature from 30 to 70 °C the peak capacity can be increased 
by 17%. This agrees with data by Guillarme et al. who reported a gain of peak capacity of about 
20-30% by increasing the temperature to 90 °C [23]. Petersson et al. also investigated the 
influence of temperature on peak capacity. They found increased peak capacity for low and 
well-retained compounds between 40 and 60 °C [22]. 
The experimentally determined peak capacity can also be transformed into gradient kinetic plots 
by following Equation 5.9 - Equation 5.11 [34]. Thereby, the different temperatures are 
compared at maximum efficiency [33]. 
𝜆 =
∆𝑃𝑚𝑎𝑥
∆𝑃𝑒𝑥𝑝 − ∆𝑃𝑒𝑐
 Equation 5.9 
𝑛𝑝,𝐾𝑃𝐿 = 1 + √𝜆 ∙ (𝑛𝑝,𝑒𝑥𝑝 − 1) Equation 5.10 
𝑡𝐺,𝐾𝑃𝐿 = 𝜆 ∙ 𝑡𝐺,𝑒𝑥𝑝 Equation 5.11 
where ΔPexp is the experimentally obtained backpressure, ΔPec the extra-column backpressure, 
λ the length-elongation factor, np,exp the experimentally obtained peak capacity, np,KPL the peak 
capacity and tG,KPL the gradient time of the gradient kinetic plot limits (KPL). 
When comparing the np,KPL in Figure 5.5 b), the peak capacity increases from 34 to 60 by 
maximizing temperature and column length until the maximum pressure is obtained as indicated 
by the dashed lined arrows. The gain by the factor of 1.8 is accompanied by an enlargement of 
the gradient time of about a factor of 2.2. At a constant tG of approximately 3.3 min, the peak 
capacity can be increased by 29% when raising temperature from 30 to 70 °C. Considering the 
peak capacity production rate (ξ) [32, 40], the rise of temperature leads to an increase of ξ from 
0.17 s-1 to 0.30 s-1 according to Equation 5.12. 
𝜉 =
𝑛𝑝
𝑡𝐺
 Equation 5.12 
To increase peak capacity for ultra-fast chromatography smaller particle diameters are explored 
[11]. Moreover, temperature is assumed to further increase peak capacity as was already shown 
for the 3.0 µm fully porous particle packed column in Figure 5.5 [18, 22, 23]. In addition, it 
was demonstrated that an optical waveguide based UV detector with less contribution to extra-
column variance is suitable to increase peak capacity even further [11]. To minimize this 
influence is of particular importance for steep gradients because the generated bands are more 
vulnerable to extra-column band broadening. In Figure 5.6, the resulting gradient kinetic plot 
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limits are shown for the detection cell with a volume of 100 nL as well as for the optical 
waveguide based UV detector with a cell volume of only 6 nL. 
 
Figure 5.6: Illustration of the resulting np,KPL at a tG/t0 of 2 for the column packed with 1.9 µm fully 
porous particles at 30 (black squares), 50 (red circles) and 70 °C (green triangles) using a) a UV 
detector with a cell volume of 100 nL and b) a UV detector on the basis of an optical waveguide 
with a cell volume of 6 nL (n=3). Best fit lines are displayed as well. The dashed lines illustrate the 
gain in peak capacity at a gradient time of 30 s for the three different temperatures. 
Independent of the detector cell volume, the value for np,KPL increases with rising temperature. 
However, for the applicability in LCxLC, the maximum gradient time of 30 s should be 
evaluated. The dashed lines in Figure 5.6 a) and b) show that for this tG the peak capacity can 
be further increased with temperature. Peak capacity increases by 25% from 30 °C to 70 °C for 
the standard detector cell and the effect is even more pronounced for the low volume detector 
cell with an increase of 40%. Considering the peak capacity production rate for the UV detector 
with a cell volume of 100 nL for a tG of 30 s, a ξ of 0.77 s-1 at 70 °C is obtained and therefore 
comparable to the peak capacity production rate (ξ = 0.73 s-1) derived for the low volume 
detection cell at 30 °C. The highest ξ of 1.03 s-1 can be achieved at 70 °C using the low volume 
detection cell. Therefore, it can be demonstrated that increased temperature is suitable to 
maximize peak capacity for ultra-fast chromatography as it was already discussed above for 
isocratic elution. 
5.4 Conclusion 
A rise in temperature for isocratic elution is more effective to maximize separation efficiency 
as compared to increased pressure capabilities at low temperature. However, the maximum 
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efficiency can be achieved using elevated temperatures in combination with higher ΔPmax 
especially in the range of ultra-fast chromatography with column void times of only 1 to 10 s. 
The peak capacity for gradient elution increases with rising temperature as well. Peak capacity 
production rates up to 1 s-1 can be achieved when using a column temperature of 70 °C, 1.9 µm 
fully porous particles, and a minimized detector cell volume as results from gradient kinetic 
plot analysis. In further studies the application of even smaller particle diameters will be 
investigated. 
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5.7 Chapter appendix 
5.7.1 Structural formula of the investigated analytes 
The chemical structures of the analytes are depicted in Figure-S 5.1. 
 
Figure-S 5.1: Chemical structures of the investigated analytes. (1) 5-fluorouracil, (2) uracil, (3) 
methotrexate, (4) etoposide, (5) diclofenac and (6) naphthalene [1]. 
Uracil was used for the determination of the column void times. The remaining compounds are 
pharmaceuticals analyzed within our routine analysis. All analytes differ in polarity which is of 
utmost importance for the characterization of peak capacity to obtain a uniform distribution 
across the gradient window. In addition, etoposide and naphthalene were used for the isocratic 
evaluation. 
5.7.2 Mobile phase compositions 
For the adjustment of the retention factor (k) in isocratic measurements, the mobile phase 
composition was varied for every column and temperature according to Table-S 5.1 - Table-S 
5.3. 
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Table-S 5.1: Overview of the mobile phase composition at 30 °C for every column. 
column 
Mobile phase composition: water / acetonitrile (v/v) 
30 °C 
etoposide naphthalene 
Fully porous 
(50 x 0.3 mm, 1.9 µm) 
72.2 / 27.8 58.2 / 41.8 
Fully porous 
(50 x 0.3 mm, 3.0 µm) 
72.2 / 27.8 57.4 / 42.6 
Core-shell 
(50 x 0.3 mm, 2.7 µm) 
75.0 / 25.0 59.8 / 40.2 
 
Table-S 5.2: Overview of the mobile phase composition at 50 °C for every column. 
column 
Mobile phase composition: water / acetonitrile (v/v) 
50 °C 
etoposide naphthalene 
Fully porous 
(50 x 0.3 mm, 1.9 µm) 
73.0 / 27.0 61.2 / 38.8 
Fully porous 
(50 x 0.3 mm, 3.0 µm) 
73.2 / 26.8 61.6 / 38.4 
Core-shell 
(50 x 0.3 mm, 2.7 µm) 
77.0 / 23.0 63.5 / 36.5 
 
Table-S 5.3: Overview of the mobile phase composition at 70 °C for every column. 
column 
Mobile phase composition: water / acetonitrile (v/v) 
70 °C 
etoposide naphthalene 
Fully porous 
(50 x 0.3 mm, 1.9 µm) 
74.0 / 26.0 64.8 / 35.2 
Fully porous 
(50 x 0.3 mm, 3.0 µm) 
74.5 / 25.5 64.7 / 35.3 
Core-shell 
(50 x 0.3 mm, 2.7 µm) 
* * 
* not specified for this temperature 
 
5.7.3 Resulting gradient times for the determination of peak capacity 
depending on temperature 
Table-S 5.4 - Table-S 5.15 shows the resulting gradient times (tG) depending on the flow rate, 
column and temperature. 
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Table-S 5.4: Resulting gradient times depending on the flow rate and column for a tG/t0 of 2 at 
30 °C. 
tG/t0 = 2 Gradient times (tG) / min at 30 °C 
Flow rate / µL min-1 1.9 µm fully porous 3.0 µm fully porous 2.7 µm core-shell 
10 0.49 0.49 0.38 
15 0.32 0.32 0.25 
20 0.24 0.24 0.18 
25 0.20 0.20 0.15 
30  0.16 0.12 
35  0.14 0.10 
40  0.12 0.09 
45  0.11  
 
Table-S 5.5: Resulting gradient times depending on the flow rate and column for a tG/t0 of 2 at 
50 °C. 
tG/t0 = 2 Gradient times (tG) / min at 50 °C 
Flow rate / µL min-1 1.9 µm fully porous 3.0 µm fully porous 2.7 µm core-shell 
10 0.49 0.49 0.38 
15 0.32 0.32 0.25 
20 0.24 0.24 0.18 
25 0.20 0.20 0.15 
30 0.16 0.16 0.12 
35 0.13 0.14 0.10 
40 0.11 0.12 0.09 
45   0.11   
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Table-S 5.6: Resulting gradient times depending on the flow rate and column for a tG/t0 of 2 at 
70 °C. 
tG/t0 = 2 Gradient times (tG) / min at 70 °C 
Flow rate / µL min-1 1.9 µm fully porous 3.0 µm fully porous 2.7 µm core-shell 
10 0.49 0.49  
15 0.32 0.32  
20 0.24 0.24  
25 0.20 0.20  
30 0.16 0.16  
35 0.13 0.14  
40 0.11 0.12  
45 0.10 0.11   
 
Table-S 5.7: Resulting gradient times depending on the flow rate and column for a tG/t0 of 4 at 
30 °C. 
tG/t0 = 4 Gradient times (tG) / min at 30 °C 
Flow rate / µL min-1 1.9 µm fully porous 3.0 µm fully porous 2.7 µm core-shell 
10 0.99 0.99 0.75 
15 0.65 0.65 0.50 
20 0.48 0.48 0.37 
25 0.39 0.39 0.29 
30  0.32 0.24 
35  0.28 0.21 
40  0.24 0.18 
45  0.22  
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Table-S 5.8: Resulting gradient times depending on the flow rate and column for a tG/t0 of 4 at 
50 °C. 
tG/t0 = 4 Gradient times (tG) / min at 50 °C 
Flow rate / µL min-1 1.9 µm fully porous 3.0 µm fully porous 2.7 µm core-shell 
10 0.97 0.99 0.75 
15 0.65 0.65 0.50 
20 0.48 0.48 0.37 
25 0.39 0.39 0.29 
30 0.32 0.32 0.24 
35 0.26 0.28 0.21 
40 0.23 0.24 0.18 
45   0.22   
 
Table-S 5.9: Resulting gradient times depending on the flow rate and column for a tG/t0 of 4 at 
70 °C. 
tG/t0 = 4 Gradient times (tG) / min at 70 °C 
Flow rate / µL min-1 1.9 µm fully porous 3.0 µm fully porous 2.7 µm core-shell 
10 0.97 0.99  
15 0.65 0.65  
20 0.48 0.48  
25 0.39 0.39  
30 0.32 0.32  
35 0.26 0.28  
40 0.23 0.24  
45 0.20 0.22   
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Table-S 5.10: Resulting gradient times depending on the flow rate and column for a tG/t0 of 12 at 
30 °C. 
tG/t0 = 12 Gradient times (tG) / min at 30 °C 
Flow rate / µL min-1 1.9 µm fully porous 3.0 µm fully porous 2.7 µm core-shell 
10 2.97 2.98 2.29 
15 1.99 1.98 1.53 
20 1.48 1.44 1.14 
25 1.18 1.15 0.89 
30  0.96 0.74 
35  0.82 0.62 
40  0.71 0.54 
45  0.65  
 
Table-S 5.11: Resulting gradient times depending on the flow rate and column for a tG/t0 of 12 at 
50 °C. 
tG/t0 = 12 Gradient times (tG) / min at 50 °C 
Flow rate / µL min-1 1.9 µm fully porous 3.0 µm fully porous 2.7 µm core-shell 
10 2.92 2.96 2.26 
15 1.96 1.94 1.49 
20 1.47 1.44 1.10 
25 1.17 1.15 0.88 
30 0.97 0.96 0.72 
35 0.79 0.82 0.62 
40 0.68 0.71 0.54 
45   0.65   
 
  
Chapter 5: The influence of temperature on efficiency of microbore liquid chromatography 
columns  144 
 
Table-S 5.12: Resulting gradient times depending on the flow rate and column for a tG/t0 of 12 at 
70 °C. 
tG/t0 = 12 Gradient times (tG) / min at 70 °C 
Flow rate / µL min-1 1.9 µm fully porous 3.0 µm fully porous 2.7 µm core-shell 
10 2.92 2.85  
15 1.93 1.90  
20 1.45 1.44  
25 1.15 1.15  
30 0.95 0.96  
35 0.79 0.82  
40 0.68 0.71  
45 0.60 0.65   
 
Table-S 5.13: Resulting gradient times depending on the flow rate and column for a tG/t0 of 20 at 
30 °C. 
tG/t0 = 20 Gradient times (tG) / min at 30 °C 
Flow rate / µL min-1 1.9 µm fully porous 3.0 µm fully porous 2.7 µm core-shell 
10 4.94 4.96 3.82 
15 3.32 3.30 2.55 
20 2.47 2.44 1.90 
25 1.97 1.95 1.49 
30  1.62 1.23 
35  1.39 1.03 
40  1.22 0.90 
45  1.08  
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Table-S 5.14: Resulting gradient times depending on the flow rate and column for a tG/t0 of 20 at 
50 °C. 
tG/t0 = 20 Gradient times (tG) / min at 50 °C 
Flow rate / µL min-1 1.9 µm fully porous 3.0 µm fully porous 2.7 µm core-shell 
10 4.87 4.93 3.77 
15 3.26 3.24 2.49 
20 2.44 2.42 1.83 
25 1.94 1.93 1.46 
30 1.61 1.60 1.20 
35 1.32 1.38 1.03 
40 1.14 1.19 0.90 
45   1.05   
 
Table-S 5.15: Resulting gradient times depending on the flow rate and column for a tG/t0 of 20 at 
70 °C. 
tG/t0 = 20 Gradient times (tG) / min at 70 °C 
Flow rate / µL min-1 1.9 µm fully porous 3.0 µm fully porous 2.7 µm core-shell 
10 4.86 4.76  
15 3.21 3.17  
20 2.41 2.36  
25 1.92 1.88  
30 1.59 1.56  
35 1.32 1.33  
40 1.14 1.15  
45 1.01 1.03   
 
5.7.4 Temperature depending van Deemter curves 
Figure-S 5.2 illustrates the resulting temperature depending van Deemter curves for etoposide 
on the columns packed with 1.9 µm and 3.0 µm fully porous as well as 2.7 µm core-shell 
particles. 
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Figure-S 5.2: Resulting van Deemter curves at 30, 50 and 70 °C for etoposide on the column 
packed with a) 1.9 µm fully porous particles, b) 3.0 µm fully porous particles and c) 2.7 µm core-
shell particles. 
 
5.7.5 Temperature depending gradient kinetic plots 
The resulting gradient kinetic plots (np,KPL) for the column packed with 3.0 µm fully porous 
particles for the ratios of the gradient times (tG) to the column void times (t0) of 2, 4, 12 and 20 
at the three different temperatures of 30, 50 and 70 °C are shown in Figure-S 5.3. For np,KPL a 
maximum pressure of 600 bar was used. 
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Figure-S 5.3: Comparison of the gradient kinetic plots for the column packed with 3.0 µm fully 
porous particles at a tG/t0 of a) 2, b) 4, c) 12 and d) 20 for the temperatures of 30, 50 and 70 °C. For 
the calculation of the gradient kinetic plots, a maximum pressure of 600 bar was used (n=3). 
Figure-S 5.4 illustrates the comparison of gradient kinetic plots for all tG/t0 ratios for the column 
packed with 2.7 µm core-shell particles at a temperature of 30 and 50 °C. 
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Figure-S 5.4: Comparison of the gradient kinetic plots for the column packed with 2.7 µm fully 
porous particles at a tG/t0 of a) 2, b) 4, c) 12 and d) 20 for the temperatures of 30 and 50 °C. For 
the calculation of the gradient kinetic plots, a maximum pressure of 600 bar was used (n=3). 
In Figure-S 5.5, the results for np,KPL of all applied tG/t0 ratios are depicted for the column packed 
with 1.9 µm fully porous particles at 30, 50 and 70 °C using the built-in UV detector. 
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Figure-S 5.5: Comparison of the gradient kinetic plots for the column packed with 1.9 µm fully 
porous particles at a tG/t0 of a) 2, b) 4, c) 12 and d) 20 for the temperatures of 30, 50 and 70 °C 
using the built-in UV detector. For the calculation of the gradient kinetic plots, a maximum 
pressure of 600 bar was used (n=3). 
The results for np,KPL of all applied tG/t0 ratios are shown in Figure-S 5.6 for the column packed 
with 1.9 µm fully porous particles at 30, 50 and 70 °C using the alternative UV detector on the 
basis of an optical waveguide. 
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Figure-S 5.6: Comparison of the gradient kinetic plots for the column packed with 1.9 µm fully 
porous particles at a tG/t0 of a) 2, b) 4, c) 12 and d) 20 for the temperatures of 30, 50 and 70 °C 
using the alternative UV detector on the basis of an optical waveguide. For the calculation of the 
gradient kinetic plots, a maximum pressure of 600 bar was used (n=3). 
5.7.6 References 
[1]  ChemSpider, http://www.chemspider.com, (accessed 04.02.2017). 
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Chapter 6 Micro-liquid chromatography mass spectrometry 
for the analysis of antineoplastic drugs from wipe 
samples 
 
Redrafted from “Hetzel, T., vom Eyser, C., Tuerk, J., Teutenberg, T., Schmidt, T.C., Micro-
liquid chromatography mass spectrometry for the analysis of antineoplastic drugs from wipe 
samples, Analytical and Bioanalytical Chemistry, 408 (2016) 8221–8229.” 
 
 
Abstract 
A fast quantification method for the determination of eleven antineoplastic drugs from wipe 
samples was developed using micro scale liquid chromatography in combination with tandem 
mass spectrometry. The extraction efficiency from the wipes has been investigated using 
different extraction solvents. The results indicate that a mixture of 70/30 water/isopropanol 
(v/v) acidified with 0.1% formic acid is suitable to desorb the antineoplastic drugs with 
sufficient recovery between 80-120%. Compared to conventional liquid chromatography, the 
total analysis time can be reduced to 2.25 min using a 50 x 0.3 mm column at a flow rate of 
25 µL min-1. Ion source parameters as well as the injection volume were optimized to ensure 
the highest sensitivity. The results of method validation showed an instrumental limit of 
quantification between 0.0068 and 0.0488 ng mL-1 using an injection volume of 4.25 µL 
estimated by the signal to noise ratio. Moreover, the retention time repeatability was determined 
with a maximum relative standard deviation of 0.4%. 
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6.1 Introduction 
According to the world health organization, cancer is responsible for 13% of all deaths 
worldwide and current estimations predict an increase of 70% new cases within the next twenty 
years [1]. The established treatment strategy during cancer therapy is the application of 
antineoplastic drugs [2, 3]. Apart from patients’ wellbeing, the potential health risk for other 
persons getting in contact with hazardous drugs such as antineoplastics must be considered [4]. 
Besides pharmacists, nurses, physicians, and other health care workers, staff involved in 
cleaning, transport, and disposal of hazardous drugs or contaminated material is concerned. 
Monitoring of occupational exposure has been employed in many healthcare settings and the 
pharmaceutical industry. Wipe sampling for surface residues of cytostatic drugs is currently the 
method of choice to determine surface contaminations of the workplace with these drugs as 
well as the success of cleaning procedures [5-9]. In Germany a substance-independent reference 
value of 0.1 ng cm-2 was established after the Monitoring-Effect Study of Wipe Sampling in 
Pharmacies (MEWIP) [10]. Therefore, reliable and fast analytical methods are needed for 
routine monitoring to ensure personal safety of health care workers. The common way is the 
analysis by liquid chromatography (LC) mass spectrometry (MS) [2, 9, 11]. Whereas in the past 
compound specific analysis methods were used [6, 12-14], multicomponent analysis 
approaches are getting of interest [5, 7, 15-17]. This strategy has the advantages of increased 
information for one sample as well as reducing resources like time, energy and solvents. 
Nevertheless, these methods are usually based on conventional LC characterized by large 
analysis time, which decreases sample throughput. In order to be able to detect low 
concentrations in the ng cm-2 range of cytostatic drugs, routine laboratories are forced to invest 
in highly sensitive detection equipment to further optimize routine monitoring of occupational 
exposure, detection of residual surface contaminations and risk assessment. Besides the primary 
safety goal, alternative approaches must be found to save resources and costs without 
compromising sample throughput and data quality to ensure a high return of investment for 
routine laboratories applying LC-MS/MS. One way to achieve these requirements is the 
application of miniaturized separation techniques like micro scale liquid chromatography in 
combination with tandem mass spectrometry (micro-LC-MS/MS) because of the reduced 
solvent consumption which decreases costs for purchase and disposal of organic solvents. 
Moreover, the reduced injection volume can significantly contribute to prolong the cleaning 
intervals of highly sensitive mass spectrometers [18-20]. In general, technological progress 
must consider all aspects and must not disregard safety issues. In terms of laboratory safety, 
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toxic organic solvents are a major safety issue. Micro-LC is perfectly suited to reduce the 
solvent load of a laboratory significantly. In addition, the combination of flow rates in the range 
of several microliters per minute (µL min-1) and decreased column inner diameter (i.d.) between 
0.3 to 0.5 mm leads to high linear velocities. In order to achieve similar linear velocities with 
conventional column i.d. (e.g. 4.6 mm), flow rates in the mL min-1 range must be applied. 
Moreover, the reduced gradient delay volumes of dedicated micro-LC systems are a key feature 
to achieve fast separations and reduced analysis cycle times. As a consequence, the sample 
throughput can be significantly increased which represents a major advantage for routine 
analysis. Therefore, micro-LC combines all requirements in terms of green analytical chemistry 
and covering safety aspects within the laboratory [21]. 
Although the separation power of micro-LC has been demonstrated in various application areas 
[18, 20, 22-25] and despite its advantages, the use of micro-LC for routine analysis is often 
confronted with persistent prejudices like missing robustness and sensitivity [18, 19, 26, 27]. 
In terms of sensitivity it clearly depends on whether the sample volume is limited, as is often 
the case for biological applications [19], or the sample volume is not limited. Injecting a sample 
with a volume of only e.g. 100 nL will always lead to higher sensitivity when using microbore 
columns instead of analytical columns. 
Therefore, the aim of this study is the development and validation of a robust and highly 
sensitive micro-LC-MS/MS method for regular monitoring and control of the reference value 
of 0.1 ng cm-2 for selected antineoplastic drugs. For this purpose, the extraction and separation 
of eleven antineoplastic drugs from wipe samples are investigated. 
6.2 Material and methods  
6.2.1 LC-MS method parameters 
All measurements were performed on an Eksigent ExpressLC ultra system coupled to a QTrap 
6500 tandem mass spectrometer (Sciex, Dublin, CA). The micro-LC system is based on 
pneumatic piston pumps with a pressure limit up to 690 bar. Flow calibration was done with a 
volume of 100 µL at a flow rate of 25 µL min-1 using a standard 5-50 µL min-1 flow module. 
Aspirating and dispensing of the sample was done by an HTS PAL autosampler (CTC 
Analytics, Zwingen, Switzerland), whereas the actual injection was done by the built-in six port 
valve using the metered injection mode. The installed sample loop has a volume of 10 µL with 
an inner diameter of 150 µm made of stainless steel. All other system connections were made 
Chapter 6: Micro-liquid chromatography mass spectrometry for the analysis of antineoplastic 
drugs from wipe samples  154 
 
of fused silica surrounded by polyetherether ketone (PEEKSil) capillaries with an inner 
diameter of 50 µm. For temperature control, a column static air oven was used at a temperature 
of 40 °C. The chromatographic separation was performed on a multistage endcapped YMC 
Triart C18 (50 x 0.3 mm, 1.9 µm, YMC Europe GmbH, Dinslaken, Germany) column. The 
flow rate was adjusted to 25 µL min-1 to ensure a high linear velocity and to achieve a fast 
separation. The following gradient program was used: from 10% ACN to 50% in 1.6 min before 
increasing the organic portion to 99% in 0.9 min. The injection volume was optimized starting 
from 250 nL. 
For MS data acquisition, the multiple reaction monitoring (MRM) mode was used. A list of 
mass transitions is given in Table-S 6.2. The optimization of ion source parameters can be found 
in the supplementary material (Chapter 6.7.4). For data acquisition and analysis the Eksigent 
control software (Version 4.1 Patch for ekspert nanoLC 400 and batch acquisition control) and 
Analyst (Version 1.6.3) were used. Further data processing was done using Origin Lab v. 9.1 
and Microsoft Excel 2010. 
6.2.2 Sampling protocol 
The sampling and subsequent extraction of the antineoplastic drugs is accomplished by the 
following protocol. For sampling, three wipes from Kimtech Science (Kimberly-Clark 
Professional, Koblenz, Germany) are moistened with 1 mL wetting solution per wipe. The 
investigated surface is swept in three different directions using one wipe for each step. The 
sampling procedure is illustrated in Figure 6.1. 
 
Figure 6.1: Schematic sampling procedure with one wipe for each step. Recommended sampling 
area: 30 x 30 cm. 
Afterwards, the samples are stored in a beaker (Rotilabo, Carl Roth, Karlsruhe, Germany). For 
sample extraction, 10 mL of extraction solvent per wipe were added and treated in an ultrasonic 
bath for 15 min. Subsequently, 1 mL of the extract was aspirated and filtered using a 0.45 µm 
regenerated cellulose filter (Chromafil RC-45/25; Macherey-Nagel, Germany) connected to a 
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2 mL syringe (B Braun Injekt; B. Braun Melsungen AG; Melsungen, Germany) before 
transferred into a glass vial which was used for the final analysis. 
6.2.3 Wetting solution and evaluation of extraction efficiency by 
QC samples 
At first, the wetting solution for sampling must be specified to ensure a sufficient transfer of 
each target analyte from the investigated surface into the sampling wipe. Therefore, with respect 
to the log D values in Table-S 6.1, the wetting solution must be suitable for polar as well as 
non-polar substances. Since the sampling is done on site by the staff in the pharmacy or ward 
of the hospitals a non-toxic solution is needed. Several investigations showed sufficient 
sampling efficiency using a mixture of 30/70 (v/v) water/2-propanol [5, 15], which can be 
regarded as non-hazardous. For the investigation of sample extraction efficiency, different 
compositions of dimethyl sulfoxide (DMSO), 2-propanol (IPA), acetonitrile (ACN) with water 
(H2O) were used. The latter two were also used as mobile phase constituents with a portion of 
0.1% FA (v/v), purchased from Sigma-Aldrich (Seelze, Germany). All other solvents were 
obtained from Th. Geyer-Chemsolute (Renningen, Germany) and LGC Promochem (Wesel, 
Germany) with a purity of at least 99.5%.  
The three organic extraction agents DMSO, ACN and IPA differ in their properties and elution 
strength. Whereas DMSO and ACN are aprotic-polar and aprotic-non-polar solvents, IPA has 
a protic character. The elution strength in reversed phase chromatography increases from ACN 
over IPA to DMSO. Additionally, the composition of DMSO and ACN was varied between 5-
20% (v/v) in 5% steps in combination with H2O. For IPA five different mixtures were 
investigated because IPA was identified as suitable wetting solvent [5, 15]. A mixture of 70/30, 
80/20, 85/15, 90/10 and 95/5 (v/v) H2O:IPA was prepared. All solvent compositions used for 
sample extraction were acidified with 0.1% FA. For the evaluation of the extraction efficiency, 
four quality control samples (QC) were prepared for each solvent composition. For this purpose, 
the wipes moistened with the wetting solution were spiked with a solution of a concentration 
of 5 and 10 ng mL-1 to obtain an amount of 165 and 330 ng per sample before extraction solvent 
was added and the wipes were treated in an ultrasonic bath. Afterwards, 1 mL of the extract 
was filtered and transferred into the glass vial. The analysis was done with the corresponding 
matrix calibration as described below. 
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6.2.4 Stock solutions and matrix calibration 
An overview about the investigated substances, analyte properties as well as structural formulae 
can be found in the supplementary material (Table-S 6.1, Figure-S 6.1). The stock solutions 
were prepared using a mixture of water/acetonitrile (50/50, v/v) in a concentration of 1 mg mL-1 
and 0.1 mg mL-1, respectively. The eleven solutions were merged with a final concentration of 
10 µg mL-1. For calibration standards an individual sample matrix was made according to the 
sample preparation procedure and solvent composition. Therefore, three wipes were transferred 
into the beaker before 3 mL wetting solution and 30 mL extraction solvent were added. After 
ultrasonic treatment, the solution was filtered and stored in a second beaker. The obtained 
matrix was used for further dilution of the 10 µg mL-1 multicomponent standard to prepare the 
calibration standards in a range between 0.01 ng mL-1 to 100 ng mL-1. Matrix, multicomponent 
standard and quality control samples were prepared on the same day of measurement. 
6.2.5 Method validation protocol 
For the final method validation, the following procedure was applied: four QC samples of three 
different concentrations were prepared according to the procedure described in Chapter 6.2.3 
using an independent 1000 ng mL-1 multicomponent stock solution to obtain QC samples with 
a concentration of 1, 10 and 100 ng mL-1. The analysis was performed with the corresponding 
matrix calibration. Additionally, the limit of detection (LOD) and limit of quantification (LOQ) 
was determined by the signal-to-noise (S/N) ratio of 3:1 for the LOD and 10:1 for the LOQ. In 
addition, the method detection limit (MDL) in ng cm-2 was calculated on the basis of the 
recommended sampling area of 900 cm2. A detailed calculation for the MDL can be found in 
the supplementary material (Chapter 6.7.5). Furthermore, a tenfold injection of the 1 ng mL-1 
standard was done to evaluate the system repeatability representing the so-called intra-assay. 
Moreover, an inter-assay including a four time injection of the 1 ng mL-1 standard was 
performed to investigate the repeatability over three days. At the end, the carry-over was 
determined using the highest standard in the linear range for the individual target analyte 
followed by two blank injections. 
6.3 Results and discussion 
6.3.1 Investigation of extraction efficiency 
In order to identify a suitable extraction solution, a recovery between 80-120% was defined 
although the Occupational Safety & Health Administration (OSAH) recommends a minimum 
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recovery of 75% [28]. Figure 6.2 shows the recovery for each compound including error bars 
when using DMSO, ACN and IPA as organic solvent for the 10 ng mL-1 QC samples. The 
resulting recovery for the 5 ng mL-1 QC samples showing the same trend can be found in the 
supplementary material (Figure-S 6.2). 
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Figure 6.2: Resulting recovery of the eleven antineoplastic drugs for a mixture of a) 
H2O:DMSO + 0.1% FA, b) H2O:ACN + 0.1% FA and c) H2O:IPA + 0.1% FA in various 
compositions for a concentration of 10 ng mL-1 (see figure legend describing the amount of organic 
solvent in the extraction solution; number of QC samples = 4). 
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As can be seen from Figure 6.2 a), the recovery for topotecan, doxorubicin and epirubicin do 
not fulfill the requirement of 80-120% recovery. All other substances could be extracted 
sufficiently with a portion of 20% DMSO. This seems surprising because DMSO is often 
recommended as universal extraction solvent. Next, ACN was investigated as organic solvent 
because ACN is also used as a mobile phase constituent for chromatography. Figure 6.2 b) 
illustrates the recovery for ACN as extraction solvent. 
Again, the recovery of doxorubicin and epirubicin is below the desired validation criteria. With 
increasing content of ACN the recovery increases for these two compounds. Therefore, an even 
higher ACN concentration could lead to sufficient recovery. However, serious chromatographic 
problems are expected for polar compounds due to the missing focussing at the column head. 
This is also the reason why no recovery can be estimated for gemcitabine if the ACN content 
is higher than 10%. At the end, IPA as protic solvent was applied as organic extraction solvent. 
Finally, it was identified as suitable wetting solution. Figure 6.2 c) shows the obtained recovery 
rates for IPA. 
As illustrated, a mixture of 70/30 H2O/IPA (v/v) + 0.1% FA represents a suitable solvent 
composition to obtain sufficient recovery between 80-120% for all substances. Recovery values 
higher than 100% can be obtained due to matrix effects [29, 30]. The protic solvent property 
favours the extraction for the epimers doxorubicin and epirubicin due to the possibility of 
hydrogen bonding and solvation. As expected, the isomers ifosfamide and cyclophosphamide 
as well as the epimers doxorubicin and epirubicin show comparable behaviour in terms of the 
extraction efficiency with respect to the solvent composition.  
To summarize, a wetting solution of 30/70 H2O/IPA (v/v) in combination with an extraction 
agent of 70/30 H2O/IPA + 0.1% FA (v/v) results in sufficient recovery for all substances. 
Taking the volume of 3 mL wetting solution and 30 mL extraction solvent into account, the 
final sample composition is 66.4/33.6 H2O/IPA (v/v) + 0.1% FA. 
6.3.2 Micro-LC-MS/MS analysis 
6.3.2.1 Chromatographic requirements and conditions 
As can be seen from Table-S 6.2, the epimers doxorubicin and epirubicin have identical mass 
transitions. Therefore, a chromatographic separation is needed because a differentiation by MS 
is not possible. In addition, ifosfamide and cyclophosphamide are isomers. Although two 
different mass transitions are selected, they also must be separated chromatographically due to 
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cross talk, which is shown more detailed in Chapter 6.7.3.2. The separation of paclitaxel and 
docetaxel is deemed necessary because of ion suppression. In a previous study, the selectivity 
of the phase system was investigated [31]. As a result, the YMC Triart C18 (50 x 0.3 mm, 
1.9 µm) was identified as a suitable column for the separation of the critical peak pairs. 
Although it was found that methanol leads generally to an increased selectivity, using H2O and 
ACN + 0.1% FA as mobile phase results in a sufficient selectivity for all critical peak pairs in 
combination with this stationary phase. In addition, ACN is advantageous because of the 
reduced viscosity leading to a decreased pressure drop. Thereby, higher flow rates can be used 
to reduce the cycle times and thus increasing sample throughput which is an important factor 
for routine analysis. Next, the injection volume must be optimized in order to achieve the 
required LOQ of 0.1 ng mL-1. Usually the injection volume should be 10% maximum of the 
column void volume. According to Equation 6.1, the geometric column volume is 3.53 µL for 
a 50 x 0.3 mm column. 
𝑉𝑐𝑜𝑙 = (
𝑑𝑐
2
)
2
∙ 𝜋 ∙ 𝐿 Equation 6.1 
Since the accessible column volume is influenced by the stationary phase material, a porosity 
of 0.7 is considered to calculate the effective column volume (Veff), which is 2.47 µL. Thus the 
recommended injection volume is approximately 250 nL. Figure-S 6.3 a) shows the resulting 
chromatogram for the separation of the eleven antineoplastic drugs using an injection volume 
of 250 nL. 
As can be seen, the required LOQ can be achieved for most of the target analytes injecting a 
mass of only 25 fg. Unfortunately, docetaxel and methotrexate cannot be detected at this 
concentration. In addition, the S/N ratio for topotecan (S/N: 2.6) is critical. Therefore, a higher 
injection volume must be chosen to reach the LOQ and to improve the S/N ratio. The resulting 
chromatogram is illustrated in Figure-S 6.3 b) using an injection volume of 425 nL. 
As can be seen a minimum injection volume of 425 nL, which corresponds to an injected mass 
of 42.5 fg, is needed to achieve the required LOQ. However, peak distortion effects occur for 
the semi-polar compounds methotrexate and topotecan as becomes clear from magnification in 
Figure-S 6.3 c) representing the separation for a concentration of 1 ng mL-1. In addition, the 
peak shape of etoposide shows a peak splitting. The reason for this peak distortion is the missing 
focussing for the polar and semi-polar compounds at the column head. Due to the increased 
injection volume and higher elution strength of the injection solvent compared to the initial 
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mobile phase composition, the chromatographic band of these compounds is broadened. As a 
consequence, the remaining column volume is not sufficient to compress the band leading to 
distorted peak shapes. This phenomenon is schematically depicted in Figure-S 6.4. In addition, 
applying even higher injection volumes leads to an increased pressure drop during the injection 
when using the 66.4/33.6 H2O/IPA (v/v) + 0.1% FA solvent composition. For large volume 
injections (LVI) the pressure drop increases to the maximum system pressure. This must also 
be considered for the final method. Therefore, dilution of the samples was considered as an 
alternative approach to achieve symmetric peak shapes for all compounds. 
6.3.2.2 Sample dilution and large volume injection 
In order to compensate the peak distortion phenomena, the number of possible strategies is 
limited. A lower content of the organic solvent in the extraction solvent is not useful in terms 
of the required recovery as illustrated in Figure 6.2 c). Another approach is the aqueous dilution 
of the sample in a ratio of 1/10 (v/v) to decrease the organic portion in the injection solution. 
The resulting sample composition is 96.6/3.4 H2O/IPA (v/v) + 0.1% FA. To keep the injected 
absolute mass of 42.5 fg constant, it is necessary to increase the injection volume by the dilution 
factor. Therefore, the final injection volume is 4.25 µL. Figure 6.3 shows the resulting 
chromatogram of the diluted sample for a concentration of 1 ng mL-1. 
 
Figure 6.3: Resulting chromatogram for the separation of the eleven antineoplastic drugs for a 
concentration of 1 ng mL-1 using an injection volume of 4250 nL. Analytes: (1) gemcitabine, (2) 
methotrexate, (3) topotecan, (4) irinotecan, (5) ifosfamide, (6) cyclophosphamide, (7) doxorubicin, 
(8) epirubicin, (9) etoposide, (10) paclitaxel, (11) docetaxel. 
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As can be seen, highly symmetric peak shapes are obtained because of the reduced solvent 
strength of the sample solution. In addition, the separation of the isobaric compounds is still 
maintained with a critical resolution of 1.2 for ifosfamide (5) and cyclophosphamide (6). 
Consequently, the dilution factor needs to be considered with respect to the LOQ. Due to the 
dilution by the factor of 10, the required LOQ is also reduced by the same factor. Therefore, 
the required LOQ is 0.01 ng mL-1. 
6.3.3 Method validation data 
Since the method is applied in an accredited environment, method validation data must be 
recorded. This comprises intra-day and inter-day stability, carry-over as well as LOD and LOQ. 
The prepared samples are diluted in a ratio of 1/10. Therefore, the final concentrations of the 
QC samples are 0.1, 1.0 and 10 ng mL-1. For the determination of carry-over, the area of the 
following blank injection after the highest standard of the linear range for every compound was 
used. 
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Table 6.1: Overview of the method validation data including intra-assay, inter-assay, three different level of QC samples, LOD, LOQ, MDL, upper limit 
as well as Carry-over and retention time repeatability. For the calculation of the MDL in ng cm-2, the recommended sampling area of 900 cm2 was used. 
The dilution factor is considered. 
Compound 
intra-assay 
1 ng mL-1 / % 
(n=10) 
inter-assay 
1 ng mL-1 / % 
(n=12) 
QC 0.1 ng mL-1 
/ % 
 (n=4) 
QC 1.0 ng mL-1 
/ % 
(n=4) 
QC 10 ng mL-1 
/ % 
(n=4) 
LOD / 
ng mL-1 
LOQ / 
ng mL-1 
MDL / 
ng cm-2 
Upper limit / 
ng mL-1 
Carry-over / 
% 
tR/ min 
RSD / 
% 
(n=16) 
Gemcitabine 3.4 3.5 119 ± 3.3% 97 ± 6.4% 91 ± 3.2% 0.0020 0.0068 0.0025 25 0.04 0.400 0.4 
Methotrexate 4.0 6.8 118 ± 4.8% 104 ± 1.2% 92 ± 3.8% 0.0037 0.0123 0.0045 25 0.19 0.785 0.2 
Topotecan 3.0 6.3 110 ± 6.6% 100 ± 4.6% 89 ± 2.0% 0.0018 0.0060 0.0022 25 0.20 0.892  0.2 
Irinotecan 5.7 6.1 100 ± 14.8% 100 ± 5.6% 102 ± 3.1% 0.0038 0.0125 0.0046 25 0.19 1.260  0.0 
Ifosfamide 4.0 4.8 112 ± 11.5% 117 ± 5.1% 98 ± 3.2% 0.0032 0.0105 0.0039 10 0.34 1.201  0.3 
Cyclophosphamide 2.7 3.3 113 ± 8.1% 118 ± 5.8% 102 ± 3.0% 0.0021 0.0069 0.0025 25 0.25 1.239  0.2 
Doxorubicin 4.5 4.8 115 ± 6.7% 100 ± 5.2% 85 ± 3.4% 0.0016 0.0052 0.0019 100 0.12 1.304  0.4 
Epirubicin 5.4 5.3 115 ± 5.3% 100 ± 4.9% 104 ± 7.2% 0.0029 0.0095 0.0035 25 0.20 1.349  0.3 
Etoposide 4.9 11.2 108 ± 24.6% 102 ± 3.0% 93 ± 8.7% 0.0032 0.0108 0.0040 25 0.12 1.420  0.0 
Paclitaxel 9.4 12.9 106 ± 13.0% 103 ± 9.5% 111 ± 3.5% 0.0062 0.0207 0.0076 50 0.26 2.172  0.2 
Docetaxel 13.5 16.2 107 ± 24.6% 111 ± 19.7% 117 ± 13.1% 0.0146 0.0488 0.0179 25 0.18 2.126  0.2 
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The data included in Table 6.1 show a sufficient intra- and inter-day stability with a maximum 
standard deviation below 5% for most of the target compounds. Higher deviations are especially 
observed for the last eluting analytes paclitaxel and docetaxel. This result is attributed to the 
low response, as can be seen from the LOD and LOQ, as well as to the elution in the region 
with an increased gradient slope of 54.4% B min-1. Thereby, the resulting peak width is around 
3 to 4 s. As a consequence, with a cycle time of 0.3502 s only 11-12 data points per peak are 
obtained. This could be the reason why higher deviations are observed for these two 
compounds. Although it would be possible to decrease the dwell time in order to reduce the MS 
cycle time, the S/N ratio would be negatively affected due to the increased noise at reduced 
MRM dwell times. Another strategy would be a decreased gradient slope to increase the peak 
width in order to collect more data points per peak. This approach has several disadvantages. 
First of all, the sensitivity would decrease because of the increased peak width. Furthermore, 
higher analysis cycle times are obtained which would impede high sample throughput. 
The results for the QC samples for the concentrations of 0.1, 1.0 and 10.0 ng mL-1 show 
sufficient recovery between 80 and 120% for all target analytes. In general, with increasing 
concentration the standard deviation decreases for almost every substance. This is expected 
because in particular the QC concentration of 0.1 ng mL-1 is near the LOQ. 
The LOD and LOQ for an injection of 42.5 fg is around 10 pg mL-1 for almost every compound. 
Again, paclitaxel and docetaxel have an increased LOQ due to the lower response. In order to 
further decrease the LOQ, the method could be split into two methods, one for the polar and 
semipolar compounds and one for the nonpolar target analytes. Thereby, a higher injection 
volume for the nonpolar substances could be used because of the enrichment on the column 
head. As consequence, two injections for every sample need to be done, which decreases sample 
throughput. Nevertheless, if higher sensitivity is required, this strategy could be easily applied.  
For a valid quantification in the lower ng mL-1 range low carry-over and stable retention times 
are a prerequisite. The data in Table 6.1 show a maximum carry-over of 0.34% for ifosfamide. 
Therefore, a second blank injection is always done to further decrease the carry-over. The 
retention time variability with a maximum deviation of 0.4% underlines the stability of the 
developed method and is below the required limits [32, 33]. To that end, the validation data 
reveal the applicability of micro-LC separations for routine analysis. 
Chapter 6: Micro-liquid chromatography mass spectrometry for the analysis of antineoplastic 
drugs from wipe samples  165 
 
6.3.4 Analysis of real samples 
Figure 6.4 shows the separation of three different real samples for the eleven antineoplastic 
drugs using the micro-LC-MS/MS hyphenation. These real samples were taken from different 
sampling locations using the described sampling procedure within the hospital pharmacies and 
application areas at the hospital wards. 
 
Figure 6.4: Resulting chromatograms for the separation of three different real samples for the 
eleven antineoplastic drugs using the micro-LC-MS/MS hyphenation. Observed interferences on 
the selected mass transitions for cyclophosphamide are highlighted by a star. 
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As can be seen from Figure 6.4, the developed method can be applied for real samples. Mainly, 
gemcitabine, ifosfamide, cyclophosphamide and paclitaxel were found with a maximum 
concentration of 28.5 ng mL-1 for paclitaxel. 
The signals in Figure 6.4 a) and b), highlighted by a star, represent interferences of the second 
mass transition of cyclophosphamide. If only one MRM was recorded, a reliable identification 
only by this selected MRM and resulting retention time would be difficult. Therefore, these 
examples clearly show the advantages of using the retention time as well as recording two MRM 
transitions for every target analyte as identification criteria. 
6.4 Conclusion 
The data of method validation clearly show the successful applicability for the analysis of 
eleven antineoplastic drugs using micro-LC-MS/MS in a routine environment. The common 
prejudice that this technique can only be used for limited sample volume can be refuted. The 
instrumental LOQ for an injection of 42.5 fg is sufficient for all target analytes. Because of the 
dilution factor of 10 the sensitivity of paclitaxel and docetaxel is higher than defined 
(LOQ = 0.1 ng mL-1) with a maximum instrumental LOQ of 0.49 ng mL-1 for docetaxel. 
However, the reference value depends on the actual sampling area (recommended: 900 cm2). 
Therefore, no limitations with respect to the achieved LOQ (MDLmax = 0.018 ng cm
-2) occurs 
and thus, the reference value can be achieved when a minimum sampling area of 161 cm² is 
available if small objects like e.g. a telephone handset or a door knob have to be wiped. This 
equals an area of approximately 13 x 13 cm. Compared to already established conventional LC-
MS methods, the obtained instrumental LOQ could be decreased for all substances. In addition, 
the runtime could be significantly reduced to only 2.25 min per analysis. Thereby, a higher 
utilization of resources can be ensured leading to higher sample throughput and reduced solvent 
consumption without compromising sensitivity. As a consequence, the developed method can 
also be applied for quality control. 
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6.7 Chapter appendix 
6.7.1 Structure and analyte properties 
Table-S 6.1 shows the selected substances including important physico-chemical properties, 
while the structural formulas are compiled in Figure-S 6.1. The depicted log D values clearly 
show that the investigated compounds include polar as well as non-polar substances. 
Table-S 6.1: List of the investigated compounds including CAS number, sum formula, pKa and 
log D [1-3]. 
number compound CAS sum formula 
Purity / 
% 
provider 
pKa 
(T=25 °C) 
log D  
(T=25 °C, pH=3) 
(1) gemcitabine 95058-81-4 C9H11F2N3O4 ≥ 98 Sigma 3.60 / 11.52 -3.34 
(2) methotrexate 59-05-2 C20H22N8O5 ≥ 98 Fluka 3.41 / 4.70 -2.95 
(3) topotecan 123948-87-8 C23H23N3O5 ≥ 98 Sigma 8.00 -3.36 
(4) irinotecan 97682-44-5 C33H38N4O6 ≥ 97 Sigma 11.71 -0.34 
(5) ifosfamide 3778-73-2 C7H15Cl2N2O2P ≥ 98 Sigma 13.24 0.75 
(6) cyclophosphamide 50-18-0 C7H15Cl2N2O2P ≥97 Sigma 12.78 0.50 
(7) doxorubicin 23214-92-8 C27H29NO11 ≥ 98 Sigma 9.53 -2.86 
(8) epirubicin 56420-45-2 C27H29NO11 ≥ 90 Sigma 9.53 -2.86 
(9) etoposide 33419-42-0 C29H32O13 ≥ 98 Sigma 9.33 0.28 
(10) paclitaxel 33069-62-4 C47H51NO14 ≥ 95 Sigma 10.36 3.95 
(11) docetaxel 114977-28-5 C43H53NO14 ≥ 97 Sigma 10.96 2.46 
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Figure-S 6.1: Structures of the investigated compounds: (1) gemcitabine, (2) methotrexate, (3) 
topotecan, (4) irinotecan, (5) ifosfamide, (6) cyclophosphamide, (7) doxorubicin, (8) epirubicin, (9) 
etoposide, (10) paclitaxel, (11) docetaxel [1]. Note: Only the neutral species are shown which are 
not necessarily present at the applied pH. 
A list of the applied MRM transitions and MS/MS parameter is given in Table-S 6.2. 
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Table-S 6.2: Mass transitions and MS/MS parameter of the investigated compounds. 
number compound 
Ionization 
mode 
Q1  
m/z 
Q3 
m/z 
Dwell time 
/ ms 
DP  
/ mV 
EP  
/ mV 
CE  
/ eV 
CXP  
/ mV 
1 gemcitabine ESI pos. 264 
112 
10 55 10 
25 12 
95 61 12 
2 methotrexate ESI pos. 455 
308 
10 80 10 
25 14 
175 47 10 
3 topotecan ESI pos. 422 
377 
10 56 10 
25 22 
46 61 12 
4 irinotecan ESI pos. 587 
124 
10 196 10 
43 12 
167 49 10 
5 ifosfamide ESI pos. 261 
154 
10 101 10 
29 18 
92 33 16 
6 cyclophosphamide ESI pos. 261 
140 
10 71 10 
31 16 
106 25 12 
7 doxorubicin ESI pos. 544 
397 
10 20 10 
15 16 
361 35 14 
8 epirubicin ESI pos. 544 
397 
10 36 10 
17 14 
361 37 10 
9 etoposide ESI pos. 589 
229 
10 80 10 
19 20 
185 53 18 
10 paclitaxel ESI pos. 854 
569 
10 130 10 
13 24 
286 21 20 
11 doctaxel ESI pos. 808 
527 
10 80 10 
13 10 
226 19 24 
DP: declustering potential, EP: entrance potential, CE: collision energy, CXP: cell exit potential  
6.7.2 Investigation of extraction efficiency 
Figure-S 6.2 shows the recovery rates including error bars for DMSO, ACN and IPA as organic 
solvent for the 5 ng mL-1 QC samples. 
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Figure-S 6.2: Resulting recovery rates of the eleven antineoplastic drugs for a mixture of a) 
H2O:DMSO + 0.1% FA, b) H2O:ACN + 0.1% FA and c) H2O:IPA + 0.1% FA in various 
compositions for a concentration of 5 ng mL-1 (see figure legend describing the amount of organic 
solvent in the extraction solution; number of QC samples = 4). 
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6.7.3 Separation of the eleven antineoplastic drugs 
6.7.3.1 Investigation and optimization of the injection volume 
Whereas Figure-S 6.3 a) illustrates the separation of the eleven antineoplastic drugs using an 
injection volume of 250 nL for the 0.1 ng mL-1 standard, Figure-S 6.3 b) shows the separation 
for the same concentration using an injection volume of 425 nL. For the separation in Figure-S 
6.3 c), an injection of 425 nL was performed analysing a 1.0 ng mL-1 standard. The composition 
of the injection solution is 66.4/33.6 H2O/IPA (v/v) + 0.1% FA for all chromatograms. 
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Figure-S 6.3: Resulting chromatogram for the separation of the eleven antineoplastic drugs for a 
concentration of a) 0.1 ng mL-1 using an injection volume of 250 nL, b) 0.1 ng mL-1 using an 
injection volume of 425 nL and c) 1.0 ng mL-1 using an injection volume of 425 nL. Analytes: (1) 
gemcitabine, (2) methotrexate, (3) topotecan, (4) irinotecan, (5) ifosfamide, (6) cyclophosphamide, 
(7) doxorubicin, (8) epirubicin, (9) etoposide, (10) paclitaxel, (11) docetaxel. 
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As can be seen in Figure-S 6.3 c), broadened and distorted peak shapes are obtained for an 
injection volume of 425 nL. The reason is depicted in Figure-S 6.4 illustrating the focussing 
and missing focussing of polar and non-polar substances depending on the applied injection 
volume and sample composition. 
 
 
Figure-S 6.4: Schematic illustration of the chromatographic separation and resulting peak shapes 
for a) the focusing of polar and non-polar compounds using 10% of the column void volume as 
injection volume, b) the missing focusing of polar substances as well as the focussing of non-polar 
compounds using an aqueous injection solution with an injection volume higher than 10% of the 
column void volume and c) the missing focusing of polar substances and non-polar compounds 
using an organic injection solution with an injection volume higher than 10% of the column void 
volume. 
When the injection volume is chosen below 10% of the column void volume, both polar as well 
as non-polar substances are focussed at the column head resulting in symmetric peak shapes as 
depicted in Figure-S 6.4 a). In contrast, if a large volume injection (LVI) is performed 
asymmetric peak shapes are obtained. These distortion effects are differently pronounced for 
the polar and semi-polar target analytes depending on the sample composition. When an LVI 
is applied using an aqueous injection solution, only the polar compounds become broader 
because of the missing focussing for these substances as illustrated in Figure-S 6.4 b). The 
remaining column volume is not sufficient to compress the band. Using an organic injection 
solution, the polar as well as semi-polar substances are affected due to the higher elution 
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strength of the injection solvent compared to the initial mobile phase composition as shown in 
Figure-S 6.4 c). 
6.7.3.2 Chromatographic separation of cyclophosphamide and 
ifosfamide 
The isomers cyclophosphamide and ifosfamide need to be separated chromatographically due 
to cross talk. This phenomenon is depicted in Figure-S 6.5. 
 
Figure-S 6.5: Resulting MRM signals for cyclophosphamide (m/z 261 → m/z 140, m/z 261 → m/z 
106) and ifosfamide (m/z 261 → m/z 154, m/z 261 → m/z 92) using a) a multicompound standard, 
b) single ifosfamide standard and c) single cyclophosphamide standard. 
In Figure-S 6.5 a) the separation of cyclophosphamide and ifosfamide is shown for a 
100 ng mL-1 standard. In contrast, the chromatograms illustrated in Figure-S 6.5 b) and c) only 
contain one of these substances. Although only one compound is included a signal can be 
identified for the other isomer as can be seen from the magnification highlighted by a star. 
Therefore, if the concentration of one analyte is high and no chromatographic separation is 
achieved false positive results are the consequence. This can be explained by the MS/MS 
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spectra of the individual compounds which are depicted in Figure-S 6.6. Whereas Figure-S 6.6 
a) shows the MS/MS spectrum for cyclophosphamide at a collision energy of 31 eV, the 
spectrum for ifosfamide in Figure-S 6.6 b) was recorded using a collision energy of 33 eV. 
These collision energies equal those values of the selected MRM transitions 
(cyclophosphamide: m/z 261 → m/z 140, m/z 261 → m/z 106; ifosfamide: m/z 261 → m/z 154, 
m/z 261 → m/z 92). 
 
Figure-S 6.6: Resulting MS/MS spectra for a) cyclophosphamide at a collision energy of 31 eV and 
b) ifosfamide at a collision energy of 33 eV. 
As can be seen, the selected product ions for the MRM transitions show the highest intensity 
for the individual compound. Nevertheless, both spectra reveal that cyclophosphamide as well 
as ifosfamide are capable to form the fragments of the corresponding isomer. That is why the 
signals are obtained for the individual isomers although only the other is included. As a 
consequence, a chromatographic separation is mandatory. 
6.7.4 Optimization of the ion source parameters 
After dilution of the samples by a factor of 10 the MS ion source parameters need to be further 
optimized to achieve the adapted LOQ of 0.01 ng mL-1. Therefore, flow injection analysis (FIA) 
was performed. During the optimization the influence of the following six different parameters 
were analysed: Curtain gas (CUR), collision activated dissociation gas (CAD), ionization 
voltage (IS), ion source temperature (TEM), nebulizer gas (GS1) and heater gas (GS2). At this 
point it should be noted that the GS1 depends on the position of the ESI probe and that there is 
a dependence between TEM and GS2. Higher temperature can be combined with a low GS2 and 
vice versa. Both parameters are critical values because they can cause thermal degradation of 
certain substances. 
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During optimization, the predefined values for each parameter are subsequently adjusted and 
the resulting intensity is recorded automatically by the software. Afterwards, the software 
creates a report containing all intensity values for each analyte and source parameter value. In 
addition, the software recommends a method on the basis of the highest number of counts over 
all analytes. For some cases this approach would yield a sensitive method for all target analytes. 
But it is also possible that the recommended method is influenced by high signal intensities for 
certain compounds, which leads to wrong conclusions about the optimal ion source parameters. 
Therefore, to evaluate the influence of each parameter for each compound the obtained intensity 
values are normalized to the highest number of counts. Thereby, the loss or gain of intensity 
can be illustrated when varying the parameter value. Figure-S 6.7 shows the resulting 
normalized intensities in percent for the ion source temperature between 200 and 450 °C. 
 
Figure-S 6.7: Resulting intensity for the ion source temperature normalized to the highest number 
of counts for each analyte and temperature value (n = 3). 
As can be seen, for six compounds the intensity increases with increasing temperature. In 
contrast, for the other substances a loss of intensity can be identified which is very pronounced 
for etoposide, paclitaxel and docetaxel. Nevertheless the recommended method by the software 
contains a TEM of 400 °C. If this temperature would be chosen, the intensity for the temperature 
unstable compounds decreases to 10-30%. As a consequence, a target method that achieves the 
defined LOQs for all substances would not be possible. Therefore, a lower TEM is necessary in 
order to obtain sufficient sensitivity for etoposide, paclitaxel and docetaxel. From Figure-S 6.7 
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it becomes clear that a temperature of 250 °C favours the intensity for these compounds. For 
docetaxel a TEM of 200 °C would yield even higher intensity but the loss of counts for all other 
substances is pronounced. Therefore, the ion source temperature was adjusted to 250 °C 
because it represents the best compromise for all target analytes. As described above, the 
dependence between the TEM and GS2 must be considered when changing the ion source 
temperature. That is why the optimization for GS2 was repeated for a temperature of 250 °C. 
Figure-S 6.8 shows the comparison of the GS2 optimization at 450 and 250 °C. 
 
Figure-S 6.8: Comparison of the GS2 optimization at a) 450 °C and b) 250 °C for the eleven 
antineoplastic drugs. 
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As illustrated in Figure-S 6.8 pronounced differences for the optimum GS2 value are obtained 
for the individual ion source temperature. This is attributed to the temperature distribution in 
the ion source as described above. Whereas the optimum setting for GS2 in Figure-S 6.8 a) is 
10 psi at 450 °C, a value of 30 psi should be chosen at 250 °C as depicted in Figure-S 6.8 b). In 
addition, pronounced differences regarding the error bars can be identified. In general, the error 
is reduced at 250 °C for almost all substances. The reason is the improved spray stability at the 
decreased temperature. Again, the MS software recommends a GS2 value of 60 psi. Therefore, 
a visual inspection and interpretation of the data is mandatory. 
To summarize, Table-S 6.3 gives a comparison of the different ion source parameters as 
recommended by the MS software and normalization. 
Table-S 6.3: Overview of the differences between the ion source parameter for the MS 
recommended and normalized evaluated values. 
Parameter MS software Normalization 
CUR / psi 20 20 
CAD Medium Medium 
IS / kV 5.5 5.0 
TEM / °C 400 250 
GS1 / psi 10 10 
GS2 / psi 10 30 
 
As can be seen from Table-S 6.3 all other parameters are similar for the MS software and 
graphically evaluated method. Nevertheless, the normalized intensities can be found in Figure-
S 6.10. At this point it must be noted that the ionization voltage is set to 5.0 kV although the 
resulting intensity is higher for 5.5 kV. The reason is that at 5.5 kV the ESI needle starts to glow 
leading to unstable spray conditions which is also notable for the peak shapes in the 
chromatogram. The effect of the ionization voltage at 5.0 kV and 5.5 kV on the ESI needle is 
illustrated in Figure-S 6.9. 
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Figure-S 6.9: Illustration of the ESI needle at a) 5.0 kV and b) 5.5 kV. 
 
Figure-S 6.10 shows the resulting normalized intensities in percent for the curtain gas (CUR), 
collision activated dissociation gas (CAD) and the ionization voltage (IS). 
Chapter 6: Micro-liquid chromatography mass spectrometry for the analysis of antineoplastic 
drugs from wipe samples  183 
 
 
Figure-S 6.10: Resulting intensity for a) the curtain gas (CUR), b) the collision activated 
dissociation gas (CAD) and c) ionization voltage (IS) normalized to the highest number of counts 
for each analyte and temperature value (n=3). For further information please refer to the figure 
legend. 
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6.7.5 Calculation of the area related results 
For the calculation of the area related concentration (ARC) the following Equation-S 6.1 can be 
used. In addition, it can be used to verify whether the estimated concentration is below or above 
the reference value of 0.1 ng cm-2. 
𝐴𝑅𝐶 =
𝑐 ∙ 𝐷 ∙ 𝑉
𝐴𝑥
 Equation-S 6.1 
where c is the concentration in ng mL-1, D the dilution factor of 10, V is the volume of wetting 
and extraction solution in mL and Ax the sampling area in cm
2. To demonstrate that the 
developed method is suitable for the determination of the reference value the following example 
from Figure 6.4 a) of the main document is applied. The estimated concentration for 
ifosfamide (5) was 0.293 ng mL-1 under consideration of the dilution factor. The applied 
volume was 33 mL and the sampling area 900 cm2. The corresponding area related 
concentration is 0.011 ng cm-2. Therefore, it can be demonstrated that the developed method is 
suitable to control the reference value. 
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Chapter 7 Further considerations on selectivity, peak capacity 
and robustness 
The most important parameter during method development is the selectivity of the applied 
separation technology to obtain a separation between target analytes if needed. In particular the 
separation of analytes of similar structures like isomers or epimers can only be achieved by 
sufficient selectivity. Therefore the screening of a suitable phase system is of utmost importance 
for such analytical problems. Although the choice can be simplified by PCA as shown in 
Chapter 2.3, the screening of a phase system can still be time-consuming and complex. That is 
why over the last years different separation techniques were developed to achieve higher 
selectivity. Using specialized detectors like mass spectrometers can help to distinguish between 
co-eluting analytes on the basis of their mass-to-charge (m/z) ratio [1, 2]. However, if isobaric 
compounds with identical accurate mass and mass transitions are included other approaches 
need to be considered despite the high selectivity of mass spectrometry. That is why for example 
two-dimensional liquid chromatography (2D-LC) is of broad interest due to the possibility to 
combine stationary phases with different retention mechanisms to achieve an orthogonal 
separation system and thus higher selectivity [3, 4]. One example for a resulting 2D-LC-MS 
separation for the isomers ifosfamide and cyclophosphamide as well as for the epimers 
doxorubicin and epirubicin is shown in Figure 7.1 [10]. 
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Figure 7.1: Resulting two-dimensional separation of the reconstructed peak shapes within the first 
dimension for a) the epimers doxorubicin and epirubicin and b) the isomers ifosfamide and 
cyclophosphamide. The vertical dashed red lines represent the different fractions that are 
transferred to the second separation dimension. The resulting 2D-LC separations are shown in c) 
and d) for the individual critical peak pairs. The corresponding separation for one fraction is 
shown in e) and f) [10]. 
For both critical peak pairs a partial separation can be obtained as becomes clear from the 
reconstructed peak shapes of the first dimension in Figure 7.1 a) and b). It can be seen that the 
resulting resolution is higher for the epimers doxorubicin and epirubicin (Figure 7.1 a) 
compared to the isomers ifosfamide and cyclophosphamide (Figure 7.1 b). The vertical dashed 
red lines represent the different fractions that are transferred to the second dimension for further 
separation as shown in Figure 7.1 c) and d). Unfortunately, a co-elution of both critical peak 
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pairs occurs in the second dimension as can be identified by the magnification of one fraction 
analyzed within the second dimension as depicted in Figure 7.1 e) and f) for the individual 
critical peak pair. The reason is the decreased peak capacity in the second dimension because 
of a gradient time of only 17 s. Because of this co-elution, the mass spectrometer is not able to 
distinguish between these compounds. Therefore, the resulting selectivity and peak capacity is 
not suitable to achieve a separation by 2D-LC-MS for this example. To further increase the 
selectivity ion mobility spectrometry (IMS) has been developed to separate analytes in the gas 
phase prior to the mass spectrometer or as a stand-alone technique as an alternative approach 
to chromatography [5]. The separation in IMS is based on different drift times of the analyte 
ions in a drift tube, when the analytes are pushed against a drift gas in an electric field [6, 7]. 
Target compounds with different mass and/or structure need different times to migrate through 
the drift tube and thus a separation can be achieved. Nowadays, different techniques of IMS are 
available [8]. It is often being stated that ion mobility can be used to increase selectivity and to 
separate isobaric substances [9]. Figure 7.2 shows the separation of the critical peak pairs by 
solely using IMS. 
 
Figure 7.2: Illustration of the resulting separation depending on the applied compensation voltage 
(COV) of a) the epimers doxorubicin and epirubicin and b) the isomers ifsofamide and 
cyclophosphamide using solely IMS [10].  
As can be identified, a separation of the isomers and epimers is not achieved by IMS even using 
isopropanol as modifier to achieve higher selectivity by clustering. In addition, investigations 
showed that the current potential of IMS is often not suitable to achieve a separation of 
compounds of similar structure because the resolving power is currently not sufficient [8, 10]. 
Sometimes a separation is only possible if for example adduct formation with sodium takes 
place as illustrated in Figure 7.3 for ifosfamide and cyclophosphamide. 
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Figure 7.3: Illustration of the resulting separation of ifosfamide and cyclophosphamide as sodium 
adducts using IMS only [10]. 
As depicted, by adduct formation the structures of the target analytes change in a way that IMS 
can partially separate ifosfamide and cyclophosphamide. However, an adduct formation not 
always occurs for the investigated analytes. Nevertheless, IMS has other advantages such as the 
separation of matrix ingredients to reduce matrix interferences [6, 9]. In general, the usage of 
such separation techniques is associated with additional costs for purchase and the complexity 
of method development and data analysis increases considering LC-IMS-MS [11]. In addition, 
the applicability with highly efficient UHPLC separations can be doubted regarding the 
sensitivity loss and resulting data acquisition rates whose influence on method robustness will 
be discussed later. However, it can be demonstrated that IMS is currently not suitable to replace 
chromatography. Therefore, liquid chromatography is still the method of choice and the easiest 
way to achieve a separation. Figure 7.4 shows the resulting micro-LC-MS/MS separation for 
the critical peak pairs using the phase system identified by the PCA. 
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Figure 7.4: Illustration of the resulting separation of a) doxorubicin and epirubicin and b) 
ifosfamide and cyclophosphamide using micro-LC-MS/MS. For further experimental details 
please refer to Chapter 6.2. 
It is clearly demonstrated that the selectivity as well as the peak capacity of the one dimensional 
micro liquid chromatography is sufficient to achieve a separation in less than 1.5 min for both 
critical peak pairs. These examples illustrate that liquid chromatography is still the easiest way 
to achieve a separation and cannot currently be replaced by IMS. Therefore, the development 
of new stationary phases is the most promising approach to handle the increased requirements 
in the analytical world until other techniques like IMS have been further improved. All 
manufacturers as well as research groups are working on new surface modifications such as 
biphenyl or ion exchange to obtain different selectivity [12, 13]. As was shown in Figure 2.4 
(PCA), the resulting selectivity is totally different compared to conventional C18 columns. 
However, whether the applied selectivity is helpful or not clearly depends on the analytical 
problem and therefore on the analytes that need to be resolved. 
The same is true for the efficiency or peak capacity when considering gradient elution. It was 
demonstrated that miniaturized LC columns can provide the same efficiency and peak capacity 
production rates as their conventional i.d. counterparts. However, the question arises whether 
high peak capacity is needed or not for the analytical problem. 
To address this issue for the method of antineoplastic drugs developed in this work, the question 
can be easily answered when considering the resolution of the critical peak pairs. To 
demonstrate the potential of higher efficiency at identical selectivity in order to obtain a 
chromatographic separation for isobaric compounds, the resulting separation of ifosfamide and 
cyclophosphamide as well as doxorubicin and epirubicin is shown in Figure 7.5. Whereas in 
Figure 7.5 a) and b) the separation was done on a column packed with 1.9 µm fully porous 
particles, Figure 7.5 c) and d) illustrate the chromatogram obtained with 3.0 µm fully porous 
particles. 
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Figure 7.5: Comparison of the separation of the critical peak pairs doxorubicin and epirubicin 
obtained on a, b) a column packed with 1.9 µm fully porous particles and c, d) a column packed 
with 3.0 µm fully porous particles. For further experimental details please refer to Chapter 6.2. 
A baseline separation can be achieved using the smaller particle diameter whereas the isobaric 
compounds co-elute when the larger particle diameter is applied. Apparently, by using the 
smaller particle diameter, higher sensitivity as well as reduced peak widths can be obtained. 
Thereby the peak capacity increases from 12 which is approximately the peak capacity of the 
second dimension in the 2D-LC approach of Figure 7.1 to 27 for the reduced particle diameter 
since the gradient time is constant, which explains approaches of developing and introducing 
even smaller particles [14-16]. The example clearly demonstrates the potential of smaller 
particle diameters for fast liquid chromatography although it might be possible to achieve a 
separation with 3.0 µm particles when using a flatter gradient slope. The consequence are 
increased analysis times reducing the sample throughput. However, the question arises why 
sub-2 µm particles have not been established for all applications since higher peak capacity can 
be achieved in a shorter analysis time. Besides the drastic increase in backpressure, the small 
resulting peak widths can cause significant limitations especially when a huge number of 
analytes has to be detected and quantified at low analyte concentrations. In addition, the smaller 
the particles, the smaller the resulting peak width leading to higher susceptibility in terms of 
the extra-column band broadening. The same is true for steep solvent gradients. To further 
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emphasize the appropriate selection of a suitable particle diameter, the probability that a certain 
number of compounds will be baseline separated depending on the peak capacity can be 
approximated using Equation 7.1 whereas the relation is graphically shown in Figure 7.6 [17]. 
𝑃′ = (1 −
𝑚 − 1
𝑛 − 1
)
𝑚−2
∙ 100% Equation 7.1 
where P’ is the probability that a baseline separation can be achieved, m the number of 
compounds and n the peak capacity. 
 
Figure 7.6: Illustration of the probability of baseline separated signals depending on the number 
of compounds and peak capacity. 
As can be identified, the probability drastically decreases with increasing number of compounds 
and decreasing peak capacity. For example, analyzing 50 compounds with a peak capacity of 
50 or 100, the probability is almost zero that all analytes are baseline separated. Even assuming 
a peak capacity of 1,000, the probability is below 10%. Therefore, when analyzing a high 
number of compounds, there are regions within the chromatogram where several analytes will 
co-elute. Usually, mass spectrometry is able to separate co-eluting compounds on the basis of 
their mass-to-charge ratio. When using triple-quadrupole mass spectrometers the acquisition 
mode is typically the multiple-reaction-monitoring (MRM) mode to ensure high selectivity and 
sensitivity. Therefore, two mass transitions are recorded, one for quantification and one for 
substance verification. However, the acquisition of MRMs needs time to achieve a sufficient 
number of data points to accurately represent the peak profile. In mass spectrometry the data 
acquisition rate depends on the adjusted cycle time which is the sum of the dwell time and pause 
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time to switch between different MRMs. In addition, the cycle time depends on the number of 
simultaneously detected mass transitions. The higher the number of compounds, the higher the 
cycle time. Therefore, for multicomponent analysis it is desirable to reduce the cycle time as 
much as possible to obtain a high data acquisition rate for a high number of simultaneously 
measured MRM. But there are some limitations with common generations of mass 
spectrometers in terms of useful values for the dwell and pause time. In general, with decreasing 
dwell time the signal-to-noise ratio decreases leading to higher limits of quantification. Even 
using sophisticated software algorithms like time-dependent acquisition of mass transitions, the 
number of compounds that has to be detected simultaneously can be huge for multicomponent 
analyses. Therefore, it can occur that certain signals cannot be detected with a sufficient number 
of data points and accuracy especially at low concentrations using sub-2 µm particles. This 
issue is shown in Figure 7.7 for the separation of antineoplastic drugs separated on the column 
packed with 1.9 µm fully porous particles. 
 
Figure 7.7: Illustration of the peak profiles for the separation of antineoplastic drugs including 
the number of data points obtained for every compound and selected mass transition. Analytes: 
1) gemcitabine (15), 2) methotrexate (13), 3) topotecan (14), 4) irinotecan (12), 5) ifosfamide (12), 
6) cyclophosphamide (12), 7) doxorubicin (12), 8) epirubicin (11), 9) etoposide (12), 10) paclitaxel 
(9) and 11) docetaxel (8). The two lines represent the different mass transitions acquired for the 
individual target compound whereas the number in brackets refers to the number of data points. 
The dashed blue line illustrates the applied solvent gradient. For further experimental details 
please refer to Chapter 6.2. 
0.0 0.5 1.0 1.5 2.0
0.0E+00
5.0E+04
1.0E+05
1.5E+05
2.0E+05
2.5E+05
3.0E+05
3.5E+05
4.0E+05
4.5E+05
 %
 B
10
11
7
9
8
4/6
5
3
2
in
te
n
s
it
y
 /
 c
p
s
time / min
1
0
20
40
60
80
100
Chapter 7: Further considerations on selectivity, peak capacity and robustness 193 
 
It becomes clear that all analytes eluting within the first 1.5 min can be represented by a 
sufficient number of data points due to the lower gradient slope of 25% B min-1. However, the 
analytes docetaxel (11) and paclitaxel (10) can only be measured by 8 and 9 data points as 
depicted in Figure 7.8. 
 
Figure 7.8: Illustration of the peak profile including the number of data points for docetaxel (8) 
and paclitaxel (9). The two lines represent the different mass transitions acquired for the 
individual target compound whereas the number in brackets refers to the number of data points. 
The dashed blue line illustrates the applied solvent gradient. For further experimental details 
please refer to Chapter 6.2. 
Therefore, the applied data acquisition rate is not suitable to represent the peak profile 
sufficiently because of a resulting peak width below 3 s due to the increased gradient slope of 
54% B min-1 and the usage of 1.9 µm fully porous particles. For an appropriate quantification, 
the number of data points should be at least 12 [18]. Otherwise lower method accuracy 
especially at low concentrations is obtained. Nevertheless, the specifications for method 
validation regarding the precision are fulfilled as was shown in Chapter 6. For this example, 
this issue can easily be resolved by increasing the data acquisition rate. However, it must be 
noted that this example only contains 11 analytes. Therefore, when analyzing a huge number 
of compounds at low concentrations the effects of an inadequate number of data points will be 
more pronounced. Moreover, using additional detection techniques like IMS will additionally 
affect the number of data points due to its contribution to the acquisition rate. 
Now the question arises why the particle diameter and gradient slope are important parameters 
for multicomponent analysis. First of all the applied gradient slope defines the resulting peak 
width. The higher the gradient slope the smaller the resulting peak width as discussed in Chapter 
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6.3.3 leading to decreased time offered for mass spectrometric detection. In addition, using 
steep gradients will lead to regions with high number of compounds eluting simultaneously and 
therefore high peak density. As demonstrated in Figure 7.5, the particle diameter also influences 
the peak width. Therefore, it can be useful to use larger particles to obtain broader peak shapes 
in order to provide sufficient time for detection to obtain a sufficient number of data points 
across a chromatographic peak when a high number of analytes co-elute in multicomponent 
analysis. Despite the lower peak capacity at constant gradient times, larger particles can be 
beneficial compared to sub-2 µm particles due to the possibility of increased detection time. 
Therefore, it must be questioned whether high peak capacity is needed for the analytical 
problem and which limitations occur due to the resulting peak widths even using fast scanning 
mass spectrometers in combination with highly efficient UHPLC separations.  
In general, if high peak capacity is needed to achieve a separation of e.g. isobaric compounds 
in fast separations, smaller particle diameters should be used. On the other hand for 
multicomponent analysis larger particle diameters are favourable with increased gradient times 
and therefore flat gradient slopes to increase peak capacity with higher peak widths until new 
generations of mass spectrometers enabling faster acquisition rates and higher sensitivity 
become available to fully take advantage of the separation power of sub-2 µm particles. 
No matter whether a limited number of analytes is investigated or multicomponent analysis is 
performed, the following conclusions are valid. Decreased gradient slope leads to higher peak 
capacity regardless which particle diameter is used [19-21]. The application of increased 
temperature reduces mobile phase viscosity leading to decreased backpressure allowing to 
apply higher linear velocities [22]. In general, higher flow rates are favourable using constant 
gradient times to increase k* [23] and therefore the chromatographic resolution when 
considering Equation 1.22 (see Chapter 1).  
Now, the benefits of micro-LC compared to conventional LC in terms of resource consumption 
and sample throughput will be discussed to demonstrate the potential of miniaturized separation 
techniques. Therefore, the developed method obtained on micro-LC-MS/MS is compared to the 
previously established conventional LC-MS/MS as shown in Figure 7.9. 
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Figure 7.9: Comparison of the separation of antineoplastic drugs obtained on a) a micro-LC 
system with a 50 x 0.3 mm column packed with 1.9 µm fully porous particles at a flow rate of 
25 µL min-1 and b) a conventional LC system with a 50 x 2.1 mm column packed with 2.6 µm core-
shell particles at a flow rate of 700 µL min-1 using an injection volume of 50 µL. The red dashed 
circle illustrates the column overloading for gemcitabine. For further experimental details please 
refer to Chapter 6.2. 
Whereas Figure 7.9 a) illustrates the separation obtained on a miniaturized LC system using a 
50 x 0.3 mm column packed with 1.9 µm fully porous particles, the same separation was done 
on a conventional HPLC system with a column inner diameter of 2.1 mm and 2.6 µm core-shell 
particles in Figure 7.9 b). As can be seen, small differences between the resulting 
chromatograms can be identified due to the fact that different surface modifications were used 
resulting in different selectivity. However, the separation of the critical peak pairs can be 
obtained for both approaches. The separation can be achieved using micro-LC in 2.5 min 
whereas the conventional LC separation takes 3.5 min. To demonstrate the benefit in terms of 
sample throughput the analysis cycle time needs to be considered. Therefore, the sample 
preparation by the autosampler is assumed to be 1 min for both LC approaches. During the 
preparation step the initial mobile phase composition is flushed through the column as part of 
re-equilibration. To fully re-equilibrate the column to ensure repeatable chromatographic 
conditions, commonly approximately ten column void volumes are used [24]. Under 
consideration of the column void volumes of the different columns, the preparation time of the 
autosampler is sufficient to re-equilibrate the 0.3 mm i.d. column. Therefore, the analysis cycle 
time is 3.5 min. In contrast, for the 2.1 mm i.d. column, the preparation time is not adequate to 
achieve ten column void volumes for re-equilibration. That is why an additional isocratic step 
needs to be programmed after the gradient to ensure full re-equilibration. As a consequence, 
the total analysis cycle time increases to approximately 7 min. Comparing the resulting analysis 
cycle times, an increase in sample throughput by the factor of 2 can be achieved using the 
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miniaturized column i.d. To achieve such cycle times, a flow rate of only 25 µL min-1 is used 
for the 0.3 mm i.d. column whereas a flow rate of 700 µL min-1 must be applied for the 2.1 mm 
i.d. column due to the fact of increased linear velocity with decreasing column i.d. as described 
in Chapter 1. Consequently the consumption of mobile phase can be reduced by 98% leading 
to decreased costs for purchase and disposal of LC-MS grade solvents. This is an undisputed 
benefit of miniaturized separation techniques. To obtain a similar fast separation with a 
conventional column inner diameter of 2.1 mm the flow rate must be increased to almost 
2.0 mL min-1 under consideration of the maximum backpressure. Thereby the amount of 
solvent dramatically increases. In addition, the ionization efficiency of electro-spray ionization 
(ESI) decreases with increasing flow rates although conventional ESI sources are specified for 
flow rates up to 3.0 mL min-1 [25]. Regarding the resulting response differences can be 
identified. However, the limit of quantification is similar for the miniaturized as well as 
conventional LC-MS approach although the injection volume is decreased for miniaturized 
column i.d. An injection volume of 50 µL was used for the conventional column inner diameter, 
whereas only 4.25 µL are injected onto the miniaturized column. Thereby, the injected mass is 
reduced by 92% leading to reduced sample consumption which is of utmost importance for 
several fields of application. Considering a 0.01 ng mL-1 standard, the injected mass is only 
42.5 fg for the 0.3 mm i.d. column whereas 500 fg are injected on the 2.1 mm i.d. column. 
Nevertheless, the LOQ’s are comparable due to the improved signal-to-noise ratio because of 
the lower amount of matrix ingredients introduced into the mass spectrometer. Of course, it 
would be possible to choose higher injection volumes for the 2.1 mm i.d. column but then even 
higher amounts of matrix will be transferred into the system and chromatographic issues due to 
overloading effects can occur as demonstrated by the dashed circle in Figure 7.9 b) for 
gemcitabine. In addition, the sample consumption as well as the gradient delay volume 
increases leading to increased analysis time using a fixed-loop autosampler design. Therefore, 
it could be demonstrated that miniaturized column i.d. can offer similar LOQ compared to 
conventional LC even when the sample volume is not limited. Furthermore, it must be 
considered that the applied ion source is designed for increased sensitivity at high flow rates. 
Therefore, it would be necessary to design ion-sources with optimized source geometries for 
decreased flow rates to further improve the sensitivity because it is possible that the full 
potential of miniaturized column i.d. is currently not being exploited. Regarding the robustness 
and reproducibility of miniaturized LC columns which is often a point of criticism [26-28], the 
developed method is compared on two different miniaturized columns as depicted in Figure 
7.10. Whereas Figure 7.10 a) illustrates the obtained separation on a new column, Figure 7.10 
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b) demonstrates the resulting chromatogram achieved on a column of a different batch after 
4,000 injections. 
 
Figure 7.10: Comparison of the separation of antineoplastic drugs obtained on a) new column and 
b) different batch column after 4,000 injections. For further experimental details please refer to 
Chapter 6.2. 
As can be seen, comparable separations can be achieved on the two different columns although 
the column used for the separation in Figure 7.10 b) was previously applied for thousands of 
injections. Only the peak of the polar compound gemcitabine (1) is broadened and little 
deviations for the semi-polar analytes (4-8) can be identified. In addition, small differences in 
sensitivity are obtained due to the increased peak width for the intensively stressed column. 
However, the separation of the critical peak pairs is still sufficient. Therefore, a reliable batch-
to-batch column reproducibility can be demonstrated which is important for validated analytical 
methods [29]. In addition, a sufficient long-term stability is given for miniaturized 
commercially available LC columns as becomes clear from the total injection number. 
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Chapter 8 General conclusions and outlook 
 
In general, it could be demonstrated that miniaturized LC systems exhibit the same robustness 
and sensitivity compared to conventional LC separations as was presented in Chapter 6. Fast, 
reliable and efficient separations can be achieved with less resource consumption qualifying 
micro-LC-MS/MS as a future technology in terms of green analytical chemistry for routine 
application and high throughput separations. Therefore, this technique is ideally suited in the 
field of quality control within the pharmaceutical industry due to the need of increased 
productivity at reduced costs without compromising quality [1]. Multivariate data analysis like 
the principal component analysis (PCA) is suitable to simplify the identification of a 
chromatographic phase system for the separation of the critical peak pairs. This approach has 
the advantage of taking into account the properties of the compounds of interest. Conventional 
column classification methods are usually applied to compare different stationary phases with 
respect to their retention mechanisms using model analytes [2]. Therefore, for real applications, 
the obtained information are often not suitable to directly identify a suitable phase chemistry 
and can therefore only suggest a possible stationary phase due to the provided interactions. 
Performance characterization procedures like the van Deemter analysis or the kinetic plot 
theory can be performed to evaluate the quality of LC columns and their time-based potential 
to provide efficiency for practical purposes. Although the efficiency of miniaturized columns 
is often being questioned, it was shown that a sub-2 µm fully porous particle packed column 
with an inner diameter of 300 µm achieves similar packing quality compared to their 
conventional counterparts [3, 4]. Moreover, comparable peak capacity production rates in 
gradient elution can be obtained [5]. Therefore, no compromise in terms of efficiency due to 
the usage of micro-LC columns with an inner diameter of 300 µm must be made. Nevertheless, 
the influence of the extra-column volume needs to be further decreased to take full advantage 
of the separation efficiency as discussed in Chapter 1 [1, 6, 7]. By using such tools it can be 
ensured that optimum conditions are chosen for the developed liquid chromatography method 
in terms of selectivity, efficiency and analysis time [8, 9]. 
To further improve the separation different strategies can be applied. First of all, the system 
design needs to be improved to reduce extra-column band broadening. After reducing the extra-
column variance, the possibility of using even smaller particles in the lower sub-2 µm range 
packed in shorter columns (L ≤ 3 cm) should be evaluated to accelerate the separation to further 
increase sample throughput at reduced resource consumption. After implementing optimized 
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system and column designs, the sample throughput can be further increased by using 
sophisticated valve technology. So-called multiplexing systems can be used to interlace the 
workflow of sample preparation steps and subsequent analysis to minimize the downtime of 
mass spectrometers leading to an increased return of invest. If this succeeds, micro-LC-MS/MS 
can further change the field of high-throughput analysis to replace conventional liquid 
chromatography.  
Moreover, different types of particle morphologies such as non-porous particles or core-shell 
particles obtained by pseudomorphic transformation to obtain uniform pore-channels should be 
applied at higher system pressure capabilities [10-12]. The benefit of increased heat dissipation 
favours the applicability of miniaturized column i.d. at increased pressure due to the decreased 
impact of frictional heating [13]. Furthermore, sample enrichment techniques as well as 
approaches to increase the injection volume need to be further developed to increase detection 
sensitivity to take full advantage of decreased dilution by the column volume. In general, this 
topic is of huge interest as can be identified by previously published approaches like online 
solid phase extraction hyphenated to nano-LC as well as temperature-assisted on column solute 
focusing [14-16]. In addition, the development of even more sensitive and micro-LC compatible 
detection techniques is mandatory to obtain a diverse repertoire of different detection 
capabilities and to ensure higher acceptance of these miniaturized chromatographic systems. 
 
 
  
General conclusions and outlook  202 
 
8.1 References 
[1]  S. Fekete, I. Kohler, S. Rudaz, D. Guillarme, Importance of instrumentation for fast liquid 
chromatography in pharmaceutical analysis, J. Pharm. Biomed. Anal., 87 (2014) 105-119. 
[2]  M.R. Euerby, M. James, B.O. Axelsson, O. Rosen, P. Petersson, Validation of the 
extended Tanaka column characterization protocol by multivariate analysis of 
chromatographic retention of low-molecular-weight analytes on reversed phase columns 
using methanol and acetonitrile as organic modifiers, J. Sep. Sci., 35 (2012) 2592-2598. 
[3]  T. Hetzel, D. Loeker, T. Teutenberg, T.C. Schmidt, Characterization of the efficiency of 
microbore liquid chromatography columns by van Deemter and kinetic plot analysis, J. 
Sep. Sci., 39 (2016) 3889–3897. 
[4]  G. Desmet, S. Eeltink, Fundamentals for LC Miniaturization, Anal. Chem., 85 (2013) 
543-556. 
[5]  T. Hetzel, C. Blaesing, M. Jaeger, T. Teutenberg, T.C. Schmidt, Characterization of peak 
capacity of microbore liquid chromatography columns using gradient kinetic plots, J. 
Chromatogr. A, 1485 (2017) 62-69. 
[6]  S. Fekete, J. Fekete, The impact of extra-column band broadening on the chromatographic 
efficiency of 5 cm long narrow-bore very efficient columns, J. Chromatogr. A, 1218 
(2011) 5286-5291. 
[7]  S. Buckenmaier, C.A. Miller, T. van de Goor, M.M. Dittmann, Instrument contributions 
to resolution and sensitivity in ultra high performance liquid chromatography using small 
bore columns: Comparison of diode array and triple quadrupole mass spectrometry 
detection, J. Chromatogr. A, 1377 (2015) 64-74. 
[8]  G. Desmet, D. Cabooter, K. Broeckhoven, Graphical data representation methods to 
assess the quality of LC columns, Anal. Chem., 87 (2015) 8593-8602. 
[9]  G. Desmet, D. Clicq, P. Gzil, Geometry-independent plate height representation methods 
for the direct comparison of the kinetic performance of LC supports with a different size 
or morphology, Anal Chem, 77 (2005) 4058-4070. 
[10]  J. De Vos, M. De Pra, G. Desmet, R. Swart, T. Edge, F. Steiner, S. Eeltink, High-speed 
isocratic and gradient liquid-chromatography separations at 1500 bar, J. Chromatogr. A, 
1409 (2015) 138-145. 
[11]  F. Gritti, Impact of straight, unconnected, radially-oriented, and tapered mesopores on 
column efficiency: A theoretical investigation, J. Chromatogr. A, 1485 (2017) 70-81. 
[12]  T.-C. Wei, A. Mack, W. Chen, J. Liu, M. Dittmann, X. Wang, W.E. Barber, Synthesis, 
characterization, and evaluation of a superficially porous particle with unique, elongated 
pore channels normal to the surface, J. Chromatogr. A, 1440 (2016) 55-65. 
[13]  J. De Vos, K. Broeckhoven, S. Eeltink, Advances in ultrahigh-pressure liquid 
chromatography technology and system design, Anal. Chem., 88 (2016) 262-278. 
[14]  R.E. Wilson, S.R. Groskreutz, S.G. Weber, Improving the Sensitivity, Resolution, and 
Peak Capacity of Gradient Elution in Capillary Liquid Chromatography with Large-
Volume Injections by Using Temperature-Assisted On-Column Solute Focusing, Anal. 
Chem., 88 (2016) 5112-5121. 
[15]  M.A. Stravs, J. Mechelke, P.L. Ferguson, H. Singer, J. Hollender, Microvolume trace 
environmental analysis using peak-focusing online solid-phase extraction-nano-liquid 
chromatography-high-resolution mass spectrometry, Analytical and Bioanalytical 
Chemistry, 408 (2016) 1879-1890. 
[16]  S.R. Groskreutz, S.G. Weber, Temperature-assisted on-column solute focusing: A 
general method to reduce pre-column dispersion in capillary high performance liquid 
chromatography, J. Chromatogr. A, 1354 (2014) 65-74. 
 
List of abbreviations and symbols  203 
 
List of abbreviations and symbols 
% percent CXP cell exit potential 
%B percent of organic solvent D dilution factor 
(v/v) volume percent d10 cumulative 10% point of diameter 
< less-than d90 cumulative 90% point of diameter 
> greater-than DAD diode array detector 
°C degree Celsius dc column diameter 
µL microliter dd domain size 
µm micrometer Dm molecular diffusion coefficient 
2D-LC 
two-dimensional liquid 
chromatography 
DMSO dimethyl sulfoxide 
2D-LC-MS 
two-dimensional liquid 
chromatography mass spectrometry 
Doc docetaxel 
A Eddy diffusion Doxo doxorubicin 
Ax sampling area dp particle diameter 
Å angstrom DP declustering potential 
a, b ,c dimensionless Knox coeffcients e. g. exempli gratia 
A1, A2 cross sectional area E0 separation impedance 
ACN acetonitrile EP entrance potential 
AFC automatic flow control EPG embedded polar group 
ARC area related concentration Epi epirubicin 
B longitudinal diffusion ESI electrospray ionization 
BEH Ethylene Bridged Hybrid ESOP 
European Society of Oncology 
Pharmacy 
C mass transfer etc. et cetera 
c concentration eV electronvolt 
C18 octadecylsilane F flow rate 
CAD collision activated dissociation gas FA formic acid 
CAS Chemical Abstracts Service fg femtogram 
CE collision energy GS1 nebulizer gas 
CFD computational fluid dynamic GS2 heater gas 
Chip-LC chip liquid chromatography H plate height 
cm centimeter h reduced plate height 
CP cyclophosphamide H2O water 
cps counts per second Hmin minimum plate height 
CUR curtain gas hmin minimum reduced plate height 
List of abbreviations and symbols  204 
 
HPLC 
high performance liquid 
chromatography 
m/z mass-to-charge ratio 
HSS High Strength Silica mAU milli absorbance units 
Hz hertz MDL method detection limit 
i.d.  inner diameter MEWIP 
Monitoring-Effect Study of Wipe 
Sampling in Pharmacies 
ID inner diameter MFC microfluidic flow control 
IF ifosfamide mg milligram 
IMS ion mobility spectrometry micro-LC  micro-liquid chromatography 
IPA 2-propanol 
micro-LC-
MS/MS 
micro liquid chromatography 
tandem mass spectrometry 
IS ionization voltage min minutes 
k retention factor mL milliliter 
k* gradient retention factor mm millimeter 
ke 
retention factor at the point of 
elution 
MRM multiple reaction monitoring 
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comprehensive two-dimensional 
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Occupational Safety & Health 
Administration 
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P’ probability sxy covariance 
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PC principal component T temperature 
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ultra-high performance liquid 
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R2 coefficient of determination uopt optimum linear velocity 
rc column radius UV ultraviolet 
RP reversed phase v reduced velocity 
RSD relative standard deviation V volume of the wetting solution 
s seconds v1, v2 flow velocity 
S 
constant of the linear solvent 
strength model 
Vcap capillary volume 
S/N signal-to-noise ratio Vcol column volume 
s2 unexplained variance Vcol,eff effective column volume 
SAX strong anion exchange Vd,cor corrected gradient delay volume 
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delay volume SS stainless steel 
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Vdelay gradient delay volume σ²v,det variance of the detector 
Vdet detector volume σ²v,ec extra-column variance 
Vdwell gradient dwell volume σ²v,ec,cap variance of the capillaries 
Veff effective column volume σ²v,ec,det variance of the detector 
Vinj injection volume σ²v,ec,inj variance of the injector 
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w̅ average peak width σ²v,total total system variance 
w4σ,ec extra-column peak width Φ flow resistance 
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ZDV zero-dead volume   
α selectivity factor   
α* gradient selectivity factor   
γ tortuosity factor   
Δ delta   
Δ(klast-kfirst) 
difference of the retention factor 
between the first and last eluting 
compound 
  
Δktotal available chromatographic space   
ΔP backpressure   
ΔPec  extra-column backpressure   
ΔPexp  experimental pressure drop   
ΔPmax maximum backpressure   
ΔPsystem system backpressure   
ΔPtotal total backpressure   
Δϕ 
change in mobile phase 
composition 
  
ε porosity   
η mobile phase viscosity   
λ length-elongation factor   
ξ peak capacity production rate   
σ standard deviation   
σ2 peak variance   
σ²ec extra-column variance   
σ²v,cap variance of the capillaries   
σ²v,col variance of the column   
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